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1. Syntheses 
 
1.1. General methods 
 
Analytical characterization of the synthesized compounds was done by common methods.  
Melting Points were determined on Büchi SMP or a Lambda Photometrics OptiMelt MPA 
100 and are uncorrected. IR Spectra were recorded with a Bio-Rad FT-IR Excalibur FTS 
3000. Absorption  spectra were  recorded  on  a  Varian  Cary  BIO  50 UV/VIS/NIR  spectro-
meter  with temperature  control  using 1  cm  quartz  cuvettes  (Hellma) and Uvasol  solvents  
(Merck, Baker or Acros). Fluorescence measurements were performed with UV-grade 
solvents (Baker or Merck) in 1 cm quartz cuvettes (Hellma) and recorded on a Varian ‘Cary 
Eclipse’ fluorescence spectrophotometer with temperature control. Electro spray mass spectra 
were performed on a Finnigan MAT TSQ 7000 ESI-spectrometer. Other Mass Spectra were 
recorded on Varian CH-5 (EI), Finnigan MAT 95 (CI; FAB and FD); Xenon serves as the 
ionization gas for FAB. 
NMR spectra were recorded on Bruker Avance 600 (1H: 600.1 MHz, 13C: 150.1 MHz, T = 
300 K), Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, T = 300 K) or Bruker Avance 
300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 300 K) relative to external standards. NMR spectra 
were recorded in CDCl3 at 300 MHz (
1H) or 75 MHz (13C) unless stated otherwise. 
Characterization of the signals: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
bs = broad singlet, dd = double doublet, dt = double triplet, ddd = double double doublet. 
Integration  is  determined  as  the  relative  number  of  atoms,  the  coupling  constants  are  
given  in Hertz  [Hz]. The multiplicity of the carbon atoms is given as (+] = CH3 or CH, (-] = 
CH2 and (Cquat) for quaternary carbon atoms. Structural assignments are based on DEPT and 
COSY experiments where applicable. Error of reported values: chemical shift: 0.01 ppm for 
1H-NMR, 0.1 ppm for 13C-NMR and 0.1 Hz for coupling constants. The solvent used is 
reported for each spectrum.  
Analytical TLC plates (silica gel 60 F254) and silica gel 60 (70-230 or 230-400 mesh) were 
used for chromatographic separations. Visualization of the spots was by UV light and/or 
staining with phosphomolybdate or ninhydrin, both in ethanol. DMF, CH3CN, CHCl3, THF, 
and Et2O were dried by standard procedures and stored over molecular sieves. PE means 
petrol ether with a boiling range of 70 - 90 oC. All other solvents and chemicals were of 
reagent grade and used with out further purification. 
All test substances were of pro analysi grade, checked by NMR or HPLC and used as 
purchased with out further purification.  
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The Solvents for the fluorescence measurements were from special spectroscopic purity 
purchased from Acros or Baker or Uvasol from Merck. Millipore water (18 MΩ, Milli QPlus) 
was used; the HEPES buffer was from according purity, suitable for biochemical optical 
screenings. As far as not stated differently tetraethylammoniumhydroxide or 0.1 molar 
hydrochloric acid both analytical grade were used to adjust the pH in the titrations and 
screenings. 
Reagents were used as received. DMF was purchased anhydrous (Fluka) and used as 
received. Other solvents used were reagent or pro analysi grade, THF was dried over sodium 
and distilled. Chloroform was dried over CaCl2 and P2O5 and distilled. Acetonitrile was dried 
over CaH2 and distilled. Pyrene-1-carboxylic acid
1 is commercially available. All reagents 
were used as received (Merck, Aldrich, Fluka). 1-N-tertbutoxycarbonyl isothiourea,2 1,3-
di(tertbutoxycarbonyl) isothiourea,2 1-N-tertbutoxycarbonylamino-ethyl-2-isothiocyanate2 and 
1,3-di(tertbutoxycarbonyl) guanidine-ethyl-2-amine3 were prepared after literature known 
prescriptions. 
 
 
1.2. Syntheses of building blocks 
 
1.2.1. Simple building blocks and comparison material 
 
1-(
tert
Butyloxycarbonyl)-3-acetyl-2-methyl-2-isothiourea (9) (literature known
4
, improved 
synthesis) 
N NH
S
O
O
O
 
1-N-Boc-2-methyl-2-isothiourea (1.90 g, 10.0 mmol) was dissolved in 30 mL of DCM 
containing 4.0 mL triethylamine (3.03 g, 30.0 mmol). Under cooling in an ice bath and 
vigorous stirring acetanhydride (1.42 mL, 1.53 g, 15.0 mmol) was added drop wise. The 
mixture was stirred 2 h at room temperature, then diluted with 70 mL of ethyl acetate, washed 
with 5 % aqueous acetic acid and three times with water. The organic phase was dried over 
MgSO4 and evaporated at reduced pressure. The remaining solid was purified by column 
chromatography with ethyl acetate / petrol ether 1:2 to isolate the product as a white solid 
(2.04 g, 93 %).  
 
M.p. = 83 – 84 °C (uncorrected); - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.42 (s, 9 H), 
2.16 (s, 3 H), 2.31 (s, 3 H), 12.10 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] =14.4 (+, 
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1 C), 24.6 (+, 1 C), 28.0 (+, 3 C), 81.3 (Cquat, 1 C), 160.9 (Cquat, 1 C), 168.4 (Cquat, 1 C), 171.3 
(Cquat, 1 C); - MS (ESI(+), DCM/MeOH  +  10 mmol NH4OAc): m/z (%) = 231.4 (100, 
MH+); - MF: C9H16N2O3S – FW: 232.3 g/mol; 
 
 
1-(
tert
Butyloxycarbonyl)-3-(pyrene-1-carbonyl)-2-methyl-2-isothiourea (29) (literature known 
compound,
5
 alternative procedure) 
N
H
N
S
O
OO
 
Pyrene-1-carboxylic acid1 (490 mg, 2.0 mmol) was suspended in a 1:1 mixture of DMF and 
DCM (2.0 mL), triethylamine (0.36 mL, 0.30 g, 3.0 mmol), HOBt (324 mg, 2.4 mmol) and 
DCC (497 mg, 2.4 mmol) were added and it was stirred for 30 mins in an ice bath. 1-N-Boc-
2-methyl-2-isothiourea (380 mg, 2.0 mmol) was added in one portion and the mixture was 
stirred for 2 h at room temperature, and then heated to 40 °C for 4 h under nitrogen. The 
solvents were evaporated, the residue was suspended in 10 mL of ethyl acetate, the solution 
was filtered and the filtrate was washed with 5 % ammonium chloride solution once and three 
times with water (5 mL). The organic phase was dried over MgSO4 and evaporated to 
dryness. The remaining solid was purified by flash chromatography with ethyl acetate / petrol 
ether 1:9 to yield 372 mg of a fine yellow powder (1.78 mmol, 89 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.53 (s, 9 H), 2.74 (s, 3 H), 8.03 – 8.19 (m, 2 H), 
8.20 – 8.31 (m, 5 H), 8.93 (m, 1 H), 9.47 (m, 1 H); - IR (KBr): ν [cm-1] = 3042 (m), 2980 
(m), 2930 (m), 1743 (m), 1707 (m), 1643 (m), 1597 (m), 1537 (s), 1504 (m), 1391 (m), 1362 
(m), 1324 (m), 1251 (m), 1229 (m), 1135 (s), 1086 (m), 1052 (m), 845 (m), 767 (m), 711 (m); 
- MS (ESI(+), DCM/MeOH  +  10 mmol NH4OAc): m/z (%) = 419.5 (100, MH
+);+); - MF: 
C24H22N2O3S – FW: 418.52 g/mol; 
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1-(
tert
Butyloxycarbonyl)-3-benzyl-2-(pyrene-1-carbonyl)-guanidine (35) 
N
H
N
H
O
N
O
O
 
Compound 29 (210 mg, 0.5 mmol) was dissolved in DMF (3 mL), benzylamine (200 µl,  
190 mg, 1.6 mmol) and mercury(II)chloride (150 mg, 0.6 mmol) were subsequently added. 
The mixture was stirred for 6 h, and then warmed to 40 °C for 1 h. It was diluted with ethyl 
acetate (30 mL), washed twice with 10 % aqueous citric acid and two times with water. The 
organic phase was dried over MgSO4 and evaporated at reduced pressure. The remaining solid 
was purified by flash chromatography with ethyl acetate / petrol ether 1:9. The product was 
isolated as a white solid (218 mg, 0.456 mmol, 91 %). 
 
M.p. = 105 – 107 °C (uncorrected); - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.52 (s, 6 H), 
1.53 (s, 3 H), 4.88 (m, 2 H), 7.29 – 7.47 (m, 5 H), 7.96 – 8.29 (m, 7 H), 8.71 (d, 1 H, J = 4.6 
Hz), 8.98 (bs, 1 H), 9.32 (d, 1 H, J = 4.6 Hz), 9.68 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ 
[ppm] = 28.2 (+, 2 C), 28.3 (+, 1 C), 45.2 (-, 1 C), 82.4 (Cquat, 1 C), 124.1 (+, 1 C), 124.6 
(Cquat, 1 C), 124.7 (+, 1 C), 125.2 (Cquat, 1 C), 125.6 (+, 1 C), 125.7 (+, 1 C), 125.9 (+, 1 C), 
126.0 (Cquat, 1 C), 127.6 (+, 1 C), 127.8 (+, 2 C), 127.9 (+, 1 C), 128.2 (+, 1 C), 128.8 (+, 3 
C), 130.5 (Cquat, 1 C), 130.6 (Cquat, 1 C), 131.1 (Cquat, 1 C), 133.1 (Cquat, 1 C), 136.7 (Cquat, 1 
C), 156.3 (Cquat, 1 C), 181.1 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3317 (bm), 3036 (m), 2968 
(m), 2929 (m), 1716 (m), 1599 (s), 1574 (s), 1503 (m), 1396 (m), 1359 (m), 1329 (s), 1257 
(m), 1141 (s), 1112 (m), 1046 (m), 994 (m), 910 (m), 842 (m), 812 (m), 731 (m), 707 (m); - 
MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 478.0 (100, MH
+); - HRMS 
(EI-MS 70eV): calc. for C30H27N3O3
*+: 477.2052, found: 477.2046; +); - MF: C30H27N3O3 – 
FW: 477.57 g/mol; 
 
 
1-Benzyl-2-(pyrene-1-carbonyl)-guanidine hydrochloride (36) 
N
H
2
+
NH
2
O
N
Cl
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Compound 35 (192 mg, 0.4 mmol) was dissolved in 2 mL of DCM, 0.5 mL of HCl saturated 
diethylether was added and the mixture was stirred 2 h at room temperature. Diethylether  
(3 mL) was added, the product was allowed to settle completely and the solvent was decanted 
off. After drying at the pump the product was isolated as a faintly yellow, fine powder  
(74 mg, 0.192 mmol, 96 %). 
 
M.p. = 164 – 169 °C (decomp.); - 1H-NMR (300 MHz, DMSO-d6): δ [ppm] = 4.72 (m, 2 H), 
7.39 – 7.56 (m, 5 H), 8.33 – 8.51 (m, 7 H), 8.67 (d, 1 H, J = 4.6 Hz), 9.11 (d, 1 H, J = 4.6 Hz), 
9.19 (bs, 1 H), 9.81 (bs, 1 H); - 13C-NMR (75 MHz, DMSO-d6): δ [ppm] = 44.3 (-, 1 C), 
123.7 (Cquat, 1 C), 123.9 (+, 1 C), 124.2 (+, 1 C), 126.3 (+, 1 C), 126.4 (+, 1 C), 126.5 (Cquat,  
1 C), 126.6 (+, 1 C), 127.0 (+, 2 C), 127.4 (+, 1 C), 127.7 (+, 1 C), 128.0 (+, 1 C), 128.2 (+, 1 
C), 128.6 (Cquat, 1 C), 128.6 (+, 2 C), 129.4 (+, 1 C), 129.6 (Cquat, 1 C), 129.8 (Cquat, 1 C), 
130.5 (Cquat, 1 C), 133.5 (Cquat, 1 C), 135.6 (Cquat, 1 C), 153.7 (Cquat, 1 C), 176.1 (Cquat, 1 C); - 
IR (KBr): ν [cm-1] = 3320 (bm), 2972 (m), 2931 (m), 2876 (m), 1719 (m), 1597 (s), 1576 (s), 
1505 (m), 1398 (m), 1361 (m), 1327 (m), 1256 (m), 1145 (s), 1113 (m), 1048 (m), 996 (m), 
911 (m), 842 (m), 810 (m), 732 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): 
m/z (%) = 478.0 (100, MH+); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) 
= 378.0 (100, MH+), 419.0 (27, (M+MeCN)H+), 755.1 (17, 2MH+); - HRMS (EI-MS 70 eV): 
calc. for C25H19N3O
*+: 377.1528, found: 377.1528; - UV (MeOH): λ (ε) = 238 (52000), 277 
(47000), 238 (68000); - MF: C25H20N3OCl – FW: 413.91 g/mol; 
 
 
N,N,N-Trimethyl-propargyl-ammonium iodide (23) (literature known,
6
 improved synthesis) 
 
N
+
I
 
 
Propargylamine (110 mg, 0.14 mL, 2.0 mmol) was dissolved in 3 mL of acetonitrile. Methyl 
iodide (1430 mg, 0.63 mL, 10.0 mmol) and potassium carbonate (690 mg, 5.0 mmol) were 
added and the suspension vigorously stirred over night under light protection and protective 
gas atmosphere in a water bath. All volatiles were removed at reduced pressure and the 
remaining salt mixture was suspended in 10 mL of dichloromethane. The inorganic salts were 
filtered off and washed with small amounts of DCM. The filtrate was evaporated to give the 
crude material, which was recrystallised from isopropanol to yield the product as fine 
crystalline, pale brown powder (447 mg, 1.98 mmol, 99 %). 
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M.p. > 139 °C (decomp.); - 1H-NMR (300 MHz, MeOD): δ [ppm] = 3.24 (s, 9 H), 4.41 (s, 2 
H), 4.76 (s, 1 H); - 13C-NMR (75 MHz, MeOD): δ [ppm] = 14.2 (+, 1 C), 53.6 (+, 3 C), 57.3 
(-, 1 C), 143.2 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3170 (s), 3005 (m), 2945 (m), 2123 (m), 
1970 (w), 1506 (m), 1472 (s), 1435 (m), 1406 (m), 1363 (m), 1276 (m), 1237 (m), 1131 (m), 
1066 (m), 964 (m), 924 (m), 899 (s), 765 (m), 723 (s); - MS (ESI-MS, CH2Cl2/MeOH + 10 
mmol NH4OAc): m/z (%) = 97.8 (100 %, M
+); - MF: C6H12NI – FW: 225.07 g/mol; 
 
 
N,N,N-Trimethyl-4-azido-anilinium iodide (20) (literature known,
7
 improved synthesis route) 
 
N
+
N
3I
 
 
The 4-iodoaniline (2.19 g, 10.0 mmol) was dissolved in ethanol (25 mL), 1,2-N,N-
dimethylethylendiamine (0.13 g, 1.42 mmol), three drops 1M aqueous NaOH, ascorbatic acid 
(0.1g, 0.57 mmol) and sodium azide (1.3 g, 20.0 mmol) were added. The atmosphere in the 
flask was exchanged by nitrogen and copper(I)iodide (0.25g, 1.31 mmol) was quickly added. 
The solution was stirred for 90 mins. at room temperature under the protective nitrogen 
atmosphere and was then added to a vigorously stirred 1:1 mixture of ethyl acetate and brine 
(100 mL). The organic phase was separated and the aqueous phase was extracted trice with 
ethyl acetate (20 mL). The combined organic phases were dried over MgSO4, the solvent was 
evaporated and the residue was purified by column chromatography with ethyl acetate. The 
product 4-azidoaniline8 was pale brown oil (1.32 g, 9.62 mmol, 96 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 3.58 (bs, 2 H), 6.61 (d, 2 H, J = 5.3 Hz), 6.82 (d, 2 
H, J = 5.3 Hz); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 116.3 (+, 2 C), 120.0 (+, 2 C), 130.2 
(Cquat, 1 C), 143.8 (Cquat, 1 C); - MS (CI-MS, NH3): m/z (%) = 107.0 (100, ((M-N2)+H
+)), 
135.0 (12, MH+); - MF: C6H6N4 – FW: 134.14 g/mol; 
 
The above product (1.21 g, 9.0 mmol) was dissolved in 35 mL of methanol. Methyl iodide 
(5.15 g, 2.28 mL, 36.0 mmol) and potassium carbonate (4.14 g, 30.0 mmol) were added. The 
reaction mixture was heated to 50 °C over night. After cooling to room temperature, all 
volatiles were evaporated and the remaining salt mixture was suspended in 60 mL of 
dichloromethane. The inorganic salts were filtered off, washed with small amounts of DCM. 
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The filtrate was evaporated to give the crude product, which was purified by recrystallisation 
from isopropanol / ethyl acetate to yield N,N,N-trimethyl-4-azido-anilinium iodide as pale 
yellow crystal plates (2.41 g, 7.92 mmol, 88 %). 
 
M.p. > 145 °C (decomp.); - 1H-NMR (300 MHz, MeOD): δ [ppm] = 3.71 (s, 9 H), 7.28 (d, 2 
H, J = 5.3 Hz), 7.93 (d, 2 H, J = 5.3 Hz); - 13C-NMR (75 MHz, MeOD): δ [ppm] = 58.0 (+, 3 
C), 121.7 (+, 2 C), 123.2 (+, 2 C), 144.0 (Cquat, 1 C), further signals were not detectable; - IR 
(KBr): ν [cm-1] = 3380 (bm), 3010 (m), 2980 (m), 2408 (w), 2254 (w), 2116 (s), 2090 (s), 
1602 (m), 1506 (s), 1483 (m), 1456 (m), 1410 (m), 1284 (s), 1202 (m), 1177 (m), 1133 (m), 
1120 (m), 1009 (m), 958 (m), 936 (m), 914 (m), 850 (m), 838 (m), 711 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 176.8 (100, M
+); C9H13N4I: calcd.: C 35.5 H 
4.3 N 18.4, found: C 35.2 H 4.1 N 18.2; - MF: C9H13N4I – FW: 304.13 g/mol; 
 
 
2-(2,3-di-(
tert
Butyloxycarbonyl)-guanidino)ethylamine (18) (literature known compound,
5
 
improved procedure) 
NH
N
H
N
O
O
NH
2
O
O
 
Ethylenediamine (6.6 mL, 6.0 g, 0.1 mol) was dissolved in DCM (70 mL), the solution was 
cooled in an ice bath and 1-N-tertbutyloxycarbonyl-methyl-isothiourea (1.90 g, 10.0 mmol) in 
80 mL DCM was added over 3 h to the vigorously stirred mixture. Stirring was continued for 
2 h at room temperature, then the mixture was warmed to 40 °C for 4 h. It was washed four 
times with water (50 mL) and dried over MgSO4. All volatiles were evaporated at reduced 
pressure to give the product as a white, oily solid (2.93 g, 9.70 mmol, 97 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.51 (s, 9 H), 2.86 (t, 2 H, J = 5.9 Hz), 3.47 (m, 2 H), 
8.68 (bs, 1 H), 11.52 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 28.1 (+, 3 C), 28.3 
(+, 3 C), 41.0 (-, 1 C), 43.4 (-, 1 C), 79.2 (Cquat, 1 C), 153.2 (Cquat, 1 C), 156.4 (Cquat, 1 C), 
163.6 (Cquat, 1 C); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 303.1 
(100, MH+), 247.0 (8, MH+-C4H8), 203.0 (6, MH
+-CO2 -C4H8); - MF: C13H26N4O4 – FW: 
302.38 g/mol;  
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14-[2-(Isothiocyanato)-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-
5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester 
(17) 
O
O
O
O
O
O
O
O
O
N
O
N
C
S  
Compound 4a (230 mg, 0.4 mmol) was dissolved in 1.0 mL of dichloromethane and 1.0 mL 
of a saturated aqueous sodium hydrogen carbonate solution was added. Under vigorous 
stirring in an ice bath 5.0 mL of a solution of thiophosgene (0.1 M, 0.5 mmol) in 
dichloromethane was slowly dropped in the mixture. After 5 h of stirring at room temperature 
the phases were separated and the organic solution was washed with 2.0 mL of brine and  
2.0 mL of water. The solution was dried and all volatiles were evaporated to give the product 
as clear, yellow oil (205 mg, 0.368 mmol, 92 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 2.81 (m, 4 H), 2.93 (m, 2 H), 3.56 – 3.71 (m, 12 H), 
3.72 – 3.79 (m, 4 H), 3.83 (s, 6 H), 3.88 – 3.93 (m, 4 H), 4.16 – 4.23 (m, 4 H), 7.16 (s, 2 H) - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 52.6 (+, 2 C), 54.3 (-, 1 C), 54.4 (-, 2 C), 68.9 (-, 1 
C), 69.0 (-, 2 C), 69.3 (-, 2 C), 69.4 (-, 2 C), 70.4 (-, 2 C), 70.6 (-, 2 C), 113.6 (+, 2 C), 125.6 
(Cquat, 2 C), 150.2 (Cquat, 2 C), 167.7 (Cquat, 2 C), 176.3 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 
2932 (m), 2875 (m), 2188 (m), 2108 (m), 1720 (m), 1598 (m), 1519 (m), 1436 (m), 1350 (m), 
1287 (s), 1195 (s), 1136 (s), 1058 (s), 978 (m), 947 (m), 863 (m), 798 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 557.1 (100, MH
+); - MF: C25H36N2O10S – 
FW: 556.64 g/mol; 
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1.2.2. General procedures for the Boc deprotection of the crown ether amino acids: 
 
 
N
H
O
O
O
O
O
O
O
O
O
O
O
N
O
n
 
N
H
O
O
O
O
O
O
O
O
O
O
O
N
O
E-1a   n = 1
E-1b   n = 2
E-1c   n = 3
E-1d
 
 
The crown ether amino acids were prepared as published.9 We deprotected their amine 
functionality by standard conditions10 with very good to quantitative yields. 
  
 R NH3
+
 R
NH
3
+
 NH3
+
R
 NH
3
+
R
N
H
S
NH
 
Starting material 1.28 g 1.34 g 1.38 g 1.43 g 
Yield of product 1.11 g (91 %) 1.11 g (87 %) 1.27 g (96 %) 1.37 g (83 %) 
Appearance 
Pale yellow 
powder 
Yellow powder 
Slightly yellow 
powder 
Pale brown powder 
Melting point 63 – 64 °C 66 – 68 °C 70 – 71 °C 74 – 75 °C 
Table S-1: Amounts of starting material, yields, appearance and melting points (HCl salts) 
 
General procedures for the Boc deprotection with HCl in diethylether (GP I): The according 
starting material (2.0 mmol) was dissolved in 10 mL of dry dichloromethane and a saturated 
solution of hydrochloric acid in diethyl ether (4 mL) was added. After three hours of stirring 
at room temperature the HCl gas was removed in a N2 stream. All volatiles were evaporated 
at reduced pressure. The residue was taken up in a minimum amount of dichloromethane and 
the product was precipitated carefully by slow addition of diethyl ether. The solution was 
decanted off the precipitate, it was washed once with diethyl ether, decanted off again and the 
product was finally dried under reduced pressure to furnish a hygroscopic powder. 
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General procedures for the Boc deprotection with TFA (GP II): The according starting 
material (2.0 mmol) was dissolved in 8 mL of dichloromethane and TFA (2 mL) was slowly 
added. After four hours of stirring at room temperature, all volatiles were evaporated at 
reduced pressure. The residue was taken up in a minimum amount of dichloromethane and the 
product was precipitated carefully by slow addition of diethyl ether. The solution was 
decanted off the precipitate and the product was dried in the vacuum to furnish hygroscopic 
sticky syrup. 
 
14-[4-Amino-butyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-
hexaoxa-14-aza-benzocyclohenicosene-2,3-dicarboxylic acid dimethylester hydrochloride 
(4b) 
O
O
O
O
O
O
O
O
O
N
+
O
NH
3
+
H
 
The according Boc protected compound E-1b (1.28 g, 2.0 mmol) was deprotected according 
to GP I. After drying a yellow, hygroscopic solid (1.11 g, 1.81 mmol, 91 %) is obtained. 
 
M.p. = 63 – 64 °C - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.82 (m, 2 H), 1.95 (m, 2 H), 
3.03 (m, 2 H), 3.27 (m, 2 H), 3.41 – 3.60 (m, 4 H), 3.60 – 3.75 (m, 8 H), 3.75 – 4.05 (m, 8 H), 
3.81 (s, 6 H), 4.16 (m, 4 H), 7.14 (s, 2 H), 8.24 (bs, 3 H, NH3
+), 10.03 (bs, 1 H, NH+); - 13C-
NMR (75 MHz, CDCl3): δ [ppm] = 21.2 (-, 1 C), 24.3 (-, 1 C), 39.1 (-, 1 C), 52.6 (+, 2 C), 
53.4 (-, 1 C), 54.2 (-, 2 C), 65.5 (-, 2 C), 68.9 (-, 2 C), 69.4 (-, 2 C), 70.4 (-, 2 C), 70.8 (-, 2 C), 
113.3 (+, 2 C), 125.4 (Cquat, 2 C), 150.2 (Cquat, 2 C), 167.7 (Cquat, 2 C); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 543.4 (100, MH
+), 272.1 (6, (M+2H+)2+); - 
MF: C26H44N2O10Cl2 – FW: 615.55 g/mol; 
 
 
14-[6-Amino-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-
hexaoxa-14-aza-benzocyclohenicosene-2,3-dicarboxylic acid dimethylester hydrochloride 
(4c) 
NH
3
+
O
O
O
O
O
O
O
O
O
N
+
O
H
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Compound E-1c (1.34 g, 2.0 mmol) was deprotected according to GP I. After drying a 
yellow, hygroscopic solid (1.11 g, 1.74 mmol, 87 %) is obtained. 
 
M.p. = 66 – 68 °C - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.29 (m, 2 H), 1.39 (m, 2 H), 
1.73 (m, 4 H), 2.93 (m, 2 H), 3.19 (m, 2 H), 3.21 – 3.75 (m, 14 H), 3.75 – 4.03 (m, 8 H), 3.81 
(s, 6 H), 4.16 (m, 4 H), 7.14 (s, 2 H), 8.16 (bs, 3 H, NH3
+), 10.15 (bs, 1 H, NH+); - 13C-NMR 
(75 MHz, CDCl3): δ [ppm] = 23.0 (-, 1 C), 25.4 (-, 1 C), 25.6 (-, 1 C), 26.4 (-, 1 C), 39.6 (-, 1 
C), 52.7 (+, 2 C), 53.3 (-, 1 C), 54.6 (-, 2 C), 65.4 (-, 2 C), 68.7 (-, 2 C), 69.4 (-, 2 C), 70.4 (-, 
2 C), 70.7 (-, 2 C), 113.1 (+, 2 C), 124.5 (Cquat, 2 C), 150.1 (Cquat, 2 C), 167.7 (Cquat, 2 C); - 
MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 571.3 (100, MH
+), 296.2 (17, 
(M+2H+)2+); - MF: C28H48N2O10Cl2 – FW: 643.60 g/mol; 
 
 
14-[(4-Aminomethyl)phenyl)methyl-amino]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid 
dimethylester hydrochloride (4d) 
O
O
O
O
O
O
O
O
O
N
+
O
NH
3
+
H
 
Compound E-1d (1.38 g, 2.00 mmol) was reacted according to GP I. The product was dried at 
reduced pressure to yield 4d as a yellow, hygroscopic solid (1.27 g, 1.75 mmol, 96 %). 
 
M.p. = 70 – 71 °C - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 3.32 (m, 4 H), 3.48 – 3.72 (m, 8 
H), 3.72 – 4.22 (m, 14 H), 3.79 (s, 6 H), 4.52 (m, 2 H), 6.96 (s, 2 H), 7.35 (m, 2 H), 7.46 (m, 2 
H), 8.40 (bs, 1 H), 10.55 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 43.1 (-, 1 C), 
52.8 (+, 2 C), 57.8 (-, 1 C), 65.7 (-, 2 C), 68.5 (-, 4 C), 69.3 (-, 2 C), 70.2 (-, 2 C), 70.4 (-, 2 
C), 112.6 (+, 2 C), 125.1 (Cquat, 2 C), 129.9 (Cquat, 1 C), 130.1 (+, 2 C), 132.2 (+, 2 C), 134.2 
(Cquat, 1 C), 149.7 (Cquat, 2 C), 167.7 (Cquat, 2 C); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 591.4 (100, MH
+), 296.1 (19, MH2
2+); - MF: C30H44N2O10Cl2 – FW: 
663.59 g/mol; 
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14-[2-(3-(2-Aminoethyl)thioureido)ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl 
ester hydrochloride (4e) 
O
O
O
O
O
O
O
O
O
N
+
O
N
H
N
H
S
NH
3
+
 
Compound 6 (1.43 g, 1.00 mmol) was deprotected after GP I. The product was dried at 
reduced pressure to furnish a yellow, hygroscopic solid (1.37 g, 1.65 mmol, 83 %). 
 
M.p. (uncorrected) = 74 – 75 °C; - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 2.95 – 3.05 (m, 2 
H), 3.30 (m, 2 H), 3.53 – 3.72 (m, 14 H), 3.77 – 4.01 (m, 10 H), 3.82 (s, 6 H), 4.14 – 4.19 (m, 
4 H), 7.16 (s, 2 H), 7.86 (bs, 1 H), 8.23 (bs, 3 H), 9.74 (bs, 1 H); - 13C-NMR (75 MHz, 
CDCl3): δ [ppm] = 39.8 (-, 1 C), 41.7 (-, 1 C), 52.7 (+, 2 C), 53.7 (-, 1 C), 53.8 (-, 1 C), 65.5 (-
, 2 C), 68.9 (-, 2 C), 69.5 (-, 2 C), 70.4 (-, 4 C), 70.7 (-, 2 C), 113.5 (+, 2 C), 125.4 (Cquat, 2 C), 
150.3 (Cquat, 2 C), 167.8 (Cquat, 2 C), 182.8 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3226 (bm), 
2937 (m), 2882 (m), 2184 (w), 2062 (w), 1935 (w), 1720 (m), 1550 (m), 1521 (m), 1437 (m), 
1349 (m), 1288 (s), 1195 (s), 1125 (s), 1062 (m),  977 (m), 918 (m), 782 (m), 729 (m), 643 
(m), 602 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 617.3 (63 %, 
MH+), 309.1 (100%, (M + 2H+)2+); - MF: C27H46N4O10SCl2 – FW: 689.65 g/mol;  
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1.3. Syntheses and deprotections of the receptors 
 
1.3.1. Cbz protected guanidines 
 
14-[2-[2,3-di-(Benzyloxycarbonyl)-guanidino]-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (E-2) 
N
O
O
O
O
O
O
O
O
O
N
O
N
H
NH
O
O
O
O
 
Compound 4a (0.59 g, 1.0 mmol) was stirred with triethylamine (0.4 g, 4.0 mmol) in DMF 
(20 mL) for 15 minutes at room temperature. 1,3-Bis(benzyloxycarbonyl)-2-methyl-2-
thiopseudourea (0.72 g, 2.0 mmol) and mercury(II)chloride (0.54 g, 2.00 mmol) were 
subsequently added in several small portions. The mixture was again stirred at room 
temperature over night. The reaction mixture was poured into 50 mL of water and the aqueous 
phase was extracted trice with 30 mL of DCM. The combined organic phases were washed 
two times with 20 mL of brine. After drying over MgSO4, the solvent was evaporated and the 
residue was purified via column chromatography (ethanol / ethyl acetate 3:1) to yield a clear, 
yellow oil (710 mg, 0.861 mmol, 86 %) (Rf = 0.2).  
 
1
H-NMR (400 MHz, CDCl3): δ [ppm] = 2.70 (m, 2 H), 2.78 (m, 4 H), 3.46 (m, 2 H), 3.58 (m, 
4H), 3.60 – 3.64 (m, 4 H), 3.72 – 3.76 (m, 4 H), 3.86 (s, 6 H), 3.87 – 3.94 (m, 4 H), 4.16 – 
4.21 (m, 4 H), 5.10 (s, 2 H), 5.15 (s, 2 H), 7.18 (s, 2 H), 7.28 – 7.39 (m, 10 H), 8.63 (bs, 1 H), 
11.68 (bs, 1 H) - 13C-NMR (100 MHz, CDCl3): δ [ppm] = 39.0 (-, 1 C), 52.5 (+, 2 C), 53.4 (-, 
1 C), 54.0 (-, 2 C), 67.0 (-, 1 C), 67.9 (-, 1 C), 69.4 (-, 2 C), 69.6 (-, 2 C), 70.7 (-, 2 C), 71.1 (-, 
2 C), 113.7 (+, 2 C), 125.3 (Cquat, 2 C), 127.8 (+, 2 C), 128.1 (+, 2 C), 128.2 (+, 2 C), 128.3 
(+, 2 C), 128.4 (+, 2 C), 128.6 (+, 2 C), 134.7 (Cquat, 1 C), 136.8 (Cquat, 1 C), 150.5 (Cquat, 2 
C), 153.4 (Cquat, 1 C), 155.7 (Cquat, 1 C), 163.6 (Cquat, 1 C), 167.8 (Cquat, 2 C); - IR (KBr): ν 
[cm-1] = 3320 (bm), 2947 (m), 2867 (m), 1723 (m), 1636 (m), 1586 (m), 1520 (m), 1433 (m), 
1380 (m), 1346 (m), 1284 (s), 1199 (s), 1123 (s), 1046 (s), 979 (m), 944 (m), 909 (m), 802 
(m), 726 (s), 697 (s), 645 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) 
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= 825.5 (100, MH+); - HRMS (PI-LSIMS FAB, glycerine): calc. for C41H53N4O14
+: 757.3558, 
found: 825.3546; - MF: C41H52N4O14 – FW: 824.89 g/mol; 
 
 
14-[2-Guanidino-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-
hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester (E-3) 
NH
O
O
O
O
O
O
O
O
O
N
O
N
H
NH
2   
Compound E-2 (206 mg, 0.25 mmol) were dissolved in methanol (10 mL) and three spatula 
tips of palladium catalyst on charcoal were added. After stirring for two days under 20 bar of 
hydrogen the catalyst was filtered off, washed trice with methanol and the solvent was 
evaporated to give the product E-3 (140 mg, 0.24 mmol, 97 %) as a clear, faintly yellow 
glass.  
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 2.60 – 2.65 (m, 6H), 3.16 – 3.21 (m, 2H), 3.48 – 
3.53 (m, 4 H), 3.59 – 3.62 (m, 4 H), 3.69 – 3.73 (m, 4 H), 3.81 – 3.92 (m, 4 H), 3.86 (s, 6 H), 
4.20 – 4.26 (m, 4 H), 7.17 (s, 2 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 41.6 (-, 1 C), 
52.7 (+, 2 C), 56.0 (-, 2 C), 57.0 (-, 1 C), 68.8 (-, 2 C), 69.1 (-, 2 C), 69.2 (-, 2 C), 70.8 (-, 2 
C), 71.3 (-, 2 C), 113.3 (+, 2 C), 125.7 (Cquat, 2 C), 149.8 (Cquat, 2 C), 159.2 (Cquat, 1 C), 167.6 
(Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3360 (bm), 2948 (m), 2874 (m), 1719 (m), 1663 (m), 1598 
(m), 1519 (m), 1435 (m), 1349 (m), 1285 (s), 1194 (s), 1184 (s), 1122 (s), 1029 (s), 976 (m), 
945 (m), 888 (m), 827 (m), 780 (m), 730 (m), 660 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 
mmol NH4OAc): m/z (%) = 557.4 (100, MH
+); - HRMS (PI-LSIMS FAB, glycerine): calc. 
for C25H41N4O10
+: 557.2823, found: 557.2825; - MF: C25H40N4O10 – FW: 556.62 g/mol; 
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1.3.2. General procedure for synthesis of the bis-Boc-protected guanidine moiety 
(isothiourea route, GP III) 
 
NH
N
H
N
R´
N
H
N
HS
bocboc
N
H
NH
N
R´
boc
boc
N
H
NH
NR´
n
 
boc
boc
O
O
O
O
O
O
O
O
O
N
O
= R´
13a   n = 1
13b   n = 2
13c   n = 3
13d   13e 
 
The according crown ether amino acid hydrochloride (0.3 mmol, approx. 200 mg) or TFA salt 
(0.3 mmol, approx. 300 mg) was dissolved in 5 mL of dried chloroform, freshly distilled 
triethylamine (1.0 mmol, 101 mg, 0.14 mL) was dropped in and the mixture was stirred for  
20 min. at room temperature. After addition of 290 mg of 1,3-bis(Boc)-2-methyl-2-
isothiourea (1.0 mmol), the well stirred solution was to heated to reflux under nitrogen 
atmosphere and held at this temperature for two days. 
The solution was cooled to room temperature, diluted with 30 mL of ethyl acetate and 
filtered. The filtrate was washed with saturated ammonium chloride solution (10 mL) and 
water (10 mL), dried over magnesium sulfate and the solvent was evaporated. After vacuum 
drying the crude product was purified by column chromatography on silica gel with ethyl 
acetate/ethanol or chloroform/methanol as eluent. (Rf ca. 0.2 to 0.3 in EtOAc / EtOH 3:1). 
 
14-[4-[2,3-di-(
tert
Butyloxycarbonyl)-guanidino]-butyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (13b) 
O
O
N
N
H
N
HO
O
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4b (185 mg, 0.30 mmol) was reacted according to GP III to give the product as a 
faintly yellow glass (176 mg, 0.224 mmol, 75 %) (Rf [CHCl3 / MeOH 10:1] = 0.2). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.41 (s, 9 H), 1.43 (s, 9 H), 1.45 – 1.49 (m, 4 H), 
2.55 (m, 2 H), 2.76 – 2.78 (m, 4 H), 3.33 – 3.35 (m, 2 H), 3.54 - 3.62 (m, 8 H), 3.66 - 3.69 (m, 
4 H), 3.81 (s, 6 H), 3.82 – 3.86 (t, 4 H), 4.12 – 4.16 (t, 4 H), 7.13 (s, 2 H), 8.24 (bs, 1 H); - 
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13
C-NMR (75 MHz, CDCl3): δ [ppm] = 26.8 (+, 1C), 28.1 (+, 3 C), 28.3 (+, 3 C), 40.6 (-, 1 
C), 52.6 (+, 2 C), 53.8 (-, 2 C), 55.1 (-, 1 C), 61.2 (-, 1 C), 69.3 (-, 4 C), 69.5 (-, 2 C), 70.6 (-, 
2 C), 71.1 (-, 2 C), 79.2 (Cquat, 1 C), 83.1 (Cquat, 1 C), 113.6 (+, 2 C), 125.3 (Cquat, 2 C), 150.5 
(Cquat, 2 C), 153.2 (Cquat, 1 C), 156.2 (Cquat, 1 C), 163.6 (Cquat, 1 C), 167.8 (Cquat, 2 C); - IR 
(KBr): ν [cm-1] = 3329 (bm), 2937 (m), 2870 (m), 1726 (m), 1631 (m), 1593 (m), 1520 (m), 
1433 (m), 1414 (m), 1327 (m), 1284 (s), 1180 (s), 1124 (s), 1051 (m), 981 (m), 915 (m), 876 
(m), 803 (m), 778 (m), 730 (m), 650 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 785.5 (31, MH
+), 393.3 (100, (M+2H+)2+); - UV (MeOH): λ (ε) = 267 
(7300), 224 (30300); - HRMS (PI-LSIMS FAB glycerine): calc. for C37H61N4O14
+: 785.4184, 
found: 785.4181; - MF: C37H60N4O14 – FW: 784.91 g/mol; 
 
 
14-[6-[2,3-di-(
tert
Butyloxycarbonyl)-guanidino]-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (13c) 
O
O
N
N
H
N
HO
O
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4c (195 mg, 0.30 mmol) is submitted to GP III to yield a yellow glass (124 mg, 
0.153 mmol, 51 %) (Rf [CHCl3 / MeOH 10:1] = 0.26). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.29 (m, 4 H), 1.48 (s, 9 H), 1.49 (s, 9 H), 1.40 – 
1.49 (m, 4 H), 2.51 (m, 2 H), 2.78 (m, 4 H), 3.34 – 3.37 (m, 2 H), 3.56 - 3.70 (m, 8 H), 3.72 - 
3.78 (m, 4 H), 3.86 (s, 6 H), 3.88 – 3.91 (t, 4 H), 4.16 – 4.21 (t, 4 H), 7.13 (s, 2 H), 8.24 (bs, 1 
H), 11.61 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 26.8 (-, 1 C), 26.9 (-, 1C), 27.1 
(-, 1 C), 28.1 (+, 3 C), 28.3 (+, 3 C), 29.0 (-, 1 C), 40.9 (-, 1C), 52.6 (+, 2 C), 53.9 (-, 2 C), 
55.6 (-, 1 C), 69.3 (-, 2 C), 69.5 (-, 4 C), 70.7 (-, 2 C), 71.1 (-, 2 C), 79.2 (Cquat, 1 C), 83.1 
(Cquat, 1 C), 113.6 (+, 2 C), 125.4 (Cquat, 2 C), 150.5 (Cquat, 2 C), 153.3 (Cquat, 1 C), 156.1 
(Cquat, 1 C), 163.7 (Cquat, 1 C), 167.8 (Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3334 (bm), 2934 (m), 
2868 (m), 1721 (m), 1633 (m), 1591 (m), 1519 (m), 1415 (m), 1328 (m), 1284 (s), 1126 (s), 
1053 (s), 982 (m), 916 (m), 805 (m), 779 (m), 731 (m), 646 (m); - MS (ESI-MS, 
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CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 813.5 (72 %, MH
+), 393.2 (100 %, 
(M+2H+)2+); - UV (MeOH): λ (ε) = 267 (7300), 223 (30500); - HRMS (PI-LSIMS FAB 
glycerine): calc. for C39H65N4O14
+: 813.4497, found: 813.4495; - MF: C39H64N4O14 – FW: 
812.96 g/mol; 
 
 
14-[2-(3-(2-(2,3-di-(
tert
Butyloxycarbonyl)-guanidinoethyl)thioureido)ethyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester (13e) 
O
O
N
N
H NH
O
O
O
O
O
O
O
O
O
O
O
N
O
N
H
N
H
S
 
Conversion of compound 4e (210 mg, 0.30 mmol) according GP III yields 13e as a faintly 
yellow glass (107 mg, 0.126 mmol, 42 %) (Rf [CHCl3 / MeOH 12:1] = 0.26; Rf [EtOAc / 
EtOH 3:1] = 0.1). 
 
Alternative route: 
Compound 17 (170 mg, 0.3 mmol) was stirred with compound 18 (182 mg, 0.6 mmol) in dry 
ethanol for 1 h at room temperature, then the solution was slowly heated to reflux and held at 
this temperature over night. The solvent was evaporated and the oily residue was purified by 
column chromatography with ethyl acetate / ethanol 6:1. The product appears as yellow, 
sticky oil (166 mg, 0.193 mmol, 65 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.43 (s, 9 H), 1.46 (s, 9 H), 2.71 – 2.83 (m, 6 H), 
3.53 – 3.55 (m, 4 H), 3.56 – 3.64 (m, 8 H), 3.67 – 3.74 (m, 4 H), 3.79 – 3.86 (m, 4 H), 3.84 (s, 
6 H), 4.12 – 4.20 (m, 4 H), 7.14 (s, 2 H), 8.53 (bs, 1 H), 9.91 (bs, 1 H), 10.01 (bs, 1 H); - 13C-
NMR (75 MHz, CDCl3): δ [ppm] = 28.1 (+, 3 C), 28.4 (+, 3 C), 29.3 (-, 1 C), 40.2 (-, 1 C), 
43.6 (-, 1 C), 52.6 (+, 2 C), 53.8 (-, 1 C), 54.0 (-, 2 C), 69.3 (-, 2 C), 69.6 (-, 2 C), 70.2 (-, 2 
C), 70.7 (-, 2 C), 71.2 (-, 2 C), 79.1 (Cquat, 1 C), 81.2 (Cquat, 1 C), 113.3 (+, 2 C), 125.4 (Cquat, 
2 C), 150.5 (Cquat, 2 C), 153.0 (Cquat, 1 C), 163.4 (Cquat, 1 C), 166.0 (Cquat, 2 C), 167.8 (Cquat, 1 
C); - IR (KBr): ν [cm-1] = 3326 (m), 3299 (m), 2922 (m), 2867 (m), 2132 (m), 1724 (m), 
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1617 (m), 1577 (m), 1520 (m), 1434 (m), 1411 (m), 1346 (m), 1285 (s), 1196 (s), 1133 (s), 
1101 (s), 1052 (s), 1028 (m), 914 (m), 864 (m), 731 (m), 658 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 859.5 (11, MH
+), 430.1 (100, (M+2H+)2+); - 
UV (MeOH): λ (ε) = 267 (7600), 223 (31600); - MF: C38H62N6O14S – FW: 859.01 g/mol; 
 
 
1.3.3. General procedure for the synthesis of the receptors with acetyl guanidine 
moiety (isothiourea route, GP IV): 
 
N
H
NH
N
R´
boc
O
N
H
NH
NR´
n
 boc
O
O
O
O
O
O
O
O
O
O
N
O
= R´
15a   n = 1 
15a   n = 2 
15a   n = 3 
15d   
 
The according crown ether amino acid hydrochloride or tfa salt (0.15 mmol, approx. 100 mg 
for the hydrochloride or approx. 150 mg for the tfa salt) was dissolved in 3.0 mL of dried 
chloroform, freshly distilled triethylamine (0.5 mmol, 51 mg, 0.07 mL) was added and the 
mixture was stirred for 20 min. at room temperature. After addition of 145 mg of 1-Boc-3-
acetyl-2-methyl-2-isothiourea (0.5 mmol), the well stirred solution was heated to 40°C under 
nitrogen atmosphere and held at this temperature over night.  
The solution was cooled to room temperature, diluted with 20.0 mL of ethyl acetate and 
filtered. The filtrate was washed with saturated ammonium chloride solution (5 mL) and 
water (5 mL), dried over magnesium sulfate and the solvent was evaporated. After vacuum 
drying the crude product was purified by column chromatography on silica gel with ethyl 
acetate / ethanol as eluent. (Rf ca. 0.2 to 0.3 in EtOAc / EtOH 3:1). 
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14-[2-[2-(
tert
Butyloxycarbonyl)-3-acetyl-guanidino]-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (15a) 
O
N
O
O
O
O
O
O
O
O
O
N
O
N
H
N
HO
O
 
Submitting compound 4a (176 mg, 0.30 mmol) to GP IV gives a yellow glass as the product 
(145 mg, 0.207 mmol, 69 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.41 (s, 9 H), 2.11 (s, 3 H), 2.62 (m, 2 H), 2.71 (m, 4 
H), 3.36 – 3.42 (m, 2 H), 3.49 – 3.62 (m, 8 H), 3.65 – 3.71 (m, 4 H), 3.84 (s, 6 H), 3.85 – 3.92 
(m, 4 H), 4.12 – 4.18 (m, 4 H), 7.12 (s, 2 H), 8.57 (bs, 1 H), 9.11 (bs, 1 H); - 13C-NMR (75 
MHz, CDCl3): δ [ppm] = 25.0 (+, 1 C), 28.3 (+, 3 C), 38.7 (-, 1 C), 52.7 (+, 2 C), 53.4 (-, 1 
C), 53.9 (-, 2 C), 69.3 (-, 2 C), 69.5 (-, 2 C), 70.0 (-, 2 C), 71.1 (-, 2 C), 79.4 (Cquat, 1 C), 113.7 
(+, 2 C), 125.3 (Cquat, 2 C), 150.5 (Cquat, 2 C), 155.8 (Cquat, 1 C), 163.7 (Cquat, 1 C), 167.8 
(Cquat, 2 C), 171.3 (Cquat, 1 C); - IR (KBr): ν [cm-1] = 3296 (bm), 2946 (m), 2872 (m), 1720 
(m), 1643 (m), 1605 (m), 1516 (m), 1435 (m), 1346 (m), 1284 (s), 1182 (s), 1128 (s), 1052 
(s), 978 (m), 954 (m), 877 (m), 803 (m), 775 (m), 734 (m), 661 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 699.3 (100, MH
+), 599.2 (7, MH+-Boc), 
350.2 (19, (M+2H+)2+); - UV (MeOH): λ (ε) = 269 (7500), 222 (30100); - HRMS (PI-LSIMS 
FAB glycerine): calc. for C32H51N4O13
+: 699.3453, found: 699.3442; - MF: C32H50N4O13 – 
FW: 698.77 g/mol; 
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14-[4-[2-(
tert
Butyloxycarbonyl)-3-acetyl-guanidino]-butyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (15b) 
O
N
N
H
N
HO
O
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4b (185 mg, 0.30 mmol) was reacted after GP IV to yield the product 15b as a 
yellow glass (161 mg, 0.222 mmol, 74 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.40 (s, 9 H), 1.39 – 1.49 (m, 4 H), 2.16 (s, 3 H), 
2.46 (m, 2 H), 2.72 – 2.79 (m, 4 H), 3.21 (m, 2 H), 3.43 (m, 2 H), 3.52 - 3.56 (m, 4 H), 3.59 - 
3.64 (m, 4 H), 3.73 - 3.77 (m, 4 H), 3.82 (s, 6 H), 3.84 – 3.86 (t, 4 H), 4.15 – 4.19 (t, 4 H), 
7.16 (s, 2 H), 7.72 (bs, 1 H), 8.91 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 25.1 (+, 
1 C), 26.8 (-, 1 C), 28.3 (+, 3 C), 39.6 (-, 1 C), 40.7 (-, 1 C), 52.6 (+, 2 C), 53.9 (-, 2 C), 54.8 
(-, 1C), 69.3 (-, 2 C), 69.5 (-, 4 C), 70.7 (-, 2 C), 71.1 (-, 2 C), 79.6 (Cquat, 1 C), 113.7 (+, 2 C), 
125.4 (Cquat, 2 C), 150.5 (Cquat, 2 C), 153.1 (Cquat, 1C), 156.0 (Cquat, 1 C), 167.8 (Cquat, 2 C), 
172.0 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3320 (bm), 2935 (m), 2872 (m), 1717 (m), 1644 (m), 
1601 (m), 1568 (m), 1520 (m), 1436 (m), 1350 (m), 1285 (s), 1245 (s), 1192 (s), 1125 (s), 
1056 (m), 978 (m), 945 (m), 877 (m), 778 (m), 732 (m), 642 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 727.3 (48, MH
+), 365.2 (100, (M+2H+)2+); - 
UV (MeOH): λ (ε) = 268 (7200), 222 (29800); - HRMS (PI-LSIMS FAB glycerine): calc. for 
C34H55N4O18
+: 727.3766, found: 727.3756; - MF: C34H54N4O13 – FW: 726.83 g/mol; 
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14-[6-[2-(
tert
Butyloxycarbonyl)-3-acetyl-guanidino]-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (15c) 
O
N
N
H
N
HO
O
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4c (195 mg, 0.30 mmol) gives a yellow glass by reaction after GP IV (97 mg, 
0.129 mmol, 43 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.28 (m, 4 H), 1.40 (s, 9 H), 1.38 – 1.46 (m, 4 H), 
2.16 (s, 3 H), 2.46 (m, 2 H), 2.78 (m, 4 H), 3.33 – 3.38 (m, 2 H), 3.56 - 3.61 (m, 4 H), 3.62 - 
3.68 (m, 4 H), 3.70 - 3.78 (m, 4 H), 3.85 (s, 6 H), 3.88 – 3.94 (m, 4 H), 4.15 – 4.22 (m, 4 H), 
7.13 (s, 2 H), 8.32 (bs, 1 H), 8.87 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 25.1 (+, 
1 C), 26.8 (-, 1 C), 27.1 (-, 1 C), 28.1 (+, 3 C), 28.3 (-, 1 C), 28.9 (-, 1 C), 40.8 (-, 2 C), 52.6 
(+, 2 C), 53.8 (-, 2 C), 69.3 (-, 2 C), 69.5 (-, 4 C), 70.6 (-, 2 C), 71.0 (-, 2 C), 79.6 (Cquat, 1 C), 
113.7 (+, 2 C), 125.4 (Cquat, 2 C), 150.5 (Cquat, 2 C), 156.0 (Cquat, 1 C), 163.9 (Cquat, 1 C), 
167.8 (Cquat, 2 C), 172.0 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3301 (bm), 2934 (m), 2865 (m), 
1720 (m), 1643 (m), 1609 (m), 1572 (m), 1519 (m), 1435 (m), 1323 (m), 1285 (s), 1173 (s),  
1126 (s), 1057 (s), 978 (m), 946 (m), 879 (m), 802 (m), 777 (m), 660 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 755.3 (44,  MH
+), 378.9 (100, (M+2H+)2+); - 
UV (MeOH): λ (ε) = 267 (7300), 224 (28900); - HRMS (PI-LSIMS FAB glycerine): calc. for 
C36H59N4O13
+: 755.4079, found: 755.4077; - MF: C36H58N4O13 – FW: 754.88 g/mol; 
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14-[4-[2-(
tert
Butyloxycarbonyl)-3-acetyl-guanidino-methyl]-benzyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester (15d) 
O
N
N
H
N
HO
O
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4d (203 mg, 0.30 mmol) was converted to the product after GP IV. It appears as a 
yellow glass (170 mg, 0.219 mmol, 73 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.49 (s, 9 H), 2.18 (s, 3 H), 2.79 (m, 4 H), 3.49 – 
3.72 (m, 10 H), 3.70 – 3.77 (m, 4 H), 3.86 (s, 6 H), 3.87 – 3.94 (m, 4 H), 4.17 – 4.22 (m, 4 H), 
4.51 (d, 2 H, J = 5.3 Hz), 7.18 (s, 2 H), 7.16 – 7.25 (d, 2 H, J = 4.6 Hz), 7.26 – 7.34 (d, 2 H, J 
= 4.6 Hz), 8.61 (bs, 1 H), 9.14 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 25.1 (+, 1 
C), 28.3 (+, 3 C), 44.6 (-, 1 C), 52.6 (+, 2 C), 53.6 (-, 2 C), 58.9 (-, 1 C), 69.2 (-, 2 C), 69.4 (-, 
2 C), 69.5 (-, 2 C), 70.5 (-, 2 C), 71.0 (-, 2 C), 79.7 (Cquat, 1 C), 113.6 (+, 2 C), 125.4 (Cquat, 3 
C), 127.6 (+, 2 C), 129.5 (+, 2 C), 136.9 (Cquat, 1 C), 138.7 (Cquat, 1 C), 150.4 (Cquat, 2 C), 
155.9 (Cquat, 1 C), 163.8 (Cquat, 1 C), 167.8 (Cquat, 2 C), 172.0 (Cquat, 1 C); - IR (KBr): ν [cm
-1] 
= 3292 (bm), 2945 (m), 2873 (m), 1719 (m), 1643 (m), 1518 (m), 1434 (m), 1350 (m), 1318 
(m), 1286 (s), 1126 (s), 1059 (m), 977 (m), 916 (m), 882 (m), 802 (m), 778 (m), 729 (m), 657 
(m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 775.3 (27, MH
+), 388.2 
(100, (M+2H+)2+); - UV (MeOH): λ (ε) = 268 (7600), 224 (30200); - HRMS (PI-LSIMS FAB 
glycerine): calc. for C36H59N4O13
+: 775.3766, found: 775.3768; - MF: C38H54N4O13 – FW: 
774.87 g/mol; 
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1.3.4. General procedure for the Boc deprotection of the crown ether guanidines 
(GP V) 
N
H
NH
2
NH
2
+
R´
N
H
NH
2
NH
2
+
R´
n
 
O
O
O
O
O
O
O
O
O
N
O
N
H
NH
NH
2
+
R´ O
N
H
NH
NH
2
+
R´
n
 
O
NH
NH
2
NH
2
+
R´
N
H
N
HS
= R´
14a   n = 1 
14b   n = 2 
14c   n = 3 
14d   
16a   n = 1 
16b   n = 2 
16c   n = 3 
16d   
14e 
 
The according starting material (0.1 mmol) was dissolved in 0.5 mL of dry dichloromethane 
and a saturated solution of hydrochloric acid in diethyl ether (0.3 mL) was added. After four 
hours of stirring at room temperature the HCl gas was removed by bubbling N2 through the 
solution. All volatiles were evaporated at reduced pressure. The residue was taken up in a 
minimum amount of dichloromethane and the product was precipitated carefully by slow 
addition of diethyl ether. The solution was decanted off the precipitate, it was washed once 
with diethyl ether, decanted off again and the product was dried in the vacuum to furnish a 
hygroscopic powder.  
 R N
H
2
+
NH
2
NH  
R
N
H
2
+
NH
2
NH  
R
N
H
2
+
NH
2
NH  
N
H
2
+
R
NH
2
NH  
NH
2
+
R
N
H
S
NH
NH
2
NH  
Starting 
material 
89 mg 91 mg 94 mg 96 mg 100 mg 
Yield of 
product 
96 mg  
(96 %) 
98 mg  
(94 %) 
83 mg  
(78 %) 
103 mg  
(95 %) 
84 mg  
(76 %) 
Appearance 
Yellow 
powder 
Yellow 
powder 
Pale yellow 
powder 
Pale yellow 
powder 
Orange 
powder 
Mp. (not corr.) 72 – 74 °C 74 – 75 °C 72 – 73 °C 81 – 83 °C 84 – 88 °C 
Table S-2: Amounts of starting material, yields and appearance of the products 
(hydrochloride salts) 
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14-[4-Guanidino-butyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-
hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester hydrochloride 
(14b) 
 
Mp. = 74 – 75 °C (uncorrected); - 1H-NMR (600 MHz, MeOD): δ [ppm] = 1.27 – 1.39 (m, 2 
H), 1.42 – 1.58 (m, 2 H), 1.66 – 1.76 (m, 2 H), 3.22 (m, 2 H), 3.38 – 3.54 (m, 4 H), 3.57 – 
3.78 (m, 8 H), 3.79 – 3.95 (m, 8 H), 3.84 (s, 6 H), 4.19 – 4.33 (m, 4 H), 7.29 (s, 2 H); - 13C-
NMR (150 MHz, MeOD): δ [ppm] = 20.4 (-, 1 C), 29.7 (-, 1 C), 40.3 (-, 1 C), 52.8 (+, 2 C), 
53.1 (-, 2 C), 53.4 (-, 1 C), 64.8 (-, 2 C), 68.4 (-, 2 C), 69.3 (-, 2 C), 70.2 (-, 2 C), 70.6 (-, 2 C), 
113.0 (+, 2 C), 125.5 (Cquat, 2 C), 149.9 (Cquat, 2 C), 157.6 (Cquat, 1 C), 167.8 (Cquat, 2 C); - IR 
(KBr): ν [cm-1] = 3381 (bm), 2922 (m), 2876 (m), 1682 (m), 1601 (m), 1520 (m), 1437 (m), 
1351 (m), 1289 (m), 1197 (s), 1129 (s), 1063 (m), 978 (m), 947 (m), 831 (m), 800 (m), 722 
(m), 630 (m), 570 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
585.2 (53, MH+), 293.1 (100 %, (M+2H+)2+); - MF: C29H40N4O10Cl2 – FW: 653.57 g/mol;  
 
 
14-[6-Guanidino-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-
hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester hydrochloride 
(14c) 
 
Mp. = 72 – 73°C (uncorrected); - 1H-NMR (300 MHz, MeOD): δ [ppm] = 1.29 – 1.36 (m, 4 
H), 1.59 (m, 2 H), 1.68 (m, 2 H), 3.14 (m, 2 H), 3.22 (m, 2 H), 3.69 - 3.74 (m, 4 H), 3.70 - 
3.79 (m, 4H), 3.86 (s, 6 H), 3.89 – 3.93 (m, 8 H), 4.23 – 4.29 (m, 4 H), 7.29 (s, 2 H); - 13C-
NMR (75 MHz, MeOD): δ [ppm] = 24.5 (-, 1 C), 27.3 (-, 2 C), 29.7 (-, 1 C), 41.9 (-, 1 C), 
53.2 (+, 2 C), 54.4 (-, 2 C), 54.5 (-, 1 C), 61.1 (-, 2C), 67.2 (-, 2 C), 70.2 (-, 2 C), 70.7 (-, 2 C), 
71.4 (-, 2 C), 71.8 (-, 2 C), 114.5 (+, 2 C), 126.8 (Cquat, 2 C), 151.8 (Cquat, 2 C), 163.8 (Cquat, 1 
C), 169.3 (Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3321 (bm), 3163 (m), 3016 (m), 2940 (m), 2880 
(m), 2361 (w), 1691 (m), 1521 (m), 1435 (m), 1356 (m), 1290 (s), 1200 (s), 1129 (s), 1064 
(s), 980 (m), 807 (m), 723 (m), 683 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 613.3 (19, MH
+), 307.1 (100, (M+2H+)2+); - HRMS (PI-LSIMS FAB 
glycerine): calc. for C29H49N4O10
+: 613.3437, found: 613.3431; - MF: C29H49N4O10Cl2 – FW: 
681.62 g/mol; 
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14-[2-(3-(2-(2-Guanidino-ethyl)thioureido)ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester hydrochloride (14e) 
 
Mp. = 84 – 88 °C (uncorrected); - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 3.32 – 3.58 (m, 6 
H), 3.59 – 3.79 (m, 8 H), 3.80 – 3.99 (m, 10 H), 3.87 (s, 6 H), 4.02 – 4.18 (m, 4 H), 4.19 – 
4.37 (m, 6 H), 6.91 (bs, 1 H), 7.16 (s, 2 H), 7.92 (bs, 1 H), 9.51 (bs, 1 H), 9.68 (bs, 1 H), 
12.86 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 40.2 (-, 1 C), 43.6 (-, 1 C), 52.8 (+, 
2 C), 54.8 (-, 1 C), 54.8 (-, 2 C), 65.9 (-, 2 C), 68.6 (-, 2 C), 69.4 (-, 2 C), 70.2 (-, 1 C), 70.3 (-, 
2 C), 70.6 (-, 2 C), 113.2 (+, 2 C), 125.4 (Cquat, 2 C), 150.9 (Cquat, 2 C), 154.2 (Cquat, 1 C), 
167.8 (Cquat, 2 C), 180.2 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3320 (m), 2930 (m), 1723 (m), 
1677 (m), 1597 (m), 1524 (m), 1470 (m), 1438 (m), 1396 (m), 1355 (m), 1286 (m), 1264 (m), 
1176 (s), 1132 (s), 1051 (m), 948 (m), 798 (m), 705 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 
mmol NH4OAc): m/z (%) = 657.2 (23, MH
+), 328.4 (100, (M+2H+)2+); - MF: 
C28H46N6O14SCl2 – FW: 727.67 g/mol;  
 
 
N
H
2
+
R
NH
2
N
O  
R
NH
2
N
O
N
H
2
+
 
NH
2
N
O
N
H
2
+
R
 
NH
2
N
O
N
H
2
+
R
 
Starting 
material 
93 mg 88 mg 98 mg 100 mg 
Yield of 
product 
82 mg  
(91 %) 
63 mg  
(90 %) 
82 mg  
(86 %) 
90 mg  
(93 %) 
Appearance 
Slightly yellow 
powder 
Yellow  
powder 
Yellow  
powder 
Pale yellow 
powder 
Mp. (not corr.) 69 – 73 °C 71 – 73 °C 70 – 74 °C 78 – 82 °C 
 
Table S-3: Amounts of starting material, yields, appearance and melting points of the 
products (hydrochloride salts) 
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14-[2-[2-Acetyl-guanidino]-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-
5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester 
hydrochloride (16a) 
 
Mp. = 69 – 73 °C (uncorrected); - 1H-NMR (600 MHz, CDCl3): δ [ppm] = 2.11 (s, 3 H), 3.31 
(m, 4 H), 3.45 (m, 2 H), 3.62 – 3.76 (m, 8 H), 3.82 (m, 2 H), 3.86 – 3.93 (m, 8 H), 3.86 (s, 6 
H), 4.21 – 4.27 (m, 4 H), 7.18 (s, 2 H), 8.77 (bs, 1 H), 9.63 (bs, 2 H), 10.91 (bs, 1 H),; - 13C-
NMR (150 MHz, CDCl3): δ [ppm] = 24.1 (+, 1 C), 36.1 (-, 1 C), 51.8 (-, 1 C), 52.6 (+, 2 C), 
54.0 (-, 2 C), 65.3 (-, 2 C), 68.6 (-, 2 C), 69.0 (-, 2 C), 70.3 (-, 2 C), 70.4 (-, 2 C), 113.2 (+, 2 
C), 125.4 (Cquat, 2 C), 149.9 (Cquat, 2 C), 154.9 (Cquat, 1 C), 167.5 (Cquat, 2 C), 174.2 (Cquat, 1 
C); - IR (KBr): ν [cm-1] = 3292 (bm), 2948 (m), 2874 (m), 1722 (m), 1673 (m), 1598 (m), 
1518 (m), 1435 (m), 1348 (m), 1286 (m), 1193 (s), 1127 (s), 1061 (m), 978 (m), 916 (m), 830 
(m), 800 (m), 724 (m), 650 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z 
(%) = 599.2 (43, MH+), 300.1 (100, (M+2H+)2+); - MF: C27H43N4O11Cl2 – FW: 669.56 
g/mol; 
 
 
14-[4-[2-Acetyl-guanidino]-butyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-
5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester 
hydrochloride (16b) 
 
Mp. = 71 – 73 °C (uncorrected); - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.42 (m, 2 H), 
1.69 (m, 2 H), 1.73 (m, 4 H), 2.19 (s, 3 H), 3.25 (m, 2H), 3.38 – 3.47 (m, 4 H), 3.61 – 3.75 
(m, 8 H), 3.79 - 3.96 (m, 8 H), 3.87 (s, 6 H), 4.21 – 4.30 (m, 4 H), 7.16 (s, 2 H), 8.56 (bs, 1 
H), 9.39 (bs, 1 H), 10.61 (bs, 2 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 20.4 (-, 1 C), 
24.2 (+, 1 C), 26.1 (-, 1 C), 40.3 (-, 1 C), 53.0 (+, 2 C), 53.0 (-, 2 C), 53.5 (-, 1C), 65.1 (-, 2 
C), 68.4 (-, 2 C), 69.3 (-, 2 C), 70.1 (-, 2 C), 70.6 (-, 2 C), 113.2 (+, 2 C), 125.5 (Cquat, 2 C), 
149.9 (Cquat, 2 C), 154.4 (Cquat, 1 C), 167.8 (Cquat, 2 C), 174.1 (Cquat, 1 C); -IR (KBr): ν [cm
-1] 
= 3320 (bm), 2922 (m), 2870 (m), 1682 (m), 1605 (m), 1520 (m), 1437 (m), 1351 (m), 1289 
(s), 1197 (s), 1129 (s), 1063 (m), 975 (m), 948 (m), 831 (m), 800 (m), 722 (m); - MS (ESI-
MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 627.2 (48, MH
+), 314.0 (100, 
(M+2H+)2+); - MF: C29H47N4O11Cl2 – FW: 697.62 g/mol;  
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14-[6-[2-Acetyl-guanidino]-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-
5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester 
hydrochloride (16c) 
 
Mp. = 70 – 74 °C (uncorrected); - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.41 – 1.53 (m, 2 
H), 1.54 – 1.86 (m, 6 H), 2.19 (s, 3 H), 3.02 – 3.21 (m, 4 H), 3.38 – 3.56 (m, 4 H), 3.67 – 3.75 
(m, 8 H), 3.79 - 3.96 (m, 8 H), 3.88 (s, 6 H), 4.19 – 4.29 (m, 4 H), 7.18 (s, 2 H), 7.91 (bs, 1 
H), 10.04 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 24.7 (+, 1 C), 27.7 (-, 2 C), 34.8 
(-, 2 C), 42.1 (-, 1 C), 52.8 (+, 2 C), 54.8 (-, 2 C), 55.1 (-, 1 C), 66.3 (-, 2 C), 68.6 (-, 2 C), 
69.5 (-, 2 C), 70.4 (-, 2 C), 70.6 (-, 2 C), 113.5 (+, 2 C), 125.4 (Cquat, 2 C), 149.8 (Cquat, 2 C), 
153.1 (Cquat, 1 C), 167.8 (Cquat, 2 C), 176.3 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3321 (bm), 
2940 (m), 2845 (m), 1720 (m), 1691 (m), 1521 (m), 1435 (m), 1356 (m), 1290 (s), 1200 (s),  
1129 (s), 1064 (s), 807 (m), 723 (m), 683 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 655.3 (12,  MH
+), 327.9 (100, (M+2H+)2+); - MF: C31H51N4O11Cl2 – 
FW: 725.67 g/mol;  
 
 
14-[4-[2-Acetyl-guanidino-methyl]-benzyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl 
ester hydrochloride (16d) 
 
Mp. = 78 – 82 °C (uncorrected); - 1H-NMR (600 MHz, CDCl3): δ [ppm] = 2.29 (s, 3 H), 3.19 
– 3.30 (m, 4 H), 3.68 – 3.76 (m, 8 H), 3.84 – 3.98 (m, 8 H), 3.88 (s, 6 H), 4.02 – 4.12 (m, 4 
H), 4.40 (d, 2 H, J = 5.3 Hz), 4.67 (d, 2 H, J = 5.3 Hz), 6.91 (d, 2 H, J = 4.6 Hz), 6.89 (s, 2 H), 
7.34 (d, 2 H, J = 4.6 Hz); - 13C-NMR (150 MHz, CDCl3): δ [ppm] = 24.3 (+, 1 C),  43.8 (-, 1 
C), 52.2 (-, 2 C), 52.9 (+, 2 C), 56.6 (-, 1 C), 65.5 (-, 2 C), 68.3 (-, 2 C), 69.2 (-, 2 C), 70.0 (-, 
2 C), 70.2 (-, 2 C), 112.2 (+, 2 C), 124.7 (+, 2 C), 126.5 (Cquat, 2 C), 129.5 (Cquat, 1 C), 132.4 
(+, 2 C), 135.6 (Cquat, 1 C), 150.0 (Cquat, 2 C), 155.1 (Cquat, 1 C), 168.2 (Cquat, 2 C), 174.7 
(Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3320 (bm), 2930 (m), 2870 (m), 1720 (m), 1676 (m), 1599 
(m), 1519 (m), 1436 (m), 1352 (m), 1289 (s), 1198 (s), 1131 (s), 1058 (m), 980 (m), 914 (m), 
801 (m), 725 (m), 642 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
675.2 (23, MH+), 338.1 (100, (M+2H+)2+); - MF: C33H47N4O11Cl2 – FW: 745.66 g/mol; 
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14-[2-(3-(2-(2-Acetyl-guanidino-ethyl)thioureido)ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (16e) 
NH
N
H NH
O
O
O
O
O
O
O
O
O
O
N
O
N
H
N
H
S
 
Compound 14e (88 mg, 0.1 mmol) was dissolved in 1.0 mL of DCM containing 0.04 mL 
triethylamine (0.03 g, 0.3 mmol). Under cooling in an ice bath and vigorous stirring 
acetanhydride in DCM (0.1 M, 1.0 mL, 0.1 mmol) was added drop wise. The mixture was 
stirred for 3 h at 0 °C. The solvent was evaporated at reduced pressure. The remaining solid 
was purified by column chromatography with chloroform / methanol 6:1. The product was 
isolated as a colourless solid (63 mg, 90 %). 
 
Mp. = 76 – 78°C (uncorrected); - 1H-NMR (300 MHz, MeOD): δ [ppm] = 2.18 (s, 3 H), 3.29 
– 3.56 (m, 6 H), 3.61 – 3.70 (m, 8 H), 3.72 – 3.95 (m, 8 H), 3.84 (s, 6 H), 4.03 – 4.20 (m, 4 
H), 4.22 – 4.33 (m, 6 H), 7.16 (s, 2 H); - 13C-NMR (75 MHz, MeOD): δ [ppm] = 24.6 (+, 1 
C), 39.1 (-, 1 C), 42.8 (-, 1 C), 52.6 (+, 2 C), 53.6 (-, 1 C), 54.7 (-, 2 C), 65.1 (-, 2 C), 68.6 (-, 
2 C), 69.7 (-, 2 C), 70.1 (-, 2 C), 70.3 (-, 1 C), 70.6 (-, 2 C), 113.1 (+, 2 C), 125.4 (Cquat, 2 C), 
150.2 (Cquat, 2 C), 154.7 (Cquat, 1 C), 164.3 (Cquat, 2 C), 167.6 (Cquat, 2 C), 179.1 (Cquat, 1 C); - 
IR (KBr): ν [cm-1] = 3320 (m), 2930 (m), 1721 (m), 1679 (m), 1598 (m), 1521 (m), 1472 (m), 
1436 (m), 1401 (m), 1356 (m), 1286 (m), 1186 (s), 1131 (s), 1055 (m), 946 (m), 798 (m); - 
MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 701.3 (28, MH
+), 350.2 (100, 
(M+2H+)2+); - MF: C30H48N6O11S – FW: 700.67 g/mol; 
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1.3.5. General procedure for the synthesis of the N,N-dialkyl-substituted guanidine 
motifs (carbodiimide route, GP VI) 
 
NH
N
H
N
R´
N
H
N
HS
RR
N
H
NH
N
R´
R
R
N
H
NH
NR´
n
 
R
R
O
O
O
O
O
O
O
O
O
N
O
= R´
11a   n = 1; R = iPr
12a   n = 1; R = Cy
11b   n = 2; R = iPr
12b   n = 2; R = Cy
11c   n = 3; R = iPr
12c   n = 3; R = Cy
11d   R = iPr
12d   R = Cy
11e   R = iPr
12e   R = Cy
 
 
The according crown ether amino acid hydrochloride (0.3 mmol, approx. 200 mg) were 
dissolved in 10.0 mL of dry acetonitrile in a protective nitrogen atmosphere, freshly distilled 
DIPEA (1.0 mmol, 129 mg, 0.17 mL) was dropped in and the mixture was stirred 30 min. 
While cooling to 2 to 5°C DIC (190 mg) or DCC (310 mg) (1.5 mmol) were added in one 
portion and the solution was, after 2 hours of stirring in the ice bath, carefully heated to reflux 
temperature and held under dry conditions at this temperature for four days. 
After cooling to room temperature, the reaction mixture was filtered over celite and the filter 
cake was washed several times with acetonitrile and dichloromethane. The solvent was 
evaporated; the crude product was thoroughly dried and purified by column chromatography 
with silica gel and chloroform/methanol as eluent. (Rf ca. 0.2 to 0.3 in chloroform / methanol 
4:1). 
 
14-[4-[2,3-di-isopropyl-guanidino]-butyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl 
ester (11b) 
N
N
H
N
H
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4b (185 mg, 0.30 mmol) was reacted according to GP VI. The product is a yellow 
glass (116 mg, 0.174 mmol, 58 %) (Rf [CHCl3 / MeOH 4:1] = 0.16). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.29 (d, 12 H, J = 6.3 Hz), 1.69 - 1.76 (m, 4 H), 3.03 
(m, 2 H), 3.21 (m, 4 H), 3.40 (m, 2 H), 3.65 – 3.78 (m, 8 H), 3.81 – 3.92 (m, 8 H), 3.87 (s, 6 
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H), 4.19 – 4.23 (m, 4 H), 6.75 (s, 2 H), 7.20 (s, 2 H), 8.04 (bs, 2 H); - 13C-NMR (75 MHz, 
CDCl3): δ [ppm] = 22.9 (+, 4 C), 26.6 (-, 1 C), 42.0 (-, 1 C), 45.7 (+, 2 C), 45.7 (-, 1 C), 52.7 
(+, 2 C), 53.4 (-, 2 C), 54.1 (-, 1 C), 68.8 (-, 2 C), 69.4 (-, 2 C),  69.5 (-, 2 C), 70.4 (-, 2 C), 
70.8 (-, 2 C), 113.4 (+, 2 C), 125.4 (Cquat, 2 C), 150.2 (Cquat, 2 C), 154.8 (Cquat, 1 C), 167.8 
(Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3220 (bm), 2934 (m), 2887 (m), 2197 (w), 1980 (w), 1720 
(m), 1614 (m), 1519 (m), 1438 (m), 1350 (m), 1287 (s), 1196 (s), 1124 (s), 1058 (m),  978 
(m), 910 (m), 798 (m), 723 (m), 693 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 669.4 (16, MH
+), 335.2 (100, (M+2H+)2+); - UV (MeOH): λ (ε) = 267 
(8100), 223 (27800); - HRMS (EI-MS 70 eV): calc. for C33H57N4O10
+: 669.4075, found: 
669.4086; - MF: C33H56N4O10 – FW: 668.84 g/mol; 
 
 
14-[6-[2,3-Di-isopropyl-guanidino]-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl 
ester (11c) 
N
N
H
N
H
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4c (195 mg, 0.30 mmol) was reacted after GP VI to yield a faintly yellow oil  
(61 mg, 0.09 mmol, 29 %) (Rf [CHCl3 / MeOH 4:1] = 0.17). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.20 – 1.31 (m, 4 H), 1.25 (d, 12 H, J = 6.4 Hz), 1.58 
– 1.63 (m, 4 H), 2.98 - 3.04 (m, 2 H), 3.21 – 3.32 (m, 6 H), 3.59 – 3.67 (m, 8 H), 3.77 – 3.91 
(m, 8 H), 3.83 (s, 6 H), 4.12 – 4.18 (m, 4 H), 6.78 (d, 2 H, J = 6.4 Hz), 7.15 (s, 2 H), 7.83 (bs, 
1 H) - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 23.0 (+, 4 C), 24.1 (-, 1 C), 25.7 (-, 1 C),  25.8 
(-, 1 C),  28.3 (-, 1 C), 42.7 (-, 1 C), 45.9 (+, 2 C), 52.7 (+, 2 C), 53.2 (-, 2 C), 55.1 (-, 1 C), 
66.2 (-, 2 C), 68.8 (-, 2 C),  69.5 (-, 2 C), 70.5 (-, 2 C), 70.8 (-, 2 C), 113.3 (+, 2 C), 125.4 
(Cquat, 2 C), 150.2 (Cquat, 2 C), 155.5 (Cquat, 1 C), 167.8 (Cquat, 2 C); - IR (KBr): ν [cm
-1] = 
3194 (bm), 3071 (m), 2927 (m), 2871 (m), 2200 (w), 1721 (m), 1615 (m), 1519 (m), 1438 
(m), 1349 (m), 1288 (s), 1194 (s), 1127 (s), 1060 (m),  978 (m), 925 (m), 804 (m), 730 (m), 
644 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 697.4 (90 %, 
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MH+), 349.2 (100 %, (M+2H+)2+); - UV (MeOH): λ (ε) = 267 (8400), 224 (27600); - HRMS 
(EI-MS 70 eV): calc. for C35H60N4O10
*+: 696.4309, found: 696.4293; - MF: C35H60N4O10 – 
FW: 696.89 g/mol; 
 
 
14-[2-(3-(2-(2,3-Di-isopropyl-guanidino)ethyl)thioureido)ethyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester (11e) 
N
NH
N
H
O
O
O
O
O
O
O
O
O
N
O
N
H
N
H
S
 
Conversion of 4e (210 mg, 0.30 mmol) by GP VI yields the product appearing as a yellow oil 
(80 mg, 0.12 mmol, 36 %) (Rf [CHCl3 / MeOH 4:1] = 0.23). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.23 (d, 12 H, J = 6.4 Hz), 2.78 (m, 6 H), 3.38 – 3.42 
(m, 4 H), 3.48 – 3.62 (m, 8 H), 3.65 – 3.73 (m, 4 H), 3.82 (s, 6 H), 3.84 – 3.89 (m, 4 H), 3.91 
– 4.03 (heptett, 2 H, J = 6.4 Hz), 4.17 – 4.22 (m, 4 H), 6.58 (m, 2 H), 7.15 (s, 2 H), 7.88 (bs, 1 
H), 8.83 (bs, 1 H) - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 21.9 (+, 4 C), 40.0 (-, 1 C), 41.0 
(-, 1 C), 44.1 (+, 2 C), 51.6 (+, 2 C), 52.3 (-, 1 C), 52.7 (-, 1 C), 53.5 (-, 2 C), 68.1 (-, 2 C), 
68.5 (-, 4 C),  69.4 (-, 2 C), 70.0 (-, 2 C), 112.4 (+, 2 C), 124.4 (Cquat, 2 C), 149.3 (Cquat, 2 C), 
152.5 (Cquat, 1 C), 166.8 (Cquat, 2 C), 181.9 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3252 (bm), 
3200 (m), 3075 (m), 2931 (m), 2859 (m), 2182 (w), 1722 (m), 1615 (s), 1519 (m), 1439 (m), 
1350 (m), 1287 (s), 1196 (s), 1122 (s), 1055 (m),  981 (m), 917 (m), 801 (m), 729 (m), 647 
(m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 743.3 (16, MH
+), 372.0 
(100, (M+2H+)2+); - UV (MeOH): λ (ε) = 267 (8400), 223 (29400); - HRMS (PI-LSIMS FAB 
glycerine): calc. for C34H59N6O10S
+: 743.4018, found: 743.4027; - MF: C34H58N6O10S – FW: 
742.94 g/mol; 
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14-[2-[2,3-Di-cyclohexyl-guanidino]-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl 
ester (12a) 
N
N
H
N
HO
O
O
O
O
O
O
O
O
N
O
 
Compound 4a (176 mg, 0.30 mmol) was reacted according to GP VI to furnish the product 
12a as a yellow glassy solid (164 mg, 0.228 mmol, 76 %) (Rf [EtOAc / MeOH 5:2] = 0.41; Rf 
[EtOAc / EtOH 3:1] = 0.14). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.04 – 1.11 (m, 2 H), 1.30 – 1.39 (m, 8 H), 1.47 – 
1.55 (m, 2 H), 1.64 (m, 4 H), 1.84 (m, 4 H),  2.76 (m, 4 H), 3.29 (m, 2 H), 3.52 – 3.58 (m, 10 
H), 3.61 – 3.66 (m, 4 H), 3.78 – 3.83 (m, 4 H), 3.80 (s, 6 H), 4.12 – 4.17 (m, 4 H), 7.14 (s, 2 
H), 7.72 (bs, 2 H);- 13C-NMR (75 MHz, CDCl3): δ [ppm] = 24.8 (-, 4 C), 25.1 (-, 2 C), 33.1 (-
, 2 C), 42.4 (-, 1 C), 51.6 (+, 2 C), 52.6 (+, 2 C), 54.2 (-, 2 C), 55.5 (-, 1 C), 69.1 (-, 4 C), 69.5 
(-, 4 C),  70.3 (-, 2 C), 71.0 (-, 2 C), 113.7 (+, 2 C), 125.4 (Cquat, 2 C), 150.4 (Cquat, 2 C), 154.8 
(Cquat, 1 C), 167.7 (Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3270 (bm), 3140 (bm), 2929 (m), 2855 
(m), 1717 (m), 1617 (m), 1518 (m), 1435 (m), 1347 (m), 1286 (s), 1247 (m), 1182 (s), 1124 
(s), 1054 (m),  978 (m), 943 (m), 890 (m), 844 (m), 782 (m), 771 (m), 697 (m), 672 (m); - MS 
(ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 361.3 (8, (M + 2H
+)2+), 721.5 
(100, MH+); - UV (MeOH): λ (ε) = 267 (8400), 224 (26400); - HRMS (PI-LSIMS FAB 
glycerine): calc. for C37H61N4O11
+: 721.4388, found: 721.4387; - MF: C37H60N4O10 – FW: 
720.91 g/mol; 
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14-[4-[2,3-Di-cyclohexyl-guanidino]-butyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl 
ester (12b) 
N
N
H
N
H
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4b (185 mg, 0.30 mmol) was submitted to GP VI to give 12b as the product 
appearing as a yellow glass (139 mg, 0.186 mmol, 62 %) (Rf [CHCl3 / MeOH 4:1] = 0.21). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.23 – 1.54 (m, 10 H), 1.62 – 1.68 (m, 8 H), 1.80 – 
1.86 (m, 4 H), 2.88 (m, 2 H), 3.08 (m, 4 H), 3.32 (m, 2 H), 3.47 – 3.54 (m, 2 H), 3.59 – 3.63 
(m, 4 H), 3.64 – 3.69 (m, 4 H), 3.71 – 3.76 (m, 4 H), 3.78 – 3.83 (m, 4 H), 3.81 (s, 6 H), 4.12 
– 4.16 (m, 4 H), 6.77 (d, 2 H, 6.4 Hz), 7.14 (s, 2 H), 7.93 (bs, 1 H);- 13C-NMR (75 MHz, 
CDCl3): δ [ppm] = 8.8 (+, 2C), 22.3 (-, 1 C), 24.9 (-, 4 C), 25.0 (-, 2 C), 26.6 (-, 1 C), 33.1 (-, 
4 C), 42.3 (-, 1C), 45.9 (-, 1 C), 52.6 (+, 2 C), 53.4 (-, 2 C), 54.3 (-, 1 C), 67.0 (-, 2 C), 69.0 (-, 
2 C),  70.4 (-, 2 C), 70.9 (-, 2 C), 113.4 (+, 2 C), 125.4 (Cquat, 2 C), 150.3 (Cquat, 2 C), 154.9 
(Cquat, 1 C), 167.7 (Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3188 (bm), 3080 (bm), 2928 (m), 2860 
(m), 2184 (w), 1830 (w), 1721 (m), 1612 (m), 1519 (m), 1438 (m), 1351 (m), 1287 (s), 1195 
(m), 1123 (s), 1058 (m),  978 (m), 916 (m), 781 (m), 727 (m), 643 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 375.1 (100 %, (M+2H
+)2+), 749.4 (36 %, 
MH+); - UV (MeOH): λ (ε) = 268 (8100), 224 (25900); - HRMS (PI-LSIMS FAB glycerine): 
calc. for C39H65N4O10
+: 749.4701, found: 749.4693; - MF: C39H64N4O10 – FW: 748.97 g/mol; 
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14-[6-[2,3-Di-cyclohexyl-guanidino]-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-
12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic acid dimethyl 
ester (12c) 
N
N
H
N
H
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4c (195 mg, 0.30 mmol) converted to the product by GP VI. It appears as yellow, 
sticky oil (79 mg, 0.102 mmol, 34 %) (Rf [CHCl3 / MeOH 4:1] = 0.18). 
 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 1.16 – 1.22 (m, 2 H), 1.31 – 1.39 (m, 6 H), 1.46 – 
1.52 (m, 4 H), 1.58 – 1.61 (m, 2 H), 1.66 – 1.69 (m, 4 H), 1.74 – 1.78 (m, 4 H), 1.91 – 1.96 
(m, 4 H), 3.02 (m, 2 H), 3.24 (m, 4 H), 3.32 (m, 2 H), 3.51 (m, 2 H), 3.66 – 3.69 (m, 4 H), 
3.70 – 3.74 (m, 4 H), 3.82 – 3.85 (m, 4 H), 3.86 (s, 6 H), 3.88 – 3.92 (m, 4 H), 4.21 – 4.24 (m, 
4 H), 6.79 (d, 2 H, J = 6.4 Hz), 7.13 (s, 2 H), 7.81 (bs, 1 H) - 13C-NMR (150 MHz, CDCl3): δ 
[ppm] = 24.5 (-, 1 C), 24.8 (-, 4 C), 25.0 (-, 2 C), 25.7 (-, 1 C), 25.9 (-, 1 C), 27.5 (-, 1 C), 33.1 
(-, 4 C), 42.9 (-, 1 C), 52.6 (+, 2 C), 52.9 (+, 2 C), 53.2 (-, 2 C), 54.8 (-, 1 C), 66.7 (-, 2 C), 
68.9 (-, 2 C), 69.5 (-, 2 C),  70.5 (-, 2 C), 70.8 (-, 2 C), 113.4 (+, 2 C), 125.4 (Cquat, 2 C), 150.3 
(Cquat, 2 C), 155.6 (Cquat, 1 C), 167.8 (Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3186 (bm), 3072 (m), 
2929 (m), 2870 (m), 2180 (w), 1840 (w), 1722 (m), 1614 (m), 1520 (m), 1435 (m), 1352 (m), 
1288 (s), 1196 (s), 1125 (s), 1056 (m), 978 (m), 918 (m), 781 (m), 724 (m), 644 (m); - MS 
(ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 777.5 (23 %, MH
+), 389.3 (100 
%, (M+2H+)2+); - HRMS (PI-LSIMS FAB glycerine): calc. for C41H69N4O10
+: 777.5014, 
found: 777.5023; - MF: C41H68N4O10 – FW: 777.02 g/mol; 
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14-[4-[2,3-Di-cyclohexyl-guanidino-methyl]-benzyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester (12d) 
N
N
H
N
H
O
O
O
O
O
O
O
O
O
N
O
 
Compound 4d (203 mg, 0.30 mmol) was reacted according GP VI. The product is a yellow 
glass (163 mg, 0.204 mmol, 68 %) (Rf [CHCl3 / MeOH 6:1] = 0.3). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.12 – 1.16 (m, 2 H), 1.33 – 1.44 (m, 8 H), 1.48 – 
1.62 (m, 6 H), 1.83 – 1.89 (m, 4 H), 2.95 (m, 4 H), 3.63 – 3.70 (m, 8 H), 3.72 – 3.77 (m, 6 H),  
3.88 (s, 6 H), 3.90 – 3.95 (m, 4 H), 4.17 – 4.24 (m, 4 H), 4.56 (d, 2 H, J = 5.3 Hz), 5.67 (m, 2 
H), 7.17 (s, 2 H), 7.22 – 7.25 (d, 2 H, J = 4.6 Hz), 7.32 – 7.36 (d, 2 H, J = 4.6 Hz), 7.90 (bs, 1 
H) - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 23.4 (-, 4 C), 23.9 (-, 2 C), 31.8 (-, 4 C), 43.9 (-, 
1 C), 50.9 (+, 2 C), 51.8 (+, 2 C), 52.5 (-, 2 C), 57.7 (-, 1 C), 67.8 (-, 2 C), 68.4 (-, 4 C), 69.5 
(-, 2 C), 69.8 (-, 2 C), 69.9 (-, 2 C), 112.2 (+, 2 C), 124.3 (Cquat, 2 C), 124.4 (+, 2 C), 126.4 (+, 
2 C), 129.9 (Cquat, 1 C), 146.1 (Cquat, 1 C), 149.3 (Cquat, 1 C), 152.4 (Cquat, 1 C), 166.9 (Cquat, 2 
C); - IR (KBr): ν [cm-1] = 3145 (bm), 2930 (m), 2859 (m), 2193 (w), 1964 (w), 1720 (m), 
1610 (m), 1517 (m), 1437 (m), 1350 (m), 1287 (s), 1196 (s), 1122 (s), 1058 (m),  978 (m), 
913 (m), 782 (m), 727 (m), 643 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): 
m/z (%) = 797.5 (19, MH+), 399.1 (100, (M+2H+)2+); - UV (MeOH): λ (ε) = 267 (7800), 223 
(26900); - HRMS (PI-LSIMS FAB glycerine): calc. for C43H65N4O10
+: 797.4731, found: 
797.4723; - MF: C43H64N4O10 – FW: 797.01 g/mol; 
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Summary of all compounds for the screening library and their protected precursors: 
Purification e.g. 6:1  4:1, below yield in mg and in % 
 
 ethyl butyl hexyl11 p-xylyl 
bis-ethyl-
thioureido 
NH
NH N
boc
boc
 
3:1 
195 mg 
78 % 
3:1 
176 mg 
75 % 
4:1  3:1 
124 mg 
51 % 
4:1 
205 mg 
82 % 
5:1 * 
107 mg 
42 % 
R = boc
R = H
 
96 mg 
96 % 
98 mg 
94 % 
83 mg 
78 % 
103 mg 
95 % 
84 mg 
76 % 
NH
NH N
boc
O
 
3:1 
145 mg 
69 % 
3:1 
161 mg 
74 % 
3:1  5:2 
97 mg 
43 % 
4:1 
170 mg 
73 % 
--- 
R = boc
R = H
 
82 mg 
91 % 
63 mg 
90 % 
82 mg 
86 % 
90 mg 
93 % 
71 mg 
74 % 
NH
NH N
 
8:1  6:1 
133 mg 
69 % 
8:1  6:1 
116 mg 
58 % 
9:1  5:1 
61 mg 
29 % 
6:1 
131 mg 
61 % 
8:1  5:1 
** 
80mg 
36 % 
NH
NH N
 
8:1  6:1 
164 mg 
76 % 
8:1  6:1 
139 mg 
62 % 
10:1  5:1 
79 mg 
34 % 
7:1  5:1 
163 mg 
68 % 
9:1  5:1 
** 
96 mg 
39 % 
 
A second column chromatography was necessary in the case of… with…: * ethyl acetate/ethanol 3:1; ** ethyl acetate/ethanol 3:2 

 1:1  
 
Table S-4: Yields and purification conditions for the small library 
 
 
 
  
Chapter III Supporting Information Dissertation A. Späth  
 
 - 39 - 
1.3.6. General procedure for the Synthesis of the pyrrole- and pyrene substituted 
motifs (isothiourea route, GP VII) 
 
The according crown ether amino acid hydrochloride or tfa salt (0.2 mmol, approx. 200 mg as 
the tfa salt) was dissolved in 3.0 mL of dry DMF, freshly distilled triethylamine (1.0 mmol, 
101 mg, 0.14 mL) was dropped in and the mixture was stirred for 20 min. at room 
temperature. After addition of the appropriate 2-methyl-2-isothiourea (0.3 mmol), the well 
stirred solution was heated to 40 °C under nitrogen atmosphere and held at this temperature 
over night.  
The solution was cooled to room temperature, diluted with 30.0 mL of DCM and filtered. The 
filtrate was washed with saturated ammonium chloride solution (10 mL) and water (10 mL), 
dried over magnesium sulfate and the solvent was evaporated. After vacuum drying the crude 
product was purified by column chromatography on silica gel with ethyl acetate / ethanol as 
eluent. (Rf ca. 0.3 in EtOAc / EtOH 6:1). 
 
14-[2-[2-(
tert
Butyloxycarbonyl)-3-(pyrrole-2-carbonyl)-guanidino]-ethyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester (37) 
 
O
N
O
O
O
O
O
O
O
O
O
N
O
N
H
N
HO
O N
H
 
 
Compound 4a (120 mg, 0.20 mmol) was submitted to GP VII to give the product as a yellow 
glass (101 mg, 0.135 mmol, 67 %). Ethanol / ethyl acetate 1:6 was used for purification. 
 
1
H-NMR (400 MHz, CDCl3): δ [ppm] = 1.49 (s, 6 H), 1.51 (s, 3 H), 2.61 – 2.90 (m, 6 H), 
3.41 – 3.70 (m, 10 H), 3.71 – 3.80 (m, 4 H), 3.81 – 3.96 (m, 4 H), 3.86 (s, 6 H), 4.12 – 4.23 
(m, 4 H), 6.21 (m, 1 H), 6.88 (m, 1 H), 6.92 (m, 1 H), 7.17 (s, 2 H), 8.59 (bs, 1 H), 9.56 (bs, 1 
H); - 13C-NMR (100 MHz, CDCl3): δ [ppm] = 28.0 (+, 2 C), 28.3 (+, 1 C), 39.0 (-, 1 C), 52.5 
(+, 2 C), 53.3 (-, 1C), 54.4 (-, 2 C), 69.2 (-, 2 C), 69.3 (-, 2 C), 69.4 (-, 2 C), 70.5 (-, 2 C), 70.9 
(-, 2 C), 82.7 (Cquat, 1 C), 110.2 (+, 1 C), 113.8 (+, 1 C), 113.9 (+, 2 C), 121.8 (+, 1 C), 125.3 
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(Cquat, 2 C), 131.2 (Cquat, 1 C), 150.4 (Cquat, 2 C), 153.1 (Cquat, 1 C), 155.9 (Cquat, 1 C), 167.8 
(Cquat, 2 C), 171.0 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3296 (bm), 2946 (m), 2874 (m), 1720 
(m), 1614 (m), 1571 (m), 1408 (m), 1350 (s), 1287 (s), 1251 (m), 1193 (m), 1125 (s), 1061 
(m), 1028 (s), 980 (m), 913 (m), 854 (m), 780 (m), 732 (m); - MS (ESI-MS, CH2Cl2/MeOH + 
10 mmol NH4OAc): m/z (%) = 750.2 (100, MH
+), 375.7 (76, (M+2H+)2+); - UV (MeOH): λ 
(ε) = 301 (19100), 224 (28900); - HRMS (PI-LSIMS FAB, glycerine): calc. for 
C38H52N5O13
+: 750.3562, found: 750.3557; - MF: C35H51N5O13 – FW: 749.82 g/mol; 
 
 
14-[2-[2-(
tert
Butyloxycarbonyl)-3-(pyrene-1-carbonyl)-guanidino]-ethyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocycloheneicosene-2,3-dicarboxylic acid dimethyl ester (38) 
 
O
N
O
O
O
O
O
O
O
O
O
N
O
N
H
N
HO
O
 
 
Compound 4a (120 mg, 0.20 mmol) was submitted to GP VII. The product is a yellow glass 
(73 mg, 0.082 mmol, 41 %). Ethanol / ethyl acetate 1:9 was used for purification. 
 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 1.49 (s, 3 H), 1.52 (s, 6 H), 2.78 (m, 2 H), 2.86 (m, 4 
H), 3.42 – 3.53 (m, 4 H), 3.55 – 3.69 (m, 4 H), 3.70 – 3.76 (m, 2 H), 3.77 – 3.89 (m, 8 H), 
3.87 (s, 6 H), 3.90 – 4.01 (m, 4 H), 4.12 – 4.17 (m, 4 H), 7.14 (s, 2 H), 7.98 – 8.09 (m, 2 H), 
8.10 – 8.19 (m, 3 H), 8.19 – 8.27 (m, 2 H), 8.66 (bs, 1 H), 8.81 ( bs, 1 H), 9.21 (bs, 1 H), 9.60 
(bs, 1 H), 12.56 (s, 1 H); - 13C-NMR (150 MHz, CDCl3): δ [ppm] = 28.0 (+, 2 C), 28.2 (+, 1 
C), 38.7 (-, 1 C), 52.4 (-, 1 C), 52.5 (+, 2 C), 53.7 (-, 2 C), 53.9 (-, 2 C), 54.4 (-, 1 C), 69.7 (-, 
2 C), 70.1 (-, 2 C), 70.2 (-, 2 C), 70.5 (-, 2 C), 83.2 (Cquat, 1 C), 112.8 (+, 1 C), 114.0 (+, 2 C), 
124.1 (+, 1 C), 124.7 (Cquat, 1 C), 125.3 (Cquat, 2 C), 125.3 (Cquat, 1 C), 125.5 (+, 1 C), 125.9 
(+, 1 C), 126.1 (+, 1 C), 126.4 (+, 1 C), 126.7 (+, 1 C), 127.0 (Cquat, 1 C), 127.3 (+, 1 C), 
128.2 (+, 1 C), 128.8 (+, 1 C), 130.5 (Cquat, 1 C), 131.2 (Cquat, 1 C), 150.2 (Cquat, 2 C), 153.3 
(Cquat, 1 C), 156.0 (Cquat, 1 C), 163.8 (Cquat, 1 C), 167.6 (Cquat, 2 C), 180.8 (Cquat, 1 C); - IR 
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(KBr): ν [cm-1] = 3313 (bm), 2947 (m), 2877 (m), 1720 (m), 1599 (m), 1573 (m), 1435 (m), 
1342 (m), 1285 (s), 1251 (s), 1191 (m), 1128 (s), 1051 (s), 980 (m), 913 (m), 847 (m), 812 
(m), 771 (m), 643 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
885.5 (100, MH+), 433.1 (56, (M+2H+)2+); - UV (MeOH): λ (ε) = 355 (27800), 282 (37100), 
225 (74000); - HRMS (PI-LSIMS FAB, glycerine): calc. for C47H57N4O13+: 885.3922, found: 
885.3919; - MF: C47H56N4O13 – FW: 884.99 g/mol; 
 
 
General procedure for the Boc deprotection of the pyrrole- and pyrene substituted motifs (GP 
VIII): 
 
The according starting material (0.1 mmol) was dissolved in 2.0 mL of dry, cold 
dichloromethane and a cold solution of HCl in diethylether (1.0 mL) was added. After four to 
six hours of stirring at room temperature under moisture protection, all volatiles were 
removed at reduced pressure. The residue was dissolved in a minimum amount of 
dichloromethane and the product was precipitated carefully by slow addition of diethyl ether. 
The solution was centrifuged, the diethyl ether was decanted off and the process was repeated. 
The product was vacuum dried to give a fine hygroscopic, faintly yellow powder. The yield is 
nearly quantitative. 
 
14-[2-(Pyrrole-2-carbonyl)-guanidino]-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester hydrochloride (39) 
O
N
O
O
O
O
O
O
O
O
O
N
+
O
N
H
2
+
NH
2
N
H
H Cl
Cl
 
Compound 37 (75 mg, 0.10 mmol) was deprotected after GP VIII. The product is a yellow, 
sticky oil (62 mg, 0.095 mmol, 95 %). 
 
1
H-NMR (400 MHz, CDCl3): δ [ppm] = 3.31 – 3.70 (m, 6 H), 3.71 – 3.79 (m, 6 H), 3.80 – 
4.11 (m, 12 H), 3.84 (s, 6 H), 4.13 – 4.29 (m, 4 H), 6.29 (m, 1 H), 7.07 (m, 1 H), 7.21 (s, 2 H), 
7.31 (m, 1 H), 9.89 (m, 1 H), 10.65 (bs, 1 H), 10.71 (bs, 1 H), 12.41 (bs, 1 H); - 13C-NMR 
(100 MHz, CDCl3): δ [ppm] = 41.3 (-, 1 C), 51.7 (-, 1 C), 52.5 (+, 2 C), 54.1 (-, 2 C), 65.3 (-, 
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2 C), 65.8 (-, 2 C), 68.6 (-, 2 C), 69.6 (-, 2 C), 70.4 (-, 2 C), 111.2 (+, 1 C), 113.3 (+, 2 C), 
117.8 (Cquat, 1 C), 118.8 (+, 1 C), 125.4 (Cquat, 2 C), 125.9 (+, 1 C), 149.9 (Cquat, 2 C), 155.1 
(Cquat, 1 C), 160.8 (Cquat, 1 C), 167.5 (Cquat, 2 C); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 650.2 (35, MH
+), 325.5 (100, (M+2H+)2+); - UV (MeOH): λ (ε) = 294 
(19400), 222 (27800); - HRMS (PI-LSIMS FAB, glycerine): calc. for C30H44N5O11
+: 
650.3037, found: 650.3052; - MF: C30H47N5O11Cl2 – FW: 724.64 g/mol; 
 
 
14-[2-[2-(Pyrene-1-carbonyl)-guanidino]-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-
dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-benzocycloheneicosene-2,3-dicarboxylic 
acid dimethyl ester hydrochloride (40) 
O
N
O
O
O
O
O
O
O
O
O
N
+
O
N
H
2
+
NH
2
H
Cl
Cl
 
Submitting 38 (89 mg, 0.10 mmol) to the deprotection conditions of GP VII, the product 40 
was obtained as a yellow glass (71 mg, 0.09 mmol, 90 %). 
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 3.39 – 3.51 (m, 4 H), 3.61 (m, 2 H), 3.62 – 3.79 (m, 
8 H), 3.82 (s, 6 H), 3.86 – 3.98 (m, 8 H), 4.00 (m, 2 H), 4.22 – 4.29 (m, 4 H), 7.21 (s, 2 H), 
8.02 – 8.09 (m, 2 H), 8.16 – 8.21 (m, 3 H), 8.22 – 8.28 (m, 3 H), 8.71 (m, 1 H), 9.31 (bs, 1 H), 
10.01 (bs, 1 H), 11.06 (bs, 1 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 36.2 (-, 1 C), 51.8 
(-, 1 C), 52.6 (+, 2 C), 54.1 (-, 2 C), 65.2 (-, 2 C), 68.5 (-, 2 C), 69.4 (-, 2 C), 70.3 (-, 2 C), 
70.4 (-, 2 C), 113.2 (+, 2 C), 123.8 (+, 1 C), 124.0 (Cquat, 1 C), 124.2 (+, 1 C), 124.7 (Cquat, 1 
C), 124.9 (Cquat, 1 C), 125.3 (+, 1 C), 125.5 (+, 1 C), 125.6 (+, 1 C), 125.6 (+, 1 C), 125.7 
(Cquat, 2 C), 127.2 (+, 1 C), 129.9 (+, 1 C), 130.2 (Cquat, 1 C), 130.7 (+, 1 C), 130.8 (Cquat, 1 
C), 149.9 (Cquat, 2 C), 155.7 (Cquat, 1 C), 167.6 (Cquat, 2 C), 171.6 (Cquat, 1 C); - IR (KBr): ν 
[cm-1] = 3292 (bm), 2940 (m), 2899 (m), 1683 (m), 1596 (m), 1514 (m), 1436 (m), 1350 (m), 
1286 (s), 1197 (s), 1131 (s), 1064 (m), 981 (m), 916 (m), 850 (m), 808 (m), 723 (m); - MS 
(ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 785.3 (46, MH
+), 393.1 (100, 
(M+2H+)2+); - UV (MeOH): λ (ε) = 351 (26300), 277 (35300), 222 (71200); - HRMS (PI-
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LSIMS FAB, glycerine): calc. for C42H49N4O11
+: 785.3398, found: 785.3401; - MF: 
C42H52N5O11Cl2 – FW: 859.81 g/mol; 
 
 
1.4. Solid phase synthesis of the test peptides 
 
Rink amide resin MBHA (novabiochem), piperidine (iris biotech), ethyl-diisopropyl-amine 
(DIPEA) (Fluka), dimethylformamide  (DMF)  (iris biotech), Fmoc amino acids  
(novabiochem), trifluoroacetic  acid  (TFA)  (Fluka),  triisopropylsilane  (TIS)  
(novabiochem), 1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide (EDC) (Sigma  Aldrich),  
O-Benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate (HBTU) (novabio-
chem), 1-hydroxybenzotriazole  (HOBt) (Sigma Aldrich), were  bought  and  used without 
further  purification.   
 
All peptides were synthesized on Rink Amide MBHA resin using Fmoc protecting group 
strategy. Coupling was done by HBTU / HOBt / DIPEA. HOBt and HBTU were used as a 
0.45 M solution, DIPEA as a 1.2 M solution in DMF. The Fmoc protected amino acids were 
dissolved in NMP as 0.5 M solutions. Every peptide was synthesized on 100 mg of resin in 
standard 5 mL syringe. The lot of the resin used had a loading of 0.72 mmol/g 
(manufacturer’s claims). The resin was allowed to preswell in DMF for 30 min. Each 
coupling was done twice using 1.0 mL of each solution per step and shaking for 2h each. 
Fmoc deprotection was done by shaking the resin with 40 % piperidine in DMF for 5 minutes, 
subsequent washing and addition of 20 % piperidine in DMF followed by shaking for 10 
minutes. The progress of the synthesis was monitored by the Kaiser test.12 
Capping was done for 3 h using 0.5 M of Ac2O in DMF, containing 1.2 M DIPEA as base. Of 
the solution 2 mL was used. After completion of the syntheses, the resin was washed with 
DMF and DCM (5 x 5 mL each).  
From the resin was cleaved by shaking for 3 h after addition of 3.0 mL of TFA / TIS / H2O 
(90:5:5) (vol/vol). The resin was removed by filtration and washed twice with TFA.  
Combined filtrates were concentrated under reduced pressure to about 1 mL without heating. 
It was then transferred to a Falcon tube and precipitated with cold Et2O. The precipitate was 
centrifuged at –5 °C for 20 minutes. The solution was then carefully decanted off and the 
precipitate resuspended in cold Et2O before being centrifuged again. Finally, the Et2O was 
decanted off again and the peptide dried under vacuum. The peptides were analysed by ES-
MS and 1H-NMR. 
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Ac-Glu-Lys-NH2:  
1
H-NMR (300 MHz, DMSO-d6): δ [ppm] = 1.31 (m, 2 H), 1.51 (m, 1+2 H), 1.68 (m, 2 H), 
1.86 (s, 3 H), 1.88 (m, 1 H), 2.22 (t, J = 8 Hz, 2 H), 2.72 (m, 2 H), 4.18 (m, 2 H), 7.04 (s, 1H, 
NH), 7.31 (s, 1H, NH), 7.70 (bs, 2H, NH), 7.91 (d, J = 8 Hz, 1H, NH), 8.09 (d, J = 8 Hz, 1H, 
NH); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 316.9 (100 %, MH
+); - 
MF: C13H25N4O5Cl – FW: 351.81 g/mol; 
 
Ac-Glu-Gly-Lys-NH2:  
1
H-NMR (300 MHz, DMSO-d6): δ [ppm] = 1.29 (m, 2 H), 1.51 (m, 1+2 H), 1.71 (m, 2 H), 
1.83 (s, 3 H), 1.84 (m, 1 H), 2.27 (t, J = 8 Hz, 2 H), 2.74 (m, 2 H), 3.78 (m, 2 H), 4.17 (m, 2 
H), 7.09 (s, 1H, NH), 7.31 (s, 1H, NH), 7.70 (bs, 2H, NH), 7.81 (d, J = 8Hz, 1H, NH), 8.17 (d, 
J = 8 Hz, 1H, NH), 8.23 (m, 1H, NH); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): 
m/z (%) = 374.0 (100 %, MH+); - MF: C15H28N5O6Cl – FW: 408.86 g/mol; 
 
Ac-Glu-Gly-Gly-Lys-NH2: 
1
H-NMR (300 MHz, DMSO-d6): δ [ppm] = 1.30 (m, 2 H), 1.52 (m, 1+2 H), 1.71 (m, 2 H), 
1.89 (s, 3 H), 1.90 (m, 1 H), 2.28 (t, J = 8 Hz, 2 H), 2.76 (m, 2 H), 3.78 (m, 4 H), 4.19 (m, 2 
H), 7.03 (s, 1H, NH), 7.30 (s, 1H, NH), 7.73 (bs, 2H, NH), 7.89 (d, J = 8Hz, 1H, NH), 8.10 
(m, 2H, NH), 8.29 (m, 1H, NH); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z 
(%) = 431.0 (100 %, MH+);  - MF: C17H31N6O7Cl – FW: 465.91 g/mol; 
 
The isomeric glutamic acid tetrapeptide sequences H-E-G-G-G-NH2, H-E-G-G-G-NH2, H-E-
G-G-G-NH2 and H-E-G-G-G-NH2 were prepared earlier. Their preparation, purification and 
analytics were already published.13 They were properly stored below -5 °C. HPLC analysis 
showed no decomposition. 
  
Chapter III 
 
 
2. Crystal structures of new compou
 
X-Ray structure and crystal data of 28:
  
Triclinic; Space group: P -1; unit cell dimensions: a = 5.8636(9) Å, 
9.7355(15) Å,  β = 102.225(18)°, c = 13.7186(19) 
Dx = 1.265 Mg/m3; µ = 0.225 mm
Data collection: T = 296 K; graphite monochromator. A colourless plate with dimensions of 
0.320 x 0.280 x 0.120 mm was used to measure 7804 reflections (2975 unique reflections, R
= 0.0414) from 2.35° to 26.86° on a STOE
Structure refinement: The F2 value was refined using the full
method, with a goodness-of-fit of 0.88 for all reflections and 176 parameters.
 
Table of atomic coordinates (x 10
103) for 28. U(eq) is defined as one third of the trace of
 
atom x
S(1) 
O(1) 
O(2) 
O(3) 
N(1) 
N(2) 
N(3) 
5412(1)
9832(2)
7990(3)
9290(2)
8306(3)
6518(2)
7776(3)
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nds 
 
α = 102.043(17)°, b = 
Å, γ = 93.521(19)°; V = 743.9(2) 
-1; F(000] = 300. 
-IPDS diffractometer with the rotation method. 
-matrix least squares refinement 
4) and equivalent isotropic displacement parameters (A2 
 the orthogonalized Uij tensor:
 y z 
 
 
 
 
 
 
 
18(1) 
-3172(1) 
-2274(1) 
-37(1) 
-1176(2) 
749(1) 
1629(2) 
3798(1) 
2731(1) 
3990(1) 
1247(1) 
2688(1) 
2188(1) 
-120(1) 
  
Å3; Z = 2, 
int 
 
 
 
x 
 
U(eq) 
67(1) 
62(1) 
75(1) 
70(1) 
60(1) 
54(1) 
66(1) 
Chapter III Supporting Information Dissertation A. Späth  
 
 - 46 - 
C(1) 
C(2) 
C(3) 
C(4) 
C(5) 
C(6) 
C(7) 
C(8) 
C(9) 
C(10) 
C(11) 
C(12) 
6872(3) 
8651(3) 
10571(3) 
8450(4) 
11672(5) 
12326(4) 
7637(3) 
6780(3) 
6673(5) 
4959(5) 
4999(4) 
3721(4) 
-121(2) 
-2236(2) 
-4417(2) 
-5323(2) 
-5195(2) 
-3915(2) 
674(2) 
1557(2) 
2509(2) 
3018(2) 
2417(2) 
1451(2) 
2799(1) 
3224(1) 
3131(1) 
3213(2) 
2303(2) 
4142(2) 
1386(1) 
686(1) 
-655(2) 
-201(2) 
644(1) 
3588(2) 
54(1) 
56(1) 
58(1) 
81(1) 
89(1) 
85(1) 
54(1) 
56(1) 
84(1) 
84(1) 
69(1) 
70(1) 
 
Table of bond lengths [Å] and angles [deg] for 28: 
 
bond length bond angle 
S(1)-C(1) 
S(1)-C(12) 
O(1)-C(2) 
O(1)-C(3) 
O(2)-C(2) 
O(3)-C(7) 
N(1)-C(1) 
N(1)-C(2) 
N(2)-C(1) 
N(2)-C(7) 
N(3)-C(8) 
N(3)-C(9) 
N(1)-H(1A) 
N(3)-H(3A) 
C(3)-C(6) 
C(3)-C(4) 
C(3)-C(5) 
C(7)-C(8) 
C(8)-C(11) 
C(9)-C(10) 
C(10)-C(11) 
C(4)-H(4A) 
C(4)-H(4B) 
C(4)-H(4C) 
C(5)-H(5A) 
C(5)-H(5B) 
C(5)-H(5C) 
C(6)-H(6A) 
1.7502(2) 
1.797(2) 
1.336(2) 
1.483(2) 
1.201(2) 
1.249(2) 
1.372(2) 
1.388(2) 
1.306(2) 
1.387(2) 
1.367(2) 
1.349(3) 
0.8600 
0.8600 
1.508(3) 
1.518(3) 
1.514(3) 
1.452(2) 
1.377(3) 
1.357(4) 
1.401(3) 
0.9600 
0.9600 
0.9600 
0.9600 
0.9600 
0.9600 
0.9600 
C(1)-S(1)-C(12) 
C(2)-O(1)-C(3) 
C(1)-N(1)-C(2) 
C(1)-N(2)-C(7) 
C(8)-N(3)-C(9) 
C(2)-N(1)-H(1A) 
C(1)-N(1)-H(1A) 
C(8)-N(3)-H(3A) 
C(9)-N(3)-H(3A) 
S(1)-C(1)-N(1) 
S(1)-C(1)-N(2) 
N(1)-C(1)-N(2) 
O(1)-C(2)-N(1) 
O(2)-C(2)-N(1) 
O(1)-C(2)-O(2) 
C(4)-C(3)-C(6) 
C(5)-C(3)-C(6) 
O(1)-C(3)-C(5) 
O(1)-C(3)-C(6) 
O(1)-C(3)-C(4) 
C(4)-C(3)-C(5) 
O(3)-C(7)-N(2) 
O(3)-C(7)-C(8) 
N(2)-C(7)-C(8) 
N(3)-C(8)-C(7) 
N(3)-C(8)-C(11) 
C(7)-C(8)-C(11) 
N(3)-C(9)-C(10) 
100.40(9) 
121.15(13) 
128.48(15) 
121.20(14) 
109.41(18) 
116.00 
116.00 
125.00 
125.00 
117.32(12) 
119.37(13) 
123.29(15) 
107.38(14) 
125.01(17) 
127.62(16) 
112.56(17) 
112.14(18) 
102.13(14) 
108.95(14) 
110.45(15) 
110.12(17) 
126.02(15) 
119.72(15) 
114.23(15) 
120.72(16) 
107.22(15) 
132.06(16) 
108.63(19) 
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C(6)-H(6B) 
C(6)-H(6C) 
C(9)-H(9) 
C(10)-H(10) 
C(11)-H(11) 
C(12)-H(12A) 
C(12)-H(12B) 
C(12)-H(12C) 
0.9600 
0.9600 
0.9300 
0.9300 
0.9300 
0.9600 
0.9600 
0.9600 
C(9)-C(10)-C(11) 
C(8)-C(11)-C(10) 
C(3)-C(4)-H(4A) 
C(3)-C(4)-H(4B) 
C(3)-C(4)-H(4C) 
H(4A)-C(4)-H(4B) 
H(4A)-C(4)-H(4C) 
H(4B)-C(4)-H(4C) 
C(3)-C(5)-H(5A) 
C(3)-C(5)-H(5B) 
C(3)-C(5)-H(5C) 
H(5A)-C(5)-H(5B) 
H(5A)-C(5)-H(5C) 
H(5B)-C(5)-H(5C) 
C(3)-C(6)-H(6A) 
C(3)-C(6)-H(6B) 
C(3)-C(6)-H(6C) 
H(6A)-C(6)-H(6B) 
H(6A)-C(6)-H(6C) 
H(6B)-C(6)-H(6C) 
N(3)-C(9)-H(9) 
C(10)-C(9)-H(9) 
C(9)-C(10)-H(10) 
C(11)-C(10)-H(10) 
C(8)-C(11)-H(11) 
C(10)-C(11)-H(11) 
S(1)-C(12)-H(12A) 
S(1)-C(12)-H(12B) 
S(1)-C(12)-H(12C)  
H(12A)-C(12)-H(12B) 
H(12A)-C(12)-H(12C) 
H(12B)-C(12)-H(12C) 
107.5(2) 
107.3(2) 
109.00 
109.00 
109.00 
109.00 
109.00 
109.00 
110.00 
110.00 
109.00 
109.00 
110.00 
109.00 
110.00 
109.00 
109.00 
109.00 
109.00 
109.00 
126.00 
126.00 
126.00 
126.00 
126.00 
126.00 
109.00 
109.00 
109.00 
109.00 
110.00 
109.00 
 
Table of torsion angles [deg] for 28: 
 
bond angle 
C(12)-S(1)-C(1)-N(1) 
C(12)-S(1)-C(1)-N(2) 
C(2)-O(1)-C(3)-C(6) 
C(2)-O(1)-C(3)-C(4) 
C(2)-O(1)-C(3)-C(5) 
C(3)-O(1)-C(2)-O(2) 
C(3)-O(1)-C(2)-N(1) 
C(2)-N(1)-C(1)-S(1) 
C(1)-N(1)-C(2)-O(1) 
C(1)-N(1)-C(2)-O(2) 
C(2)-N(1)-C(1)-N(2) 
C(7)-N(2)-C(1)-S(1) 
C(7)-N(2)-C(1)-N(1) 
C(1)-N(2)-C(7)-O(3) 
C(1)-N(2)-C(7)-C(8) 
-177.52(14) 
1.01(16) 
-64.8(2) 
59.4(2) 
176.46(16) 
-2.3(3) 
177.58(14) 
4.9(2) 
168.32(16) 
-11.8(3) 
-173.54(17) 
-179.91(12) 
-1.5(3) 
-11.2(3) 
170.70(15) 
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C(8)-N(3)-C(9)-C(10) 
C(9)-N(3)-C(8)-C(11) 
C(9)-N(3)-C(8)-C(7) 
O(3)-C(7)-C(8)-N(3) 
N(2)-C(7)-C(8)-C(11) 
N(2)-C(7)-C(8)-N(3) 
O(3)-C(7)-C(8)-C(11) 
N(3)-C(8)-C(11)-C(10) 
C(7)-C(8)-C(11)-C(10) 
N(3)-C(9)-C(10)-C(11) 
C(9)-C(10)-C(11)-C(8) 
0.2(2) 
0.2(2) 
179.80(17) 
-0.6(3) 
-2.9(3) 
177.65(15) 
178.88(19) 
-0.5(2) 
180.00(19) 
-0.5(3) 
0.6(2) 
 
 
 
 
3. 1H – and 13C-NMR spectra of new compounds 
 
For solvents and conditions of measurement, see experimental procedures. NMR spectra were 
recorded on Bruker Avance spectrometers 300, 400 and 600. Measuring temperature was 300 
K. TMS was used as external standard. 
 
Figure S-1: 1H-NMR spectrum of compound 28 
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Figure S-2: 13C-NMR spectrum of compound 28 
 
 
 
 
Figure S-3: 1H-NMR spectrum of compound 35 
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Figure S-4: 13C-NMR spectrum of compound 35 
 
 
 
 
Figure S-5: 1H-NMR spectrum of compound 36 
 
1
7
9
.9
3
0
5
1
6
9
.5
0
8
5
1
5
5
.3
2
5
9
1
5
2
.5
6
1
7
1
3
6
.6
6
0
1
1
3
2
.2
1
5
8
1
3
0
.1
1
5
8
1
2
9
.5
4
9
2
1
2
9
.1
9
7
6
1
2
7
.7
8
1
3
1
2
7
.6
0
5
5
1
2
7
.1
5
6
2
1
2
6
.9
0
2
2
1
2
6
.7
4
5
9
1
2
6
.3
0
6
4
1
2
4
.8
9
9
9
1
2
4
.4
9
9
4
1
2
3
.6
7
8
9
1
2
3
.0
6
3
6
8
2
.4
3
0
3
7
6
.4
1
3
5
7
5
.9
9
3
5
7
5
.5
6
3
7
4
4
.1
1
2
1
2
7
.0
7
7
4
(ppm)
102030405060708090100110120130140150160170180190
0
.8
4
4
2
0
.9
1
1
8
7
.1
1
0
6
5
.0
0
0
0
1
.6
4
2
7
In
te
g
ra
l
9
.0
6
9
9
9
.0
3
9
8
8
.5
4
8
7
8
.5
2
2
2
8
.2
2
5
0
8
.1
9
9
4
8
.1
6
3
8
8
.1
4
5
5
8
.1
3
1
8
8
.1
0
1
6
8
.0
7
1
4
8
.0
4
9
5
8
.0
2
3
9
7
.3
6
3
7
7
.3
4
6
3
7
.3
2
8
9
7
.2
6
1
2
4
.4
1
2
9
(ppm)
3.54.04.55.05.56.06.57.07.58.08.59.09.5
N
H
N
H
O
N
O
O
N
H
2
+
NH
2
O
N
Chapter III Supporting Information Dissertation A. Späth  
 
 - 51 - 
 
Figure S-6: 1H-NMR spectrum of compound 25 
 
 
 
 
 
Figure S-7: 13C-NMR spectrum of compound 25 
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Figure S-8: 1H-NMR spectrum of compound 18 
 
 
 
 
 
Figure S-9: 13C-NMR spectrum of compound 18 
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Figure S-10: 1H-NMR spectrum of compound 4b 
 
 
 
 
 
Figure S-11: 13C-NMR spectrum of compound 4b 
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Figure S-12: 1H-NMR spectrum of compound 4c 
 
 
 
 
 
Figure S-13: 13C-NMR spectrum of compound 4c 
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Figure S-14: 1H-NMR spectrum of compound 4d 
 
 
 
 
 
Figure S-15: 13C-NMR spectrum of compound 4d 
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Figure S-16: 1H-NMR spectrum of compound 4e 
 
 
 
 
 
Figure S-17: 13C-NMR spectrum of compound 4e 
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Figure S-18: 1H-NMR spectrum of compound 6 
 
 
 
 
 
Figure S-19: 13C-NMR spectrum of compound 6 
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Figure S-20: 1H-NMR spectrum of compound 17 
 
 
 
 
 
Figure S-21: 13C-NMR spectrum of compound 17 
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Figure S-22: 1H-NMR and COSY spectra of compound E-2 
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Figure S-23: 13C-NMR and HSQC spectrum of compound E-2 
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Figure S-24: 1H-NMR spectrum of compound 13a 
 
 
 
 
 
 
Figure S-25: 13C-NMR spectrum of compound 13a 
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Figure S-26: 1H-NMR spectrum of compound 15a 
 
 
 
 
 
Figure S-27: 13C-NMR spectrum of compound 15a 
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Figure S-28: 1H-NMR spectrum of compound 11a 
 
 
 
 
 
Figure S-29: 13C-NMR spectrum of compound 11a  
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Figure S-30: 1H-NMR spectrum of compound 12a 
 
 
 
 
Figure S-31: 13C-NMR spectrum of compound 12a 
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Figure S-32: 1H-NMR spectrum of compound 13b 
 
 
 
 
 
Figure S-33: 13C-NMR spectrum of compound 13b 
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Figure S-34: 1H-NMR spectrum of compound 15b 
 
 
 
 
 
 
Figure S-35: 13C-NMR spectrum of compound 15b  
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Figure S-36: 1H-NMR spectrum of compound 11b 
 
 
 
 
 
Figure S-37: 13C-NMR spectrum of compound 11b 
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Figure S-38: 1H-NMR spectrum of compound 12b 
 
 
 
 
 
Figure S-39: 13C-NMR spectrum of compound 12b 
0
.9
7
8
6
2
.0
0
0
0
1
.9
3
1
1
4
.0
4
1
1
1
0
.1
8
3
4
.0
9
9
8
4
.2
3
1
6
3
.9
6
7
9
2
.4
4
2
7
2
.1
1
7
4
4
.0
1
5
6
1
.9
9
3
5
4
.2
0
3
0
8
.0
3
2
1
1
2
.0
3
2
2
.4
3
7
7
In
te
g
ra
l
7
.9
2
5
7
7
.2
3
2
6
7
.1
3
6
6
6
.7
8
6
4
4
.1
5
3
9
3
.8
1
1
0
3
.7
4
3
3
3
.6
5
2
8
3
.6
1
6
2
3
.5
0
8
3
3
.3
1
9
9
3
.0
7
9
4
2
.8
8
1
0
1
.8
3
3
1
1
.6
6
3
0
1
.5
0
1
2
1
.4
6
4
6
1
.4
2
4
4
1
.3
5
0
3
1
.3
2
4
7
1
.2
7
3
5
1
.1
2
9
9
(ppm)
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
1
6
7
.7
4
0
8
1
5
4
.9
1
5
9
1
5
0
.3
0
5
6
1
2
5
.3
9
8
2
1
1
3
.4
3
2
8
7
7
.5
1
7
3
7
7
.3
0
2
5
7
7
.0
9
7
3
7
6
.6
6
7
6
7
0
.8
5
5
8
7
0
.4
3
5
8
6
9
.4
8
8
4
6
8
.9
7
0
7
6
7
.0
3
6
7
5
4
.2
5
0
9
5
3
.3
8
1
6
5
2
.6
2
9
5
4
5
.8
7
0
3
4
2
.3
1
4
9
3
3
.0
6
5
0
2
6
.5
7
9
3
2
5
.0
2
6
2
2
4
.8
6
0
2
2
2
.2
9
1
3
8
.7
8
2
7
(ppm)
102030405060708090100110120130140150160170180190
N
N
H
N
H
O
O
O
O
O
O
O
O
O
N
O
N
N
H
N
H
O
O
O
O
O
O
O
O
O
N
O
Chapter III Supporting Information Dissertation A. Späth  
 
 - 69 - 
 
Figure S-40: 1H-NMR spectrum of compound 13c 
 
 
 
 
 
Figure S-41: 13C-NMR spectrum of compound 13c 
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Figure S-42: 1H-NMR spectrum of compound 15c 
 
 
 
 
 
 
Figure S-43: 13C-NMR spectrum of compound 15c  
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Figure S-44: 1H-NMR spectrum of compound 11c 
 
 
 
 
 
Figure S-45: 13C-NMR spectrum of compound 11c 
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Figure S-46: 1H-NMR and COSY spectrum of compound 12c 
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Figure S-47: 13C-NMR spectrum of compound 12c 
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Figure S-48: 1H-NMR spectrum of compound 13d 
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Figure S-49: 13C-NMR and HSQC spectrum of compound 13d 
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Figure S-50: 1H-NMR spectrum of compound 15d 
 
 
 
 
 
Figure S-51: 13C-NMR spectrum of compound 15d   
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Figure S-52: 1H-NMR spectrum of compound 11d 
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Figure S-53: 13C-NMR spectrum of compound 11d 
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Figure S-54: 1H-NMR spectrum of compound 12d  
 
 
 
 
Figure S-55: 13C-NMR spectrum of compound 12d 
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Figure S-56: 1H-NMR spectrum of compound 13e 
 
 
 
 
 
Figure S-57: 13C-NMR spectrum of compound 13e  
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Figure S-58: 1H-NMR spectrum of compound 11e 
 
 
 
 
 
Figure S-59: 13C-NMR spectrum of compound 11e  
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Figure S-60: 1H-NMR spectrum of compound 12e 
 
 
 
 
Figure S-61: 13C-NMR spectrum of compound 12e 
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Figure S-62: 1H-NMR spectrum of compound 38 
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Figure S-63: 13C-NMR spectrum of compound 38 
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Figure S-64: 1H-NMR spectrum of compound 37 
 
O
N
O
O
O
O
O
O
O
O
O
N
O
N
H
N
HO
O N
H
Chapter III Supporting Information Dissertation A. Späth  
 
 - 86 - 
 
 
 
 
Figure S-65: 13C-NMR spectrum of compound 37 
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Figure S-66: 1H-NMR spectrum of compound 31 
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Figure S-67: 13C-NMR spectrum of compound 31 
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Figure S-68: 1H-NMR spectrum of compound 30 
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Figure S-69: 13C-NMR spectrum of compound 30 
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Figure S-70: 1H-NMR spectrum of compound 14a 
 
 
 
 
 
Figure S-71: 13C-NMR spectrum of compound 14a 
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Figure S-72: 1H-NMR spectrum of compound 16a 
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Figure S-73: 13C-NMR spectrum of compound 16a 
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Figure S-74: 1H-NMR spectrum of compound 14b 
 
 
 
Figure S-75: 1H-NMR spectrum of compound 16b 
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Figure S-76: 13C-NMR spectrum of compound 16b 
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Figure S-77: 1H-NMR spectrum of compound 14c  
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Figure S-78: 1H-NMR spectrum of compound 14d 
 
 
 
 
 
Figure S-79: 1H-NMR spectrum of compound 14d 
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Figure S-80: 1H-NMR and HSQC spectrum of compound 16d 
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Figure S-81: 1H-NMR spectrum of compound 14e 
 
 
 
Figure S-82: 1H-NMR spectrum of compound 40 
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Figure S-83: 13C-NMR and HSQC spectrum of compound 40  
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Figure S-84: 1H-NMR spectrum of compound 39  
 
 
 
 
 
Figure S-85: 1H-NMR spectrum of compound 33 
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Figure S-86: 13C-NMR and HSQC spectrum of compound 33 
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Figure S-87: 1H-NMR spectrum of compound 32  
 
 
 
 
 
Figure S-88: 1H-NMR spectrum of compound 24  
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Figure S-89: 13C-NMR spectrum of compound 24  
 
 
 
 
 
Figure S-90: 1H-NMR spectrum of compound 26  
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Figure S-91: 13C-NMR spectrum of compound 26  
 
 
 
 
 
Figure S-92: 1H-NMR spectrum of compound 27  
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Figure S-93: 1H-NMR spectrum of compound 21  
 
 
 
 
 
Figure S-94: 13C-NMR spectrum of compound 21   
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4. pH dependencies, simulations and pKa values 
 
4.1.  pH titration of selected receptors 
 
The protonation of the crown ether moiety is investigated by pH-titration with perchloric 
acid14. From the binding constants (K), the KS- values can be calculated. Without free 
guanidine this measurement is eased, but should still give the values in good approximation to 
the according unprotected species.15 
SKHX
H
K
1
][*][
]X[
==
+
+
 
⇒  log K = pKa 
Equation 1: Relationship between binding constant K and the acidity constant KS 
 
Compound Emission (λmax) K [M
-1
] pKa Ioo  /I0 
(13a) 389 nm 3.6 * 10
5 5.6 1.7 
(E-2) 389 nm 3.5 * 105 5.6 1.7 
(13b) 390 nm 3.9 * 105 5.6 1.6 
(13c) 389 nm 6.9 * 105 5.9 1.6 
(13d) 391 nm 4.1 * 106 6.6 1.7 
(13e) 390 nm 3.2 * 105 5.5 1.5 
solvent: water (2 % methanol) 
Table S-5: Emission properties of selected protected receptors upon titration with HClO4 
Comparison of entry 13a (Boc) and E-2 (Cbz), shows, that the Boc group is not affected 
under the titration conditions with the diluted acid.  
 
 
4.2. Dependency of the pH value on the methanol content in the mixture 
 
Aqueous HEPES buffer solutions (50 mM, no salt addition, tetraethylammoniumhydroxide or 
HCl for equibrillation) in the range of pH 2 to pH 11 were mixed in different ratios with 
methanol (uvasol). The pH values of the mixtures were measured after mixing and standing 
for five minutes with the aid of a pH electrode for methanolic solutions: 
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pH of the buffer 
solution 
pH of the Methanol / Buffer mixture 
1:1 7:3 9:1 
3 2.9(7) 2.8(4) 2.5(3) 
4 3.9(0) 3.7(3) 3.4(4) 
5 4.7(7) 4.7(1) 4.6(1) 
6 5.9(0) 5.9(1) 5.7(9) 
7 6.8(8) 6.8(4) 6.7(1) 
8 7.8(9) 7.8(1) 7.6(4) 
9 8.8(7) 8.8(0) 8.5(6) 
  
Table S-6: pH dependency of buffer solutions on the methanol content 
 
 
4.3. Dependency of the emission on the pH value in methanol / water mixture 
 
Aqueous HEPES buffer solutions (50 mM, no salt addition, tetraethylammoniumhydroxide or 
HCl for equibrillation) in the range of pH 3 to pH 10 and mixed with 5*10-5 molar solutions 
of the receptors in methanol (uvasol) in the ration 1:9. The pH value of the mixtures was 
checked after mixing with the aid of a pH electrode for methanolic solutions. After standing 
for five minutes the emission spectrum was recorded (deprotonated sample emission  
~ 300 a.u.). Table S-3 summarizes the results (rounded average of three measurements) 
 
pH 
value 
3 4 5 6 7 8 9 10 
11a 190 190 140 70 10 0 0 0 
11b 190 190 180 140 90 50 10 0 
11c 180 180 180 170 150 90 20 0 
11d 200 200 200 190 160 100 20 0 
11e 200 200 180 130 40 10 0 0 
39 200 150 100 70 30 10 0 0 
32 180 180 180 150 100 20 0 0 
21 170 170 170 150 80 40 0 0 
40 440 430 360 260 200 100 20 0 
33 450 450 360 180 50 20 10 0 
 
Table S-7: pH dependency of the luminescent output of representative receptors 
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Figure S-95: Shift of the emission maximum of compound 40 (left) and 33 (right) with 
decreasing pH according to table S-7 
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Figure S-96: Fluorescence enhancement of the receptor classes depending on the pH value of 
the solution (see table S-3) 
400 450 500
0
200
400
600
800
1000
Wavelength (nm)
In
te
n
s
it
y
 (
a
.u
.)
448,25 , 722,707
420,10 , 157,205
400 450 500
0
200
400
600
800
1000
Wavelength (nm)
In
te
n
s
it
y
 (
a
.u
.)
445,54 , 689,956
416,31 , 155,022
Chapter III Supporting Information Dissertation A. Späth  
 
 - 110 - 
4.4. Simulation of the properties of selected compounds 
 
Physical properties like solubility, log P values, index of refraction and the expected pKa 
values were simulated with the aid of the structure calculator Ver.12.1. of the ACD Labs 
program package. 
 
 
Name Value
LogP 0.82
MW 556.61
PSA 175.62
FRB 7
HDonors 4
HAcceptors 14
Rule Of 5 2
Molar Refractivity, cm^3 135.96
Molar Volume, cm^3 431.16
Parachor, cm^3 1127.87
Index of Refraction 1.54
Surface Tension, dyne/cm 46.82
Density, g/cm^3 1.29
Polarizability, 10e-24 cm^3 53.9
Boiling Point, °C 701.8
105
-3
-2
-1
0
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
2 MB 13.21 0.7
21 B 5.82 0.2
5 B -2.72 0.7
105
200
400
600
800
1000
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 1000 B
5.5 35.3 B
6.5 15.38 B
7.4 13.42 B
10 12.25 B
Intrinsic Solubility, mg/ml 0.1314
Intrinsic Solubility, log(S, mol/l) -3.6269
Solubility in Pure Water at pH = 11.5, mg/ml 4.0454
pH LogD
2 -3.27
5.5 -1.61
6.5 -1.25
7.4 -1.19
10 -1.15
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
 
Figure S-97: Simulation of the properties of compound 14a 
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Name Value
LogP 0.93
MW 598.64
PSA 178.7
FRB 7
HDonors 3
HAcceptors 15
Rule Of 5 2
Molar Refractivity, cm^3 146.98
Molar Volume, cm^3 467.49
Parachor, cm^3 1215.84
Index of Refraction 1.54
Surface Tension, dyne/cm 45.75
Density, g/cm^3 1.28
Polarizability, 10e-24 cm^3 58.27
105
-2
-1
0
1
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
38 MA 12.57 0.46
36 MB 8.12 0.7
16 B 5.71 0.2
38 B -1.76 0.7
105
200
400
600
800
1000
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 1000 B
5.5 6.53 B
6.5 0.77 BN
7.4 0.23 BN
10 0.15 N
Intrinsic Solubility, mg/ml 0.1522
Intrinsic Solubility, log(S, mol/l) -3.5948
Solubility in Pure Water at pH = 8.76, mg/ml 0.1557
pH LogD
2 -3.14
5.5 -0.7
6.5 0.22
7.4 0.75
10 0.93
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-98: Simulation of the properties of compound 16a 
 
Name Value
LogP 3.28
MW 640.77
PSA 147.64
FRB 9
HDonors 2
HAcceptors 14
Rule Of 5 2
Molar Refractivity, cm^3 165.15
Molar Volume, cm^3 539.68
Parachor, cm^3 1354.67
Index of Refraction 1.52
Surface Tension, dyne/cm 39.7
Density, g/cm^3 1.19
Polarizability, 10e-24 cm^3 65.47
Boiling Point, °C 708.94
105
0
1
2
3
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
36 MB 13.92 0.7
16 B 6.21 0.2
39 B -0.44 0.7
105
50
100
150
200
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 206.51 B
5.5 36.99 B
6.5 5.83 B
7.4 2.18 B
10 1.14 B
Intrinsic Solubility, mg/ml 1.6429e-2
Intrinsic Solubility, log(S, mol/l) -4.5911
Solubility in Pure Water at pH = 10.64, mg/ml 0.5619
pH LogD
2 -0.82
5.5 -7.12e-2
6.5 0.73
7.4 1.16
10 1.44
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-99: Simulation of the properties of compound 11a 
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Name Value
LogP 3.84
MW 668.82
PSA 147.64
FRB 11
HDonors 2
HAcceptors 14
Rule Of 5 2
Molar Refractivity, cm^3 174.37
Molar Volume, cm^3 571.72
Parachor, cm^3 1431.89
Index of Refraction 1.52
Surface Tension, dyne/cm 39.35
Density, g/cm^3 1.17
Polarizability, 10e-24 cm^3 69.12
Boiling Point, °C 730.06
105
0
1
2
3
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
2 MB 14.26 0.7
27 B 7.62 0.2
5 B 0.99 0.7
105
50
100
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 140.79 B
5.5 72.56 B
6.5 14.35 B
7.4 2.93 B
10 0.81 B
Intrinsic Solubility, mg/ml 1.1185e-2
Intrinsic Solubility, log(S, mol/l) -4.7767
Solubility in Pure Water at pH = 10.61, mg/ml 0.4399
pH LogD
2 -0.26
5.5 3.12e-2
6.5 0.73
7.4 1.42
10 1.98
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-100: Simulation of the properties of compound 11b 
 
Name Value
LogP 4.64
MW 696.87
PSA 147.64
FRB 13
HDonors 2
HAcceptors 14
Rule Of 5 2
Molar Refractivity, cm^3 183.59
Molar Volume, cm^3 603.74
Parachor, cm^3 1509.11
Index of Refraction 1.52
Surface Tension, dyne/cm 39.04
Density, g/cm^3 1.15
Polarizability, 10e-24 cm^3 72.78
Boiling Point, °C 747.5
105
1
2
3
4
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
2 MB 14.31 0.7
28 B 7.84 0.2
5 B 1.21 0.7
105
20
40
60
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 75.61 B
5.5 48.24 B
6.5 11.72 B
7.4 2.21 B
10 0.46 B
Intrinsic Solubility, mg/ml 6.006e-3
Intrinsic Solubility, log(S, mol/l) -5.0646
Solubility in Pure Water at pH = 10.53, mg/ml 0.2901
pH LogD
2 0.54
5.5 0.73
6.5 1.35
7.4 2.07
10 2.76
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-101: Simulation of the properties of compound 11c 
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Name Value
LogP 2.89
MW 742.92
PSA 203.79
FRB 12
HDonors 4
HAcceptors 16
Rule Of 5 2
Molar Refractivity, cm^3 192.41
Molar Volume, cm^3 605.61
Parachor, cm^3 1538.82
Index of Refraction 1.55
Surface Tension, dyne/cm 41.69
Density, g/cm^3 1.23
Polarizability, 10e-24 cm^3 76.28
Boiling Point, °C 791.43
105
-1
0
1
2
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
13 A 15.98 0.7
2 MB 14.98 0.7
13 MA 13.23 0.7
29 B 7 0.2
105
200
400
600
800
1000
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 511.95 B
5.5 94.34 B
6.5 14.69 B
7.4 5.03 B
10 2.67 B
Intrinsic Solubility, mg/ml 3.6086e-2
Intrinsic Solubility, log(S, mol/l) -4.3136
Solubility in Pure Water at pH = 10.72, mg/ml 1.2582
pH LogD
2 -1.26
5.5 -0.53
6.5 0.28
7.4 0.74
10 0.89
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-102: Simulation of the properties of compound 11e 
 
Name Value
LogP 4.53
MW 716.86
PSA 147.64
FRB 10
HDonors 2
HAcceptors 14
Rule Of 5 2
Molar Refractivity, cm^3 190.25
Molar Volume, cm^3 607.24
Parachor, cm^3 1531.53
Index of Refraction 1.54
Surface Tension, dyne/cm 40.46
Density, g/cm^3 1.18
Polarizability, 10e-24 cm^3 75.42
Boiling Point, °C 765.03
105
1
2
3
4
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
2 MB 13.27 0.7
23 B 6.75 0.2
5 B 0.24 0.7
105
20
40
60
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 58.43 B
5.5 7.39 B
6.5 1.24 B
7.4 0.56 B
10 7.61e-2 BN
Intrinsic Solubility, mg/ml 4.6519e-3
Intrinsic Solubility, log(S, mol/l) -5.1878
Solubility in Pure Water at pH = 9.76, mg/ml 0.1159
pH LogD
2 0.43
5.5 1.33
6.5 2.11
7.4 2.45
10 3.32
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-103: Simulation of the properties of compound 11d 
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Name Value
LogP 1.09
MW 623.66
PSA 203.83
FRB 8
HDonors 4
HAcceptors 17
Rule Of 5 2
Molar Refractivity, cm^3 152.69
Molar Volume, cm^3 454.71
Parachor, cm^3 1223.94
Index of Refraction 1.59
Surface Tension, dyne/cm 52.49
Density, g/cm^3 1.37
Polarizability, 10e-24 cm^3 60.53
Boiling Point, °C 764.22
105
-2
-1
0
1
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
4 MB 10.81 0.7
22 B 4.93 0.2
43 B -0.97 0.12
4 B -4.67 0.5
105
200
400
600
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 535.92 B
5.5 6.35 B
6.5 4.84 B
7.4 4.3 B
10 0.15 BN
Intrinsic Solubility, mg/ml 4.7442e-2
Intrinsic Solubility, log(S, mol/l) -4.1188
Solubility in Pure Water at pH = 10.1, mg/ml 0.131
pH LogD
2 -2.97
5.5 -1.04
6.5 -0.92
7.4 -0.87
10 0.58
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-104: Simulation of the properties of compound 27 
 
Name Value
LogP -1.03
MW 686.77
PSA 141.93
FRB 8
HDonors 0
HAcceptors 15
Rule Of 5 2
105
-1.75
-1.50
-1.25
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
16 MB 5.06 0.2
36 B -3.23 0.7
105
80
160
240
320
400
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 446.25 B
5.5 59.03 B
6.5 46.43 B
7.4 45.16 B
10 44.98 B
Intrinsic Solubility, mg/ml 44.9776
Intrinsic Solubility, log(S, mol/l) -1.1838
Solubility in Pure Water at pH = 8.94, mg/ml 44.9829
pH LogD
2 -2.02
5.5 -1.14
6.5 -1.04
7.4 -1.03
10 -1.03
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-105: Simulation of the properties of compound 21 
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Name Value
LogP 1.63
MW 649.69
PSA 191.99
FRB 8
HDonors 4
HAcceptors 16
Rule Of 5 2
Molar Refractivity, cm^3 161.5
Molar Volume, cm^3 492.54
Parachor, cm^3 1304.16
Index of Refraction 1.57
Surface Tension, dyne/cm 49.15
Density, g/cm^3 1.32
Polarizability, 10e-24 cm^3 64.02
105
-2
-1
0
1
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
5 MA 16.39 0.5
11 MB 11.77 0.7
11 B 7.86 0.7
11 B 5.99 0.7
105
100
200
300
400
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 470.59 B
5.5 7.92 B
6.5 0.46 BN
7.4 8.45e-2 BN
10 3.94e-2 AN
Intrinsic Solubility, mg/ml 3.7597e-2
Intrinsic Solubility, log(S, mol/l) -4.2375
Solubility in Pure Water at pH = 8.62, mg/ml 4.0441e-2
pH LogD
2 -2.47
5.5 -0.69
6.5 0.55
7.4 1.28
10 1.61
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-106: Simulation of the properties of compound 39 
 
Name Value
LogP 2.91
MW 725.79
PSA 194.49
FRB 9
HDonors 4
HAcceptors 16
Rule Of 5 2
Molar Refractivity, cm^3 186.6
Molar Volume, cm^3 560.1
Parachor, cm^3 1481.03
Index of Refraction 1.58
Surface Tension, dyne/cm 48.89
Density, g/cm^3 1.3
Polarizability, 10e-24 cm^3 73.98
105
0
1
2
3
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
5 A 16.25 0.5
1 MA 11.26 0.46
9 MB 7.22 0.7
27 B 6.66 0.2
105
20
40
60
80
100
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 101.2 B
5.5 1.57 B
6.5 5.34e-2 BN
7.4 1.22e-2 BN
10 8.51e-3 AN
Intrinsic Solubility, mg/ml 8.0631e-3
Intrinsic Solubility, log(S, mol/l) -4.9543
Solubility in Pure Water at pH = 8.07, mg/ml 8.9064e-3
pH LogD
2 -1.19
5.5 0.62
6.5 2.09
7.4 2.73
10 2.88
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-107: Simulation of the properties of compound 32 
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Name Value
LogP 5.03
MW 784.85
PSA 176.2
FRB 8
HDonors 3
HAcceptors 15
Rule Of 5 3
Molar Refractivity, cm^3 206.1
Molar Volume, cm^3 594.46
Parachor, cm^3 1583.34
Index of Refraction 1.61
Surface Tension, dyne/cm 50.33
Density, g/cm^3 1.32
Polarizability, 10e-24 cm^3 81.71
105
2
3
4
5
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
1 MA 10.9 0.46
7 MB 7.06 0.7
7 B 5.19 0.7
1 B -2.78 0.7
105
1
2
3
4
5
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 5.6 B
5.5 8.32e-2 B
6.5 5.49e-3 BN
7.4 1.03e-3 BN
10 5.24e-4 AN
Intrinsic Solubility, mg/ml 4.4749e-4
Intrinsic Solubility, log(S, mol/l) -6.244
Solubility in Pure Water at pH = 7.65, mg/ml 7.7698e-4
pH LogD
2 0.93
5.5 2.76
6.5 3.94
7.4 4.67
10 4.96
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-108: Simulation of the properties of compound 40 
 
Name Value
LogP 6.46
MW 860.95
PSA 178.7
FRB 9
HDonors 3
HAcceptors 15
Rule Of 5 3
Molar Refractivity, cm^3 231.21
Molar Volume, cm^3 661.93
Parachor, cm^3 1760.21
Index of Refraction 1.62
Surface Tension, dyne/cm 50
Density, g/cm^3 1.3
Polarizability, 10e-24 cm^3 91.66
105
3
4
5
6
L
o
g
D
 Acidic/Basic  Acidic/Basic Apparent pKa Value Error
1 MA 10.71 0.46
23 MB 6.86 0.2
5 B 6.1 0.7
1 B -2.75 0.7
105
0.5
1.0
1.5
S
o
l,
 m
g
/m
l
pH Sol, mg/ml Flags
2 1.6 B
5.5 1.61e-2 B
6.5 6.75e-4 BN
7.4 1.82e-4 BN
10 1.53e-4 AN
Intrinsic Solubility, mg/ml 1.276e-4
Intrinsic Solubility, log(S, mol/l) -6.8291
Solubility in Pure Water at pH = 7.22, mg/ml 2.1228e-4
pH LogD
2 2.36
5.5 4.35
6.5 5.73
7.4 6.3
10 6.38
pKa Results
Solubility Results
Single-valued Properties
LogD Results
 
Figure S-109: Simulation of the properties of compound 33 
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5. Screenings and binding studies via fluorescence and UV measurements  
 
5.1. General methods, material and sample preparation   
  
Emission Spectroscopy.  Fluorescence measurements were performed with UV-grade solvents 
(Merck, Baker or Acros) in 1 cm quartz cuvettes (Hellma) and recorded on a Varian ‘Cary 
Eclipse’ fluorescence spectrophotometer with temperature control. To determine the binding 
constants and Job´s plots fluorescence titration experiments were carried out. 
  
Absorption Spectroscopy.  Absorption  were  recorded  on  a  Varian  Cary  BIO  50 
UV/VIS/NIR  Spectrometer  with temperature  control  by  use  of  a  1  cm  quartz  cuvettes  
(Hellma)  and  Uvasol solvents or of quality for spectrophotometrical investigations (Merck, 
Baker or Acros). 
 
Sample preparation. As a standard solvent mixture 10 % water in methanol was used. No 
buffer or salt was added.  The exact solutions have been prepared by adding to a weighed 
amount of receptor or substrate, the calculated amount of solvent necessary by means of 
microliter precision pipettes. This method is more accurate than to determine exactly the 
weighed amount (to 10-5 g) and admit a certain volume, since the volume measurement has a 
higher accuracy than the weight determination. The receptor was first dissolved in the 
methanol content of the solvent mixture, then the water content was added lacking 100 µl, to 
have room to adjust the pH. For pH adjusting 1 M tetraethylammoniumhydroxide or 
hydrochloric acid of pro analysi quality in high-purity water was used. Thereafter, the water 
difference filled up to the full volume. 
For measurements with pyrene substituted compounds, all solvents used were degassed prior 
to the titration by treatment with ultrasound in the already filled cells. 
Receptor solutions were stored properly stoppered and closed with parafilm at maximum for 
one week in the refrigerator at -4 °C. They were freshly prepared every week from deep 
frozen aliquots of the receptor material. Amino acid solutions were kept at -4 °C properly 
stoppered and closed with parafilm for maximal one week. Peptide solutions were always 
freshly prepared from the properly dried and carefully stored material (nitrogen, -20 °C). 
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5.2. Fluorescence data 
 
All fluorescence experiments were performed on a Varian Cary Eclipse Fluorimeter. To 
determine the binding constants, fluorescence titration experiments were carried out. The 
screening of the amino acids and the synthesized peptide library was conducted in a microtiter 
plate (96 wells half area, UV star material). The fluorescence intensity was found to be 
constant after 5 min. 
 
Screening conditions:   
 
Solvent:     methanol / water 9:1 (vol/vol) 
Well volume:     200 µL  
Concentration [crown ether guanidine]:  0.03 - 0.05 mM  
Concentration [amino acid or peptide]: 10.0 - 50.0 mM  
 
 
Instrument Parameters:   
 
Excitation wavelength:   λex = 300 nm   
Detection wavelength:   λ = 320 – 470 nm and 360 – 530 nm 
Temperature:     T = 298 K  
PMT voltage:     500 - 600 volts 
Excitation slit:    10 nm 
Emission slit:     10 nm      
  
Procedure: To each column in the microtiter plate samples of the receptor with 150 to 500 eq. 
of the corresponding amino acid or peptide and the receptor without added peptide but 
volume corrected as reference were given. Emission spectra for all wells were recorded. 
Every solution was pH adjusted before to pH 7.5 - 8 or pH 6.5, depending on the receptor 
used (see table above)  
 
For amino acids and peptides inducing a significant emission increase over the parent 
compound (> 30 %) the binding constant and stoichiometry of the respective guest with 
selected receptors were determined by emission titration in a cuvette  
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Emission titrations: 
 
Titration conditions (amino acids and related guests):  
Solvent:      MeOH / H2O 9:1 (vol/vol), pH 6.5 or pH 7.5 - 8.5  
Starting volume:     1.2 mL  
Concentration [crown ether guanidine]:  0.02 mM  
Concentration [amino acid or peptide]:  30.0 mM  
 
Instrument Parameters 
Excitation wavelength:   λex = 300 nm  
Detection wavelength:   λ = 320 – 470 nm and 360 – 530 nm 
Temperature:     T = 298 K 
PMT voltage      700 volts     
 
 
Titration conditions (peptides):   
Solvent:      90 % aqueous methanol, pH 7.5 - 8.5 or 6.5  
Starting volume:     1.2 mL 
Concentration [receptor]:    2.0 * 10-5 M  
Concentration [guest]:    1 * 10-2 M or 5 * 10-3 M 
 
Instrument Parameters  
Excitation wavelength:     λex = 300 nm   
Detection wavelength:     λ = 320 – 500 nm or 360 – 550 nm  
Temperature:          T = 298 K  
PMT voltage:           600 volts      
 
Procedure: To a cuvette with 1.2 mL of the receptor in 90% aqueous methanol (pH adjusted, 
no salt added) were added 10 µL (≙ 1 eq.) aliquots of the amino acid or peptide solution (pH 
adjusted) or it was titrated stepwise with small amounts 5  –  100  µL, depending  on  the  
initial emission  response, of the  substrate solution. After each addition the solution was 
allowed to equilibrate for 5 min before the fluorescence intensity or the UV spectrum (see 
Figure 18 for a representative example) were recorded.  The stoichiometry was determined by 
Job´s plot analysis extracted from titration data16. 
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The pH value was checked before and after every titration with the aid of a pH electrode 
suitable for methanol/water mixtures. Measurements with the pH differing more than 0.5 units 
before and after the titrations were not used. 
To determine the binding constant the obtained fluorescence intensities were volume 
corrected, plotted against the concentration of peptide and evaluated by non linear fitting 
methods. 
 
5.2.1. Titrations of the crown ether part with ammonium guests: 
 
Receptor 
n-Butylammonium 
hydrochloride 
Acetyl-lysine 
methylester 
hydrochloride 
K [M
-1
] Ioo  /I0 K [M
-1
] Ioo  /I0 
(13a) 260 3.7 250 3.4 
(14a) 280 3.6 260 3.2 
(E-3) 280 3.7 220 3.3 
(11a) 230 3.4 190 3.2 
(11c) 250 3.3 230 3.4 
(11d) 290 3.4 270 3.4 
 
Table S-8: Binding properties of selected receptors in comparison to their protected 
precursors with different ammonium targets in methanol 
 
In methanol / water 9:1 the same couples were investigated. All binding strengths were 
weaker than 100 M-1 in this mixture. 
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5.2.2. Summary of all fluorescence enhancement factors screened: 
 
Receptor 
Amino Acid 
Peptide 
unpolar polar basic acidic 
O
O
O
O
O
O
O
O
O
N
O
 g
ly
ci
n
e 
β
-a
la
n
in
e 
G
A
B
A
 
A
H
X
 
p
h
en
yl
a
la
n
in
e 
se
ri
n
e 
ly
si
n
e 
h
is
ti
d
in
e 
g
lu
ta
m
in
ic
 a
ci
d
 
a
sp
a
rt
ic
 a
ci
d
 
g
ly
cy
l 
g
ly
ci
n
e 
g
ly
cy
l 
g
ly
cy
l 
g
ly
ci
n
e 
NH
2
+
R
N
H
NH
2  
1 1.25 1.2 1.1 1 1 1 1 1 1 1 1 
NH
NH
2
N
H
R
 
1 1.2 1.3 1.35 1 1 1 1 1 1 1.1 1 
NH
NH
2
N
H
R
 
1.1 1.15 1.25 1.2 1 1.1 1.1 1.1 1 1 1.22 1 
NH
NH
2
N
H
R
 
1 1.1 1.45 1.3 1 1 1 1 1 1 1.12 1 
NH
NH
2
N
H
R
N
H
N
H
S
 
1 1.1 1.22 1.25 1 1 1.1 1 1 1 1.25 1.2 
NH
R
N
H
N
H
O
 
1 1.28 1.2 1.1 1 1 1 1 1 1 1 1 
NH
N
H
O
N
H
R
 
1 1.2 1.32 1.38 1 1 1 1 1 1 1.1 1 
NH
N
H
O
N
H
R
 
1.1 1.15 1.28 1.22 1 1.1 1.1 1.1 1 1 1.25 1 
NH
N
H
O
N
H
R
 
1 1.12 1.48 1.28 1 1 1 1 1 1 1.12 1 
NH
NH
O
N
H
R
N
H
N
H
S
 
1 1.1 1.25 1.3 1 1 1.1 1 1 1 1.28 1.22 
N
H
+
R
N
H
N
H  
1 1.3 1.2 1.1 1 1 1 1 1 1 1 1 
N
N
H
N
H
R
 
1 1.2 1.35 1.4 1 1 1 1 1 1 1.1 1 
N
N
H
N
H
R
 
1.1 1.18 1.3 1.25 1 1.1 1.1 1.1 1 1 1.28 1 
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R
N
H
+
N
H
N
H  
1 1.15 1.5 1.3 1 1 1 1 1 1 1.15 1 
N
NH
N
H
R
N
H
N
H
S
 
1 1.1 1.28 1.32 1 1 1.12 1 1 1 1.3 1.25 
N
N
H
N
HR
 
1 1.3 1.2 1.1 1 1 1 1 1 1 1 1 
N
N
H
N
H
R
 
1 1.2 1.35 1.4 1 1 1 1 1 1 1.1 1 
N
N
H
N
H
R
 
1.1 1.18 1.3 1.25 1 1.1 1.1 1.1 1 1 1.28 1 
N
N
H
N
H
R
 
1 1.15 1.5 1.3 1 1 1 1 1 1 1.13 1 
N
NH
N
H
R
N
H
N
H
S
 
1 1.1 1.28 1.3 1 1 1.12 1 1 1 1.3 1.22 
N
+
R
N
NN
I
 1 1 1.22 1.15 1 1 1.1 1 1 1 1.2 1 
N
+
N
N
N
R
I
 
1 1 1 1.22 1 1 1.1 1 1 1 1.22 1.3 
N
H
R
N
NN
NH
2
+
NH
2
 
1 1 1.32 1.2 1 1 1.1 1 1 1 1.25 1 
 
Table S-9: Fluorescence screening results of all receptors with selected amino acids and 
glycine peptides; average of two measurements, rounded values (fluorescence 
enhancement factor of 1 means no binding event detected) 
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5.2.3. Titrations of amino acids and peptides with selected receptors: 
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Figure S-110: Emission titration of compound 11a with β-Ala (left) and GABA (right) 
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Figure S-111: Emission titration of compound 11d with GABA (left) and AHX (right)  
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Figure S-112: Emission titration of compound 27 with GABA (left) and AHX (right) 
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Figure S-113: Emission titration of compound 24 with glycyl glycine (left) and compound 21 
with glycyl glycine (right) 
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Figure S-114: Emission titration of compound 21 with AHX (left) and glycyl glycyl glycine 
(right) 
0,000 0,002 0,004 0,006 0,008 0,010 0,012
0
10
20
30
40
50
60
70
80
90
∆∆ ∆∆
 E
m
is
s
io
n
c (guest) [mol/l]
Model: Hill Plot
K ~ 350 M
-1
Error ~ 10 %
 
0,000 0,002 0,004 0,006 0,008 0,010 0,012
0
10
20
30
40
50
60
70
80
90
∆∆ ∆∆
 E
m
is
s
io
n
c (guest) [mol/l]
Model: Hill Plot
K ~ 220 M
-1
Error ~ 10 %
 
Figure S-115: Emission titration of compound 11d with H-E-G-G-G-amide (left) and H-G-E-
G-G-amide (right) 
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Figure S-116: Emission titration of compound 11d with Ac-Glu-Lys-amide 
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Figure S-117: Emission titration of compound 40 with β-Ala (left) and GABA (right) 
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Figure S-118: Emission titration of compound 33 with β-Ala (left) and GABA (right) 
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Figure S-119: Emission titration of compound 33 with AHX 
 
 
5.3. Explanation for the fluorescence decrease in pyrene receptor systems: 
 
The quenching observed can be rationalized in terms of the change in redox properties of 
guanidinium. Due to occupancy of the lone pair by protonation, the guest-free guanidinium 
has a relative lower HOMO level below that of an excited pyrene (pyr*), therefore its 
influence to fluorescent intensity is negligible. However, the formation of the complex with 
carboxylate by hydrogen bonds weakens the N-H bonds of guanidinium; hence the HOMO 
level increases to be above that of pyr* such that the electron transfer from the former to the 
half filled later one occurs, interrupting the fluorescence process of pyr*. Consequently, the 
quenching of fluorescence is observed.17 
 
 
Figure S-120: Principle of the fluorescence quenching induced by anion recognition of the 
fluorescent pyrene-guanidinium PET sensor. 
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Interestingly, the pyrene systems 33 and 40 show a recognition and distinction of aspartic and 
glutamic acid signalled by a differently strong fluorescence output. Although this can be 
attributed mainly to a pH effect – it is not seen in buffered medium above pH 6.5 – it is 
remarkably in view of the small difference of both structures. 
 
Figure S-121: Recognition of aspartic, glutaminic acid and histidine in aqueous methanol at 
pH < 6 (ethylene spacered system left, with xylylene spacer right) 
 
The difference can be even seen with the naked eye and underlines the good spectroscopic 
properties of the pyrene systems. 
 
 
 
Figure S-122: Fluorescence of crown ether guanidine systems with acyl-pyrene substituent; 
from left to right: Blanc sample, aspartic acid, histidine and glutaminic acid in 
aqueous methanol at pH < 6 (ethylene spacered system left, with xylylene 
spacer right) 
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5.4. UV measurements 
  
The cuvettes have a thickness of 1 cm and were filled with 2 mL solution. As blanc sample 
the pure solvent mixture, 10 % water in methanol, was used.  The cell was temperated to  
25 ° C. The additions were performed using precision microliter pipettes. After each addition 
the solution was given three minutes to reach the new equilibrium before the measurement 
was started. From each titration step UV spectrum in the wavelength range from 250 to 340 
nm was recorded. Prior to the acquisition of spectra a baseline correction was performed. At 
the end of a titration, the pH was checked to exclude protonation reactions. 
For the evaluation of the validity of the Lambert-Beer's a measurement of dilution series was 
conducted. For this a receptor and substrate solution was titrated with aliquots of the solvent 
(pH-adjusted value) under identical experimental conditions.  
 
Titration conditions: 
Solvent:      MeOH / H2O 9:1 (vol/vol), pH 6.5 
Starting volume:     2.0 mL  
Concentration [crown ether guanidine]:  0.05 mM  
Concentration [amino acid or peptide]:  10.0 mM  
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Figure S-123: UV titration of compound 39 with β-alanine 
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Figure S-124: UV titration of compound 32 with GABA (left) and AHX (right) 
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Figure S-125: UV titration of compound 32 with H-E-G-G-G-amide (left) and H-G-E-G-G-
amide (right) 
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6. Energy minimization calculation pictures with Spartan´06 V.112 
 
 
 
Figure S-126: Receptor 11a (left) and 39 (right) binding to β-alanine 
 
 
 
 
Figure S-127: Receptor 21 (left) binding to glycyl glycyl glycine and 11d (right) to the 
peptide E-G-G-G 
 
 
 
 
Figure S-128: Receptor 11d (left) and 32 (right) binding to GABA 
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1. Syntheses 
 
1.1. General methods 
 
Melting Points were determined on Büchi SMP or a Lambda Photometrics OptiMelt MPA 
100 and are uncorrected. IR Spectra were recorded with a Bio-Rad FT-IR Excalibur FTS 
3000. UV spectra were recorded on a Cary 50 BIO spectrometer with temperature control at 
25 °C. Electro spray mass spectra were performed on a Finnigan MAT TSQ 7000 ESI-
spectrometer. Other Mass Spectra were recorded on Varian CH-5 (EI), Finnigan MAT 95 (CI; 
FAB and FD); Xenon serves as the ionization gas for FAB. 
NMR spectra were recorded on Bruker Avance 600 (
1
H: 600.1 MHz, 
13
C: 150.1 MHz, T = 
300 K), Bruker Avance 400 (
1
H: 400.1 MHz, 
13
C: 100.6 MHz, T = 300 K) or Bruker Avance 
300 (
1
H: 300.1 MHz, 
13
C: 75.5 MHz, T = 300 K) relative to external standards. NMR spectra 
were recorded in CDCl3 at 300 MHz (
1
H) or 75 MHz (
13
C) unless stated otherwise. 
Characterization of the signals: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
bm = broad multiplet, bs = broad singlet, dd = double doublet, dt = double triplet, ddd = 
double double doublet. Integration  is  determined  as  the  relative  number  of  atoms,  the  
coupling  constants  are  given  in Hertz  [Hz]. The multiplicity of the carbon atoms is given 
as (+) = CH3 or CH, (-) = CH2 and (Cquat) for quaternary carbon atoms. Structural assignments 
are based on DEPT, COSY and HSQC experiments where applicable. Error of reported 
values: chemical shift: 0.01 ppm for 
1
H-NMR, 0.1 ppm for 
13
C-NMR and 0.1 Hz for coupling 
constants. The solvent used is reported for each spectrum. 
Analytical TLC plates (silica gel 60 F254) and silica gel 60 (70-230 or 230-400 mesh) were 
used for chromatographic separations. Visualization of the spots was by UV light and/or 
staining with phosphomolybdate or ninhydrin, both in ethanol. DMF, CH3CN, CHCl3, THF, 
and Et2O were dried by standard procedures and stored over molecular sieves. PE means 
petrol ether with a boiling range of 70 - 90 
o
C, EA means ethyl acetate. All other solvents and 
chemicals were of reagent grade and used with out further purification. 
All test substances were of pro analysi grade, checked by NMR or HPLC and used as 
purchased without further purification. The Solvents for the fluorescence measurements were 
from special spectroscopic purity purchased from Acros or Baker or Uvasol grade from 
Merck. Millipore water (18 MΩ, Milli QPlus) was used; the HEPES buffer was from according 
purity, suitable for biochemical optical screenings. As far as not stated differently 
tetraethylammoniumhydroxide or 0.1 molar hydrochloric acid, both of analytical grade, were 
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used to adjust the pH. Ac-Ser-Asp-Lys-Pro (1) was purchased from GENSCRIPT in a purity 
> 95 % and used as is. 
 
 
1.2. Syntheses of test peptides 
 
Boc-Lys(Boc)-Gly-OMe 
N
H
O
N
H
O
O
O
NH
O
O
O
 
Boc-Lys(Boc)-OH dicyclohexylamine salt (2.64 g, 5.00 mmol) was suspended with glycine 
methylester hydrochloride (630 mg, 5.00 mmol) in a mixture of dichloromethane (20 mL) and 
DMF (5 mL) at 0 °C. HOBt (750 mg, 5.50 mmol) and DCC (1.14 g, 5.50 mmol) were added 
and the mixture was stirred over night at room temperature.  
The precipitated solid was filtered off and washed with dichloromethane. The organic phase 
was washed with 20 mL of water, dried over MgSO4 and evaporated in vacuo. The residue 
was purified by column chromatography (ethyl acetate, Rf = 0.4) to obtain a colourless solid 
(2.23 g, 4.79 mmol, 96 %).  
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.42 (s, 9 H), 1.43 (s, 9 H), 1.38 – 1.49 (m, 4 H), 
1.51 – 1.68 (m, 1 H), 1.72 – 1.81 (m, 1 H), 3.07 (m, 2 H), 3.67 (s, 3 H), 3.99 (dd, 2 H, 2.8, 5.4 
Hz), 4.08 – 4.12 (m, 1 H), 4.89 (bs, 1 H), 5.48 (bs, 1 H), 7.23 (bs, 1 H); - 
13
C-NMR (75 MHz, 
CDCl3): δ [ppm] = 22.5 (-, 1 C), 28.3 (+, 3 C), 28.5 (+, 3 C), 29.5 (-, 1 C), 32.0 (-, 1 C), 39.9 
(-, 1 C), 41.1 (-, 1 C), 52.2 (+, 1 C), 54.1 (+, 1 C), 78.9 (Cquat, 1 C), 79.8 (Cquat, 1 C), 155.8 
(Cquat, 1 C), 156.2 (Cquat, 1 C), 170.2 (Cquat, 1 C), 172.8 (Cquat, 1 C); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 418.3 (100, MH
+
), 362.2 (15, MH
+
 - C4H8), 
318.2 (2, MH
+
 - CO2 - C4H8); - MF: C19H35N3O7 – FW: 417.51 g/mol; 
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Boc-Lys(Boc)-Gly-OH 
N
H
O
N
H
O
O
O
NH
O
O
OH
 
To a solution of Boc-Lys(Boc)-Gly-OMe (1.40 g, 3.36 mmol) in methanol (25 mL) was 
added an aqueous solution of LiOH (2 M, 3.36 mL, 6.71 mmol). The mixture was stirred over 
night at room temperature and the solvent was evaporated.  
The remaining substance was taken up in chloroform (120 mL) and washed with aqueous 
KHSO4 solution (5 %, 60 mL). The aqueous phase was extracted two times with chloroform 
(50 mL). The combined organic phases were dried over MgSO4 and the solvent was 
evaporated to yield a colourless solid (1.30 g, 3.22 mmol, 96 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.41 (s, 9 H), 1.43 (s, 9 H), 1.34 – 1.50 (m, 4 H), 
1.58 – 1.67 (m, 1 H), 1.73 – 1.88 (m, 1 H), 3.08 (m, 2 H), 3.80 (m, 1 H), 4.01 (m, 1 H), 4.25 
(m, 1 H), 4.81 (bs, 1 H), 5.51 (m, 1 H), 6.72 (m, 1 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] 
= 22.7 (-, 1 C), 28.3 (+, 3 C), 28.4 (+, 3 C), 29.5 (-, 1 C), 32.1 (-, 1 C), 33.5 (-, 1 C), 41.2 (-, 1 
C), 54.2 (+, 1 C), 80.0 (Cquat, 2 C), 156.1 (Cquat, 1 C),156.5 (Cquat, 1 C), 173.1 (Cquat, 1 C); - 
MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) =  404.3 (100, MH
+
), 348.3 (12, 
MH
+
 - C4H8); - HRMS (PI-LSIMS FAB, MeOH/glycerine): calc. for C18H34N2O7*H
+
: 
404.2397, found: 404.2394; - MF: C18H33N3O7 – FW: 403.48 g/mol; 
 
 
Lys-Gly-OH hydrochloride 
N
H
O
NH
3
+
O
NH
3
+
OHCl
Cl
LiCl
 
A solution of Boc-Lys(Boc)-Gly-OH lithium salt (0.41 g, 1.00 mmol) in methanol (2 mL) was 
stirred with aqueous hydrochloric acid (1.0 M, 3.0 mL, 3.00 mmol) until TLC indicated 
complete deprotection (3 h). The methanol was evaporated at reduced pressure and the 
residue was lyophilized to yield a colourless solid (0.29 g, 0.99 mmol, 99 %). 
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1
H-NMR (300 MHz, DMSO): δ [ppm] = 1.36 – 1.48 (m, 4 H), 1.52 – 1.63 (m, 1 H), 1.65 – 
1.77 (m, 1 H), 2.72 (m, 1 H), 2.89 (m, 2 H), 3.71 – 3.98 (m, 4 H), 6.61 (bs, 1 H), 8.03 (bs, 3 
H), 8.21 (bs, 1 H), 9.03 (bs, 1 H); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z 
(%) = 204.3 (100, MH
+
), 148.3 (19, MH
+
 - C4H8); - MF: C8H19N3O3Cl2 – FW: 276.161 
g/mol; 
 
 
Cbz-Lys(Boc)-Gly-OMe 
O
O
N
H
N
H
O
O
O
NH
O
O
 
Cbz-Lys(Boc)-OH (700 mg, 1.84 mmol) and glycine methylester hydrochloride (230 mg, 
1.84 mmol) were suspended in dichloromethane (10 mL) and cooled to 0 °C. After addition of 
DIPEA (0.40 mL, 300 mg, 2.21 mmol) a clear solution was obtained. HOBt (280 mg, 2.02 
mmol) and DCC (420 mg, 2.02 mmol) were successively added. The mixture was stirred over 
night at room temperature, filtered over celite and the filter cake was washed with 
dichloromethane. 
The filtrate was washed with 30 mL of a 1/1 mixture of brine and water. The aqueous phase 
was re-extracted once with dichloromethane. The combined organic phases were dried over 
MgSO4 and the solvent was evaporated. The residue is purified by column chromatography 
(ethyl acetate, Rf = 0.5) to give 828 mg colourless solid (1.83 mmol, 98 %).
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.41 (s, 9 H), 1.32 – 1.48 (m, 4 H), 1.57 – 1.67 (m, 1 
H), 1.84 – 1.95 (m, 1 H), 3.09 (m, 2 H), 3.74 (s, 3 H), 4.01 (m, 2 H), 4.20 (m, 1 H), 4.68 (bs, 1 
H), 5.10 (s, 2 H), 5.55 (m, 1 H), 6.72 (bs, 1 H), 7.33 (m, 5 H); - 
13
C-NMR (75 MHz, CDCl3): 
δ [ppm] = 22.3 (-, 1 C), 28.4 (+, 3 C), 29.6 (-, 1 C), 31.9 (-, 1 C), 33.9 (-, 1 C), 49.2 (+, 1 C), 
52.4 (+, 1 C), 67.1 (Cquat, 1 C), 79.2 (Cquat, 1 C), 128.1 (+, 2 C), 128.2 (+, 1 C), 128.5 (+, 2 C), 
136.2 (Cquat, 1 C), 156.3 (Cquat, 1 C), 170.1 (Cquat, 1 C), 172.1 (Cquat, 1 C); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) =  469.2 (100, M+NH4
+
), 452.1 (64, MH
+
), 
413.1 (76, M+NH4
+
 - C4H8), 369.2 (36, MH
+
 - C4H8); - HRMS (PI-LSIMS FAB, 
MeOH/glycerine): calc. for C22H33N3O7*
+
: 451.2319, found: 451.2315; - MF: C22H32N2O7 – 
FW: 451.52 g/mol; 
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Cbz-Lys-Gly-OH hydrochloride 
O
O
N
H
N
H
O
O
OH
NH
3
+
Cl
LiCl
 
To a solution of Cbz-Lys(Boc)-Gly-OMe (230 mg, 0.5 mmol) in methanol (3 mL) was added 
an aqueous solution of LiOH (2 M, 0.25 mL, 0.5 mmol). The mixture was stirred over night at 
room temperature and the solvents were evaporated. The residue was taken up in 
dichloromethane (5 mL), a saturated solution of HCl in diethylether (0.5 mL) was added and 
the mixture was stirred for 2 h. The solvents were evaporated and the residue was dried to 
give 190 mg of a colourless solid containing 1 eq. of LiCl (0.487 mmol, 97 %). 
1
H-NMR (300 MHz, CD3OD): δ [ppm] = 1.30 – 1.45 (m, 4 H), 1.55 – 1.64 (m, 1 H), 1.69 – 
1.82 (m, 1 H), 3.06 (m, 2 H), 3.98 (m, 2 H), 4.23 (m, 1 H), 4.68 (bs, 1 H), 5.13 (s, 2 H), 5.48 
(m, 1 H), 7.27 – 7.44 (m, 5 H); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) 
=  338.2 (100, MH
+
); - MF: C16H24N3O7Cl – FW: 373.84 g/mol; 
 
 
1.3. Solid phase synthesis of the test peptides 
Rink amide resin MBHA (novabiochem), piperidine (iris biotech), ethyl-diisopropyl-amine 
(DIPEA) (Fluka), dimethylformamide  (DMF)  (iris biotech), Fmoc amino acids  
(novabiochem), trifluoroacetic  acid  (TFA)  (Fluka),  triisopropylsilane  (TIS)  
(novabiochem), 1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide (EDC) (Sigma  Aldrich),  
O-Benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate (HBTU) (novabio-
chem), 1-hydroxybenzotriazole  (HOBt) (Sigma Aldrich), were  bought  and  used without 
further  purification.   
 
All peptides were synthesized on Rink Amide MBHA resin using Fmoc protecting group 
strategy. Coupling was done by HBTU / HOBt / DIPEA. HOBt and HBTU were used as a 
0.45 M solution, DIPEA as a 1.2 M solution in DMF. The Fmoc protected amino acids were 
dissolved in NMP as 0.5 M solutions. Every peptide was synthesized on 100 mg of resin in 
standard 5 mL syringe. The lot of the resin used had a loading of 0.72 mmol/g 
(manufacturer’s claims). The resin was allowed to preswell in DMF for 30 min. Each 
coupling was done twice using 1.0 mL of each solution per step and shaking for 2 h each. 
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Fmoc deprotection was done by shaking the resin with 40 % piperidine in DMF for 5 minutes, 
subsequent washing and addition of 20 % piperidine in DMF followed by shaking for 10 
minutes. The progress of the synthesis was monitored by the Kaiser test.
1
 
Capping was done for 3 h using 0.5 M of Ac2O in DMF, containing 1.2 M DIPEA as base. Of 
the solution 2 mL was used. After completion of the syntheses, the resin was washed with 
DMF and DCM (5 x 5 mL each).  
From the resin was cleaved by shaking for 3 h after addition of 3.0 mL of TFA / TIS / H2O 
(90:5:5) (vol/vol). The resin was removed by filtration and washed twice with TFA.  
Combined filtrates were concentrated under reduced pressure to about 1.0 mL without 
heating. It was then transferred to a Falcon tube and precipitated with cold Et2O. The 
precipitate was centrifuged at –5 °C for 20 minutes. The solution was then carefully decanted 
off and the precipitate resuspended in cold Et2O before being centrifuged again. Finally, the 
Et2O was decanted off again and the peptide dried under vacuum. The peptides were analysed 
by ES-MS and 
1
H-NMR. 
 
Analytical control of Ac-Glu-Lys-NH2: MF: C13H25N4O5Cl – FW: 351.81 g/mol; 
1
H-NMR (300 MHz, DMSO-d6): δ [ppm] = 1.31 (m, 2 H), 1.51 (m, 1+2 H), 1.68 (m, 2 H), 
1.86 (s, 3 H), 1.88 (m, 1 H), 2.22 (t, J = 8 Hz, 2 H), 2.72 (m, 2 H), 4.18 (m, 2 H), 7.04 (s, 1 H, 
NH), 7.31 (s, 1 H, NH), 7.70 (bs, 2 H, NH), 7.91 (d, J = 8 Hz, 1H, NH), 8.09 (d, J = 8 Hz, 1 
H, NH); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 316.9 (100 %, 
MH
+
); 
 
The isomeric glutamic acid tetrapeptide sequences H-E-G-G-G-NH2, H-E-G-G-G-NH2, H-E-
G-G-G-NH2 and H-E-G-G-G-NH2 were prepared according to a similar protocol earlier. Their 
preparation, purification and analytics were already published.
2
 They were properly stored 
below -5 °C. HPLC analysis showed no decomposition. 
 
 
 
 
2. 1H – / 13C-NMR and LC-MS spectra of new compounds 
 
For solvents and conditions of measurement, see experimental procedures. NMR spectra were 
recorded on Bruker Avance spectrometers 300, 400 and 600. Measuring temperature was 300 
K. TMS was used as external standard. 
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Figure S-1: 
1
H-NMR spectrum of compound 5a 
  
 
Figure S-2: 
13
C-NMR spectrum of compound 5a 
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Figure S-3: LC-MS spectrum of compound 5a 
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Figure S-4: LC-MS spectrum of compound 5b  
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Figure S-5: 
1
H-NMR spectrum of compound 7 
 
 
Figure S-6: 
13
C-NMR spectrum of compound 7  
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Figure S-7: LC-MS spectrum of compound 7  
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Figure S-8: 
1
H-NMR spectrum of compound 2  
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Figure S-9: LC-MS spectrum of compound 2
3
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3. Fluorescence data and selected emission titrations 
 
All fluorescence experiments were performed on a Varian Cary Eclipse fluorimeter. To 
determine the binding constants and Job´s plots fluorescence titration experiments were 
carried out. 
 
Instrument Parameters 
 
Excitation wavelength: λex = 310 nm  
Detection wavelength: λ= 330 – 500 nm 
Excitation slit:  10 nm 
Emission slit:   10 nm 
Temperature:   T = 298 K 
PMT voltage    560 volts     
 
The thoroughly dried substance 2 was dissolved in methanol (1*10
-3
 mol/L); this stock 
solution was kept properly closed in the fridge at -4 °C. The solutions needed for the 
measurements were always freshly prepared from this stock solution, diluting the necessary 
amount with methanol and buffer accordingly. The pH value of the solution was measured 
before use, and if necessary, adjusted with hydrochloric acid or tetrabutyl ammonium 
hydroxide. 
 
All screenings and titrations were performed in a 1.0 mL quarz cuvette using methanol / 
buffer mixtures (HEPES, 10 mM, pH 6.3, no salt addition). 
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Figure S-10: Emission titration of compound 2 with Gly-Glu-Gly-Gly-NH2 (left) and Gly-
Gly-Glu-Gly-NH2 (right) in methanol / buffer 4:1 (10 mM, pH 6.3) 
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Figure S-11: Emission titration of compound 2 with Lys-Gly in methanol / buffer 4:1  
(10 mM, pH 6.3) 
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Figure S-12: Emission titration of compound 2 with Gly-Gly-Gly (left) and Gly-Gly-Gly-Gly 
(right) in methanol / buffer 4:1 (10 mM, pH 6.3) 
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4. pKa-values and simulation of fundamental properties 
 
 
4.1. pH titration of 2 and 6b 
The protonation of the crown ether moiety is investigated by pH-titration with perchloric 
acid.
4
 From the binding constants (K), the KS- values can be calculated. Without free 
guanidine this measurement is eased, but should still give the values in good approximation to 
the according unprotected species.
5
 
AKHX
H
K
1
][*][
]X[
==
+
+
 
⇒  log K = pKa 
Equation S-1: Relationship between binding constant K and the acidity constant KS 
 
Compound 
Emission 
(λmax) 
K [M
-1
] pKa Ioo  /I0 
(2) 391 nm 6.3 * 10
5 
5.8 1.9 
(6b) 389 nm 3.7 * 10
5 
5.6 1.7 
solvent: water (2 % methanol) 
Table S-1: Emission properties of selected protected receptors upon titration with HClO4 
 
 
4.2. pH dependent emission of 2 
Aqueous HEPES buffer solutions (50 mM, no salt addition, tetraethylammoniumhydroxide or 
HCl for equibrillation) in the range of pH 3 to pH 10 were mixed in a 1:4 ratio with a 
methanol solution of compound 2 (3*10
-5
 M). After mixing and standing for five minutes an 
emission spectrum was recorded: 
pH of the 
buffer solution 
Emission [a.u.] 
pH of the 
buffer solution 
Emission [a.u.] 
10 151,02 6 193,27 
9,5 152,58 5,5 216,74 
9 152,61 5 287,17 
8,5 153,36 4,5 313,77 
8 155,71 4 320,81 
7,5 158,41 3,5 323,16 
7 162,10 3 322,38 
6,5 170,75   
Table S-2: pH dependent luminescence of compound 2  
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4.3. Simulation of fundamental properties 
 
Physical properties like solubility, log P values, index of refraction and the expected pKa 
values for all representative structures were simulated by computational methods with the aid 
of the ACD Labs program package structure calculator Ver.12.1. They are in good accordance 
with the measurements and typical literature data
6
. 
 
 
 LogD Results
pH LogD
2 -3.36
5.5 -3.19
6.5 -1.25
7.4 0.67
10 1.71
14121086420
-3
-2
-1
0
1
L
o
g
D
 Single-valued Properties
Name Value Error
LogP 1.74 1
MW 947 -
PSA 301.86 -
FRB 14 -
HDonors 9 -
HAcceptors 23 -
Rule Of 5 3 -
Molar Refractivity, cm^3 241.37 0.5
Molar Volume, cm^3 685.14 7
Parachor, cm^3 1871.28 8
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 pKa Results
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66 A 16.58 0.5
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52 B 7.37 0.7
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66 B -0.33 0.7
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51 B -3.74 0.7
48 B -4.35 0.7
 
 
Figure S-13: Simulation of the properties of compound 2 
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5. Energy minimization calculations with Spartan V.6.01 
 
Energy minimizations in the gas phase; they may supply an illustrative picture of the receptor-
guest aggregate. 
 
 
Figure S-14: Energy minimized structure of compound 2 
 
 
 
Figure S-15: Simulation of compound 1@2 (front view) 
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Figure S-16: Simulation of compound 1@2 (backside view) 
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1. Syntheses 
 
1.1. General methods 
 
Compound 71, 82, 10a3, 10c4, 163, 175, 186, 207 and 248 were prepared following literature 
known procedures. The PKG substrate (pSer 4) was purchased from Genscript (> 95 %) and 
used as is. 
 
Analytical control of the synthesized compounds was done by common methods. Melting 
points were determined on Büchi SMP or a Lambda Photometrics OptiMelt MPA 100 and are 
uncorrected. IR Spectra were recorded with a Bio-Rad FT-IR Excalibur FTS 3000. UV 
spectra were recorded on a Cary 50 BIO spectrometer with temperature control at 25 °C. 
Electro spray mass spectra were performed on a Finnigan MAT TSQ 7000 ESI-spectrometer. 
Other Mass Spectra were recorded on Varian CH-5 (EI), Finnigan MAT 95 (CI; FAB and 
FD); Xenon serves as the ionization gas for FAB. 
NMR spectra were recorded on Bruker Avance 600 (1H: 600.1 MHz, 13C: 150.1 MHz, T = 
300 K), Bruker Avance 400 (1H: 400.1 MHz, 13C: 100.6 MHz, T = 300 K) or Bruker Avance 
300 (1H: 300.1 MHz, 13C: 75.5 MHz, T = 300 K) relative to external standards. NMR spectra 
were recorded in CDCl3 at 300 MHz (
1H) or 75 MHz (13C) unless stated otherwise. 
Characterization of the signals: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
bs = broad singlet, dd = double doublet, dt = double triplet, ddd = double double doublet. 
Integration  is  determined  as  the  relative  number  of  atoms,  the coupling constants are  
given in Hertz [Hz]. The multiplicity of the carbon atoms is given as (+) = CH3 or CH, (-) = 
CH2 and (Cquat) for quaternary carbon atoms. Structural assignments are based on DEPT and 
COSY experiments where applicable. Error of reported values: chemical shift: 0.01 ppm for 
1H-NMR, 0.1 ppm for 13C-NMR and 0.1 Hz for coupling constants. The solvent used is 
reported for each spectrum. 
Analytical TLC plates (silica gel 60 F254) and silica gel 60 (70 - 230 or 230 - 400 mesh) were 
used for chromatographic separations. Visualization of the spots was by UV light and/or 
staining with phosphomolybdate or ninhydrin, both in ethanol. Solvents used were reagent or 
pro analysi grade, CH3CN, CHCl3, THF, and Et2O were dried by standard procedures and 
stored over molecular sieves. DMF was purchased anhydrous (Fluka) and used as received. 
PE means petrol ether with a boiling range of 70 - 90 oC. All reagents were reagent grade and 
used as received (Merck, Aldrich, Fluka). All test substances were of pro analysi grade, 
checked by NMR or HPLC and used as purchased without further purification.  
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The Solvents for the fluorescence measurements were from special spectroscopic purity 
purchased from Acros or Baker or Uvasol from Merck. Millipore water (18 MΩ, Milli QPlus) 
was used; the HEPES buffer was from according purity, suitable for biochemical optical 
screenings. As far as not stated differently tetraethylammoniumhydroxide or hydrochloric 
acid of analytical grade were used to adjust the pH in the titrations and screenings. 
 
 
1.2. Syntheses of building blocks 
 
(2-Amino-ethyl)-carbamic acid benzyl ester (8) (literature known
9
 but improved procedure)
N
H
O
O
NH
2
 
To a solution of 1,2-diaminoethane (30.0 g, 0.50 mmol) in DCM (500 mL) 
benzylorthochloroformiate (8.53 g, 50 mmol) in DCM (250 mL) was added drop wise at 0 °C 
over a period of 8 h. After stirring at ambient temperature over night, the mixture was washed 
five times with brine (100 mL) and then with water (100 mL). The combined organic phases 
were dried over MgSO4 and concentrated in vacuo to afford colourless oil, which solidifies in 
the refrigerator as a white solid (7.58 g, 39 mmol, 78 %). 
M.p. (uncorrected) = 80 – 82°C; - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.21 (bs, 2 H), 
2.81 (app. t, 2 H, 5.8 Hz), 3.23 (dd, 2 H, 11.3 Hz & 5.8 Hz), 5.10 (s, 2 H), 5.29 (bs, 1 H), 7.29 
- 7.38 (m, 5 H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] = 41.8 (-, 1 C), 43.8 (-, 1 C), 66.8 (-, 
1 C), 128.4 (+, 2 C), 128.6 (+, 2 C), 128.7 (+, 1 C), 136.6 (Cquat, 1 C), 156.7 (Cquat, 1 C); - MS 
(CI-MS, NH3): m/z (%) = 195.2 (100, MH
+), 104.2 (17, MH+ - C7H7); - MF: C10H14N2O2 – 
FW: 194.24 g/mol; 
 
 
{2-[4,6-Bis-(4,7,10-tri-(
tert
butyloxycarbonyl)-1,4,7,10-tetraaza-cyclododec-1-yl)-
[1,3,5]triazin-2-ylamino]-acetylamino}-acetic acid methyl ester (13b) 
N N
NN
N N
NN
N
N
N
bocboc
boc
boc
boc boc
N
H
N
H
O
O
O
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Glycyl glycine methyl ester hydrochloride (0.91 g, 5.0 mmol) and potassium carbonate (1.04 
g, 7.5 mmol) were suspended in 10 mL of dioxane. The solution was stirred for one hour, then 
compound 7 (2.11 g, 2.0 mmol) was added and the solution was stirred for two days at  
130 °C. The precipitated solids were filtered off and the solvent was removed at reduced 
pressure. The crude product was purified by column chromatography on silica gel with petrol 
ether / ethyl acetate (1:1, Rf = 0.3) as eluent to obtain a colourless solid (1.65 g. 1.41 mmol, 
71 %). 
M.p. (uncorrected) = 124 – 126 °C; - 1H-NMR (300 MHz, CDCl3): δ [ppm] = 1.37 - 1.51 (m, 
54 H), 2.28 (m, 1 H), 3.08 - 3.79 (m, 32 H), 3.67 (s, 3 H ), 3.99 (d, 4 H, 5.2 Hz), 5.30 (bs, 1 
H); - 13C-NMR (75 MHz, CDCl3): δ [ppm] =  28.5 (+, 18 C), 40.9 (-, 1 C), 44.9 (-, 1 C), 50.2 
(-, 16 C), 52.1 (+, 1 C), 79.9 (Cquat, 6 C), 156.5 (Cquat, 6 C), 165.7 (Cquat, 1 C), 170.1 (Cquat, 1 
C), 171.1 (Cquat, 1 C), further signals were not detectable; - IR (KBr): ν [cm
-1] = 3349 (bm), 
2976 (m), 2932 (m), 2876 (m), 2248 (w), 1753 (m), 1677 (s), 1537 (m), 1469 (m), 1407 (m), 
1364 (m), 1247 (m), 1158 (s), 1107 (m), 1029 (m), 972 (m), 913 (m), 858 (m), 814 (m), 776 
(m), 727 (m), 646 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
1167.0 (100, MH+), 584.1 (7, (M + 2 H+)2+); - MF: C54H95N13O15 – FW: 1166.44 g/mol; 
 
 
{2-[4,6-Bis-(4,7,10-tri-(
tert
butyloxycarbonyl)-1,4,7,10-tetraaza-cyclododec-1-yl)-
[1,3,5]triazin-2-ylamino]-acetylamino}-acetic acid lithium salt (14b) 
N N
NN
N N
NN
N
N
N
bocboc
boc
boc
boc boc
N
H
N
H
O
O
O Li
+
 
Compound 13b (1.17 g, 1.0 mmol) was dissolved in 30 mL of acetone. A freshly prepared 
aqueous solution of lithium hydroxide (2 M, 0.5 mL) was added and the mixture was stirred 
for two days at ambient temperature. The solvent was evaporated and the residue was 
lyophilised to yield 14b as colourless solid (1.11 g. 0.96 mmol, 96 %). 
M.p. (uncorrected) = 132 – 134 °C (decomp.); - 1H-NMR (300 MHz, DMSO-d6): δ = 1.29 - 
1.53 (m, 54 H), 3.02 - 3.64 (m, 32 H), 3.74 (d, 2 H, 5.5 Hz), 3.84 (m, 2 H), 6.87 (bs, 1 H), 
7.96 (bs, 1 H); - 13C-NMR (75 MHz, DMSO-d6): δ = 27.9 (+, 18 C), 40.5 (-, 1 C), 49.2 (-, 16 
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C), 78.8 (Cquat, 6 C), 155.2 (Cquat, 6 C), 171.0 (Cquat, 1 C), further signals were not detectable; 
- IR (KBr): ν [cm-1] = 3410 (bm), 2977 (m), 2935 (m), 2876 (m), 2052 (w), 1686 (s), 1538 
(m), 1471 (m), 1408 (m), 1363 (m), 1247 (m), 1157 (s), 1106 (m), 1029 (m), 971 (m), 941 
(m), 858 (m), 813 (m), 776 (m), 620 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 1153.0 (100, MH
+), 577.0 (13, (M + 2 H+)2+); - MF: C53H92N13O15Li – 
FW: 1158.34 g/mol; 
 
 
14-[3-Amino-propyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-
hexaoxa-14-aza-benzocyclohenicosene-2,3-dicarboxylic acid dimethylester hydrochloride 
(10b) 
O
O
O
O
O
O
O
O
O
N
+
O
NH
3
+
Cl
Cl
O
O
O
O
O
O
O
O
O
N
O
NHBoc
H
 
The respective N-terminal protected crown ether5 (1.25 g, 2.0 mmol) was dissolved in 20 mL 
of dry dichloromethane and a saturated solution of hydrochloric acid in diethyl ether (4 mL) 
was added. After three hours of stirring at room temperature the HCl gas was removed in a N2 
stream. All volatiles were evaporated at reduced pressure. The residue was taken up in a 
minimum amount of dichloromethane and the product was precipitated carefully by slow 
addition of diethyl ether. The solution was decanted off the precipitate, it was washed once 
with diethyl ether, decanted off again and the product was dried in the vacuum to furnish a 
yellow, hygroscopic solid (1.12 g, 1.876 mmol, 94 %). 
M.p. (uncorrected) = 66 – 67 °C - 1H-NMR (400 MHz, CDCl3): δ [ppm] = 2.38 (m, 2 H), 
3.21 (m, 2 H), 3.48 – 3.61 (m, 6 H), 3.61 – 3.75 (m, 8 H), 3.81 – 4.07 (m, 8 H), 3.85 (s, 6 H), 
4.20 (m, 4 H), 7.21 (s, 2 H), 8.43 (bs, 3 H), 10.35 (bs, 1 H); - 13C-NMR (100 MHz, CDCl3): δ 
[ppm] = 22.0 (-, 1 C), 37.4 (-, 1 C), 52.1 (-, 1 C), 52.6 (+, 2 C), 53.4 (-, 1 C), 65.4 (-, 2 C), 
69.0 (-, 2 C), 69.4 (-, 2 C), 70.4 (-, 2 C), 70.7 (-, 2 C), 113.4 (+, 2 C), 125.5 (Cquat, 2 C), 150.2 
(Cquat, 2 C), 167.7 (Cquat, 2 C); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) 
= 529.3 (100, MH+); - MF: C25H42N2O10 – FW: 601.52 g/mol; 
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1.3. Deprotection and complexation of the ligands 
 
General procedure for the deprotection of crown ether cyclenes to the free ligand salts (GP 
II)
10
  
O
O
O
O
O
O O
O
O
O
N
N
+
N
N
+
N
+
N
N
+
NN
N N
N
H
N
H
N
+
O
n m 
H
H2
H2
H
H2
H2
15a´    n = 1; m = 0
15b´   n = 1; m = 1
15c´   n = 2; m = 1
15d´   n = 2; m = 2
15e´   n = 5; m = 1
15f´    n = 5; m = 2
H
 
To a well stirred solution of the Boc protected ligand (0.1 mmol) in dichloromethane (2 mL) a 
solution of TFA in dichloromethane (2 mL, 20 % vol/vol) was added. Stirring was continued 
for 4 h (TLC control), then the solvent was evaporated. The residue was redissolved in a 
minimum amount of dichloromethane and the product was precipitated by drop wise addition 
of diethyl ether. The solvent mixture was decanted off carefully, the precipitate was 
suspended in diethyl ether, allowed to settle completely and the solvent was decanted off 
again. After drying a yellow under reduced pressure, a yellow, deliquescent solid is obtained 
in nearly quantitative yield. 
 
14-[4,6-Bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazinyl-amino-ethyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocyclohenicosene-2,3-dicarboxylic acid dimethyl ester TFA salt (15a´) 
N
H
N
+
N
N
+
N
+
N
+
N
+
N
N
+
NN
N
O
O
O
O
O
O O
O
O
N
+
O
H
H
H
H
H
H2
H2
H2
H2
7x CF3COO
-
 
Compound 11a (154 mg, 0.1 mmol) was deprotected according to GP II. After drying a 
colourless, hygroscopic solid (158 mg, 0.091 mmol, 91 %) is obtained. 
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M.p. (uncorrected) = 42 – 46 °C; - 1H-NMR (600 MHz, MeOD): δ [ppm] = 2.98 – 3.37 (m, 
36 H), 3.51 – 3.58 (m, 4 H), 3.62 – 3.74 (m, 8 H), 3.82 (s, 6 H), 3.83 – 3.95 (m, 8 H), 4.17 – 
4.25 (m, 4 H), 7.23 (s, 2 H) - 13C-NMR (150 MHz, MeOD): δ [ppm] = 36.2 (-, 1 C), 43.2 – 
45.1 (-, 4 C), 45.6 – 48.0 (-, 16 C), 53.2 (+, 2 C), 54.6 (-, 1 C), 54.8 (-, 2 C), 65.7 (-, 2 C), 70.2 
(-, 2 C), 70.6 (-, 2 C), 71.3 (-, 2 C), 71.7 (-, 2 C), 114.2 (+, 2 C), 114.2 & 116.1 & 118.1 & 
120.0 (Cquat, 7 C), 126.6 (Cquat, 2 C), 151.7 (Cquat, 2 C), 162.7 & 162.9 (Cquat, 7 C), 167.0 
(Cquat, 2 C), 168.5 (Cquat, 1 C), 169.3 (Cquat, 2 C); - IR (KBr): ν [cm
-1] = 3000 (bm), 2800 
(bm), 2360 (m), 2331 (m), 1715 (m), 1650 (m), 1600 (s), 1519 (m), 1433 (m), 1348 (m), 1286 
(s), 1194 (s), 1123 (s), 1055 (m), 972 (m), 939 (m), 778 (m) - MS (ESI-MS, CH2Cl2/MeOH + 
10 mmol NH4OAc): m/z (%) = 467.9 (21, (M+2H
+)2+), 524.9 (100, (M+TFA+2H+)2+), 934.6 
(6, MH+), 1048.6 (17, ((M+TFA+H+)+); - HRMS (PI-LSIMS FAB, glycerine): calc. for 
C43H76N13O10
+: 934.5838, found: 934.5808; - MF: C57H90N13O24 – FW: 1740.43 g/mol; 
 
 
14-[4,6-Bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-yl-amino-N-(2-
methylamino)-acetamido-3-ethyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-
5,8,11,17,20,23-hexaoxa-14-aza-benzocyclohenicosene-2,3-dicarboxylic acid dimethyl ester 
TFA salt (15b´) 
H
H
O
O
O
O
O
O O
O
O
N
+
O
N
H
O
N
H
N
+
N
N
+
N
+
N
+
N
+
N
N
+
NN
NH H
H
H2
H2
H2
H2
7x CF3COO
-
 
Compound 11b (160 mg, 0.1 mmol) was deprotected according to GP II to give a yellow, 
hygroscopic solid (166 mg, 0.093 mmol, 93 %). 
M.p. (uncorrected) = 49 – 52 °C; - 1H-NMR (600 MHz, MeOD): δ [ppm] = 2.97 – 3.38 (m, 
38 H), 3.48 – 3.53 (m, 4 H), 3.56 – 3.61 (m, 2 H), 3.62 – 3.73 (m, 8 H), 3.82 (s, 6 H), 3.83 – 
3.95 (m, 6 H), 4.17 – 4.26 (m, 4 H), 7.21 (s, 2 H) - 13C-NMR (150 MHz, MeOD): δ [ppm] = 
35.7 (-, 1 C), 43.1 – 44.8 (-, 4 C), 45.4 – 48.0 (-, 17 C), 53.1 (+, 2 C), 53.9 (-, 1 C), 54.8 (-, 1 
C), 55.0 (-, 2 C), 65.7 (-, 2 C), 66.8 (-, 2 C), 70.2 (-, 2 C), 70.6 (-, 2 C), 71.2 (-, 2 C), 71.7 (-, 2 
C), 114.2 (+, 2 C), 115.0 & 116.9 & 118.9 & 120.8 (Cquat, 7 C), 126.6 (Cquat, 2 C), 151.6 
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(Cquat, 2 C), 162.5 & 162.7 (Cquat, 7 C), 167.1 (Cquat, 1 C), 168.7 (Cquat, 1 C), 168.8 (Cquat, 1 C), 
169.3 (Cquat, 2 C), 174.9 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3000 (bm), 2800 (bm), 2360 (m), 
2331 (m), 1715 (m), 1650 (m), 1600 (s), 1519 (m), 1433 (m), 1348 (m), 1286 (s), 1194 (s), 
1123 (s), 1055 (m), 972 (m), 939 (m), 778 (m) - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 331.2 (50, (M+3H
+)3+), 494.4 (100, (M+2H+)2+), 553.4 (82, 
(M+TFA+2H+)2+), 667.3 (42, (M+3TFA+2H+)2+), 991.7 (9, MH+), 1105.7 (21, 
((M+TFA+H+)+); - MF: C59H92N14O25F21 – FW: 1796.48 g/mol; 
 
 
14-[4,6-Bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-yl-amino-N-(2-
methylamino)-acetamido-3-propyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-
5,8,11,17,20,23-hexaoxa-14-aza-benzocyclohenicosene-2,3-dicarboxylic acid dimethyl ester 
TFA salt (15c´) 
N
H
N
+
N
N
+
N
+
N
+
N
+
N
N
+
NN
N
N
H
O
O
O
O
O
O
O O
O
O
N
+
O
H
H
H
H
H
H2
H2
H2
H2
7x CF3COO
-
 
Compound 11c (161 mg, 0.1 mmol) was deprotected after GP II. A faintly yellow, 
hygroscopic solid (150 mg, 0.083 mmol, 83 %) is obtained. 
M.p. (uncorrected) = 46 – 49 °C; - 1H-NMR (600 MHz, MeOD): δ [ppm] = 1.91 (m, 2 H), 
3.00 – 3.12 (m, 8 H), 3.13 – 3.26 (m, 8 H), 3.27 – 3.35 (m, 16 H), 3.36 – 3.45 (m, 4 H), 3.68 – 
3.79 (m, 10 H), 3.81 – 3.92 (m, 8 H), 3.87 (s, 6 H), 3.95 – 3.97 (m, 2 H), 4.19 – 4.32 (m, 4 H), 
7.28 (s, 2 H) - 13C-NMR (150 MHz, MeOD): δ [ppm] = 25.0 (-, 1 C), 37.3 (-, 1 C), 43.1 – 
44.8 (-, 5 C), 46.2 – 48.6 (-, 12 C), 43.5 (-, 1 C), 53.1 (+, 2 C), 54.4 (-, 2 C), 65.7 (-, 2 C), 70.1 
(-, 2 C), 70.7 (-, 2 C), 71.4 (-, 2 C), 71.8 (-, 2 C), 114.3 (+, 2 C), 115.0 & 116.9 & 118.9 & 
120.8 (Cquat, 7 C), 126.7 (Cquat, 2 C), 151.8 (Cquat, 2 C), 162.0 & 162.2 (Cquat, 7 C), 167.1 
(Cquat, 1 C), 168.9 (Cquat, 1 C), 169.0 (Cquat, 1 C), 169.4 (Cquat, 2 C), 173.9 (Cquat, 1 C); - IR 
(KBr): ν [cm-1] = 3300 (bm), 2953 (bm), 2750 (bm), 2640 (bm), 1716 (m), 1649 (m), 1598 
(s), 1520 (m), 1432 (m), 1350 (m), 1284 (s), 1261 (m), 1195 (m), 1107 (s), 1055 (m), 972 (m), 
944 (m), 882 (m), 779 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
335.9 (47, (M+3H+)3+), 503.4 (43, (M+2H+)2+), 560.5 (100, (M+TFA+2H+)2+), 674.4 (52, 
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(M+3TFA+2H+)2+), 1005.7 (6, MH+), 1119.7 (20, ((M+TFA+H+)+); - MF: C60H94N14O25F21 – 
FW: 1810.50 g/mol;  
 
 
14-[4,6-Bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-yl-amino-N-(2-
methylamino)-acetamido-N-(2-methylamino)-acetamido-3-propyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocyclohenicosene-2,3-dicarboxylic acid dimethyl ester TFA salt (15d´) 
H
H
N
H
N
+
N
N
+
N
+
N
+
N
+
N
N
+
NN
N
O
O
O
O
O
O O
O
O
N
+
O
N
H
N
H
O
O
H H
H
H2
H2
H2
H2
7x CF3COO
-
 
Compound 11d (167 mg, 0.1 mmol) was deprotected as given in GP II to yield a colourless, 
hygroscopic solid (181 mg, 0.097 mmol, 97 %). 
M.p. (uncorrected) = 51 – 54 °C; - 1H-NMR (600 MHz, MeOD): δ [ppm] = 1.89 (m, 2 H), 
3.01 – 3.13 (m, 8 H), 3.15 – 3.26 (m, 10 H), 3.27 – 3.36 (m, 16 H), 3.38 – 3.45 (m, 4 H), 3.68 
– 3.77 (m, 8 H), 3.79 – 3.92 (m, 10 H), 3.86 (s, 6 H), 3.95 – 3.97 (m, 2 H), 4.02 – 4.07 (m, 2 
H), 4.19 – 4.32 (m, 4 H), 7.30 (s, 2 H) - 13C-NMR (150 MHz, MeOD): δ [ppm] = 25.1 (-, 1 
C), 37.1 (-, 1 C), 43.2 – 44.6 (-, 5 C), 45.5 (-, 1 C), 45.3 – 48.4 (-, 12 C), 52.9 (-, 1 C), 53.1 (+, 
2 C), 54.2 (-, 2 C), 65.7 (-, 2 C), 70.1 (-, 2 C), 70.7 (-, 2 C), 71.5 (-, 2 C), 71.9 (-, 2 C), 114.3 
(+, 2 C), 114.9 & 116.8 & 118.8 & 120.7 (Cquat, 7 C), 126.7 (Cquat, 2 C), 151.8 (Cquat, 2 C), 
161.9 & 162.1 (Cquat, 7 C), 167.2 (Cquat, 1 C), 168.9 (Cquat, 1 C), 169.1 (Cquat, 1 C), 169.4 
(Cquat, 2 C), 172.2 (Cquat, 1 C), 174.1 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3377 (bm), 2950 
(bm), 2932 (m), 2793 (bm), 2659 (m), 2362 (m), 1720 (m), 1650 (m), 1600 (s), 1519 (m), 
1432 (m), 1349 (m), 1287 (s), 1193 (m), 1116 (s), 1056 (m), 974 (m), 950 (m), 890 (m), 771 
(m), 611 (m), 529 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
354.9 (66, (M+3H+)3+), 532.0 (23, (M+2H+)2+), 588.9 (100, (M+TFA+2H+)2+), 702.9 (16, 
(M+3TFA+2H+)2+), 1062.7 (8, MH+), 1176.8 (19, ((M+TFA+H+)+);- MF: C62H97N15O26 – 
FW: 1867.56 g/mol;  
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14-[4,6-Bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-yl-amino-N-(2-
methylamino)-acetamido-6-hexyl]-6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-
5,8,11,17,20,23-hexaoxa-14-aza-benzocyclohenicosene-2,3-dicarboxylic acid dimethyl ester 
TFA salt (15e´) 
H
H
N
H
N
+
N
N
+
N
+
N
+
N
+
N
N
+
NN
N
N
H
O
O
O
O
O
O
O O
O
O
N
+
O
H H
H
H2
H2
H2
H2 7x CF3COO
-
 
Compound 11e (165 mg, 0.1 mmol) was deprotected after GP II. A colourless, hygroscopic 
solid (177 mg, 0.096 mmol, 96 %) is obtained. 
M.p. (uncorrected) = 42 – 46 °C; - 1H-NMR (600 MHz, MeOD): δ [ppm] = 1.21 (m, 4 H), 
1.42 (m, 2 H), 1.63 (m, 2 H), 3.00 – 3.12 (m, 10 H), 3.14 – 3.25 (m, 8 H), 3.27 – 3.36 (m, 16 
H), 3.38 – 3.44 (m, 4 H), 3.68 – 3.78 (m, 10 H), 3.82 – 3.92 (m, 10 H), 3.88 (s, 6 H), 4.20 – 
4.31 (m, 4 H), 7.31 (s, 2 H) - 13C-NMR (150 MHz, MeOD): δ [ppm] = 24.5 (-, 1 C), 27.2 (-, 1 
C), 27.5 (-, 1 C), 30.1 (-, 1 C), 40.2 (-, 1 C), 43.4 – 44.7 (-, 5 C), 45.7 (-, 1 C), 45.8 – 48.1 (-, 
12 C), 53.1 (+, 2 C), 54.1 (-, 2 C), 54.9 (-, 1 C), 65.7 (-, 2 C), 70.2 (-, 2 C), 70.8 (-, 2 C), 71.4 
(-, 2 C), 71.9 (-, 2 C), 114.3 (+, 2 C), 114.9 & 116.8 & 118.8 & 120.7 (Cquat, 7 C), 126.7 
(Cquat, 2 C), 151.8 (Cquat, 2 C), 161.9 & 162.2 (Cquat, 7 C), 167.2 (Cquat, 1 C), 168.9 (Cquat, 1 C), 
169.0 (Cquat, 1 C), 169.4 (Cquat, 2 C), 173.3 (Cquat, 1 C); - IR (KBr): ν [cm
-1] = 3300 (bm), 
2945 (bm), 2753 (bm), 2640 (bm), 2340 (m), 1716 (m), 1649 (m), 1599 (s), 1519 (m), 1432 
(m), 1349 (m), 1287 (s), 1194 (m), 1123 (s), 1107 (s), 1056 (m), 972 (m), 944 (m), 885 (m), 
779 (m), 655 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 349.9 (96, 
(M+3H+)3+), 524.4 (31, (M+2H+)2+), 581.4 (100, (M+TFA+2H+)2+), 695.4 (37, 
(M+3TFA+2H+)2+), 1047.7 (5, MH+), 1161.8 (12, ((M+TFA+H+)+); - MF: C63H101N14O25F21 
– FW: 1853.59 g/mol;  
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14-[4,6-Bis-(1,4,7,10-tetraaza-cyclododec-1-yl)-[1,3,5]triazin-2-yl-amino-N-(2-
methylamino)-acetamido-N-(2-methylamino)-acetamido-6-hexyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocyclohenicosene-2,3-dicarboxylic acid dimethyl ester TFA salt (15f´) 
N
H
N
+
N
N
+
N
+
N
+
N
+
N
N
+
NN
N
N
H
O
N
H
O
O
O
O
O
O
O O
O
O
N
+
O
H
H
H
H
H
H2
H2
H2
H2
7x CF3COO
-
 
Compound 11f (171 mg, 0.1 mmol) was submitted to GP II to yield a faintly yellow, 
hygroscopic solid (174 mg, 0.092 mmol, 92 %) is obtained. 
M.p. (uncorrected) = 47 – 50 °C; - 1H-NMR (600 MHz, MeOD): δ [ppm] = 1.22 (m, 4 H), 
1.41 (m, 2 H), 1.64 (m, 2 H), 3.01 – 3.13 (m, 10 H), 3.14 – 3.27 (m, 8 H), 3.29 – 3.37 (m, 16 
H), 3.38 – 3.47 (m, 4 H), 3.66 – 3.78 (m, 12 H), 3.78 – 3.91 (m, 8 H), 3.86 (s, 6 H), 4.03 (m, 2 
H), 4.19 – 4.31 (m, 4 H), 7.29 (s, 2 H) - 13C-NMR (150 MHz, MeOD): δ [ppm] = 24.5 (-, 1 
C), 27.1 (-, 1 C), 27.3 (-, 1 C), 30.1 (-, 1 C), 37.9 (-, 1 C), 40.2 (-, 1 C), 43.5 – 44.7 (-, 5 C), 
45.3 – 48.6 (-, 12 C), 53.2 (+, 2 C), 54.1 (-, 2 C), 54.8 (-, 1 C), 65.7 (-, 2 C), 70.1 (-, 2 C), 70.8 
(-, 2 C), 71.4 (-, 2 C), 71.9 (-, 2 C), 114.3 (+, 2 C), 115.0 & 117.0 & 119.0 & 120.9 (Cquat, 7 
C), 126.7 (Cquat, 2 C), 151.8 (Cquat, 2 C), 162.4 & 162.6 (Cquat, 7 C), 167.3 (Cquat, 1 C), 168.9 
(Cquat, 1 C), 169.1 (Cquat, 1 C), 169.4 (Cquat, 2 C), 171.2 (Cquat, 1 C), 174.0 (Cquat, 1 C); - IR 
(KBr): ν [cm-1] = 3300 (bm), 2944 (bm), 2790 (m), 2667 (bm), 2362 (m), 1715 (m), 1648 
(m), 1599 (s), 1518 (m), 1432 (m), 1349 (m), 1287 (s), 1262 (s), 1188 (m), 1108 (s), 1054 
(m), 971 (m), 945 (m), 889 (m), 779 (m), 579 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 369.0 (100, (M+3H
+)3+), 552.9 (19, (M+2H+)2+), 609.9 (77, 
(M+TFA+2H+)2+), 723.9 (12, (M+3TFA+2H+)2+), 1104.7 (5, MH+), 1218.8 (6, 
((M+TFA+H+)+); - MF: C65H103N15O26F21 – FW: 1909.64 g/mol;  
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14-[3-(1,4,7,10-Tetraaza-cyclododec-1-yl)-[1,4,5]triazol-amino-ethyl]-
6,7,9,10,13,14,15,16,18,19,21,22-dodecahydro-12H-5,8,11,17,20,23-hexaoxa-14-aza-
benzocyclohenicosene-2,3-dicarboxylic acid dimethyl ester TFA salt (19b´) 
N
N
+
N
+
N
+
NN
N
O
O
O
O O
O
O
N
+
O
OO
H
H2
H2
H
H
H
4x CF3COO
-
 
The Boc-protected ligand 19a (106 mg, 0.1 mmol) was dissolved in dichloromethane  
(2.0 mL). To the well stirred solution was given TFA (0.6 mL) and it was stirred for 3 h at 
room temperature. 
The dichloromethane and the TFA were evaporated, the product was taken up in a minimum 
volume of dichloromethane containing 5 % methanol and was then carefully precipitated by 
addition of diethyl ether. The product was allowed to settle and the supernatant solution was 
decanted off. The product was suspended in diethyl ether and centrifuged. It was again 
decanted. The residue was taken up in a minimum volume of water and lyophilized to give 
the free ligand salt as colourless to slightly yellow hygroscopic solid in quantitative yield  
(108 mg, 99 %).  
M.p. (uncorrected) = 47 - 48 °C; - 1H-NMR (300 MHz, MeOD): δ [ppm] = 2.78 (m, 4 H), 
2.96 (m, 4 H), 3.12 (m, 4 H), 3.20 (m, 4 H), 3.54 (m, 8 H), 3.71 (m, 8 H), 3.85 (m, 6 H), 3.89 
(m, 6 H), 3.96 (m, 2 H), 4.19 (m, 4 H), 4.94 (m, 4 H), 7.22 (s, 2 H), 7.84 (s, 1 H) – 13C-NMR 
(75 MHz, MeOD): δ [ppm] = 43.4 (-, 2 C), 43.6 (-, 4 C), 46.0 (-, 4 C), 48.0 (-, 1 C), 53.3 (+, 2 
C), 53.4 (-, 1 C), 56.0 (-, 2 C), 65.7 (-, 2 C), 70.2 (-, 2 C), 70.8 (-, 2 C), 71.4 (-, 2 C), 71.5 (-, 2 
C), 114.1 (+, 2 C), 116.2 (Cquat, 3 C), 120.0 (+, 1 C), 126.4 (+, 1 C), 126.6 (Cquat, 2 C), 143.9 
(Cquat, 1 C), 151.6 (Cquat, 2 C), 162.5 & 162.9 (Cquat, 3 C), 169.5 (Cquat, 2 C) - MS (ESI-MS, 
H2O/MeCN): m/z (%) = 264.8 (57, (M + 3H
+)3+ + MeOH), 376.2 (100, (M + 2H+)2+), 751.3 
(18, (MH+)); - MF: C43H67N8O18F12 – FW: 1213.06 g/mol; 
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1.4. Preparation of peptide 1 
 
H2N-Tyr-Ser(PO3H2)-Pro-Thr-Ser-Pro-Ser-CONH2 (1):
11 
NH
2
O
OH
NHO
N
H
N
H
O
OH
NO
P
O
OH
OH
NH
2
N
H
O
O
OH
O
O
N
OH
 
The heptapeptide was synthesized according to the following Fmoc based SPPS on rink 
amide resin after the standard protocol: 
 
MBHA resin and Fmoc protecting group strategy were used throughout all syntheses. 
Coupling was achieved by TBTU / HOBt / DIPEA. HOBt was used as a 0.45 M solution, 
TBTU as a 0.44 M solution and DIPEA as a 1.2 M solution, all in DMF. The Fmoc protected 
amino acids were dissolved in NMP as 0.4 M solutions. The peptide was synthesized on 50 
mg resin. The lot of the resin used had a loading of 0.72 mmol/g (manufacturer’s claims). 
Before each synthesis the resin was allowed to preswell in DMF for 30 min. Each coupling 
was done twice using a 5 fold excess of HOBt and slightly less than 5 fold excess of TBTU. 
DIPEA was used in 10 fold excess. Fmoc deprotection was done by shaking the resin with  
40 % piperidine in DMF for 3 minutes, subsequent washing and addition of 20 % piperidine 
in DMF followed by shaking for 10 minutes. After completion, the resin was washed with 
MeOH, DCM and Et2O (5 x 2 mL each). Where acylation was necessary, it was conducted 
using 5 eq. of Ac2O and 5 eq. of DIPEA in DMF for 30 minutes.  
Phosphorylated serine was introduced by using Fmoc-Ser(PO(OBzl)OH)-OH as the 
phosphorylated building block. As the cleavage mixture for the peptide, TFA / Phenol / H2O / 
Thioanisole / EDT (82.5:5:5:2.5) was used. After filtering off the resin, the TFA solution was 
reduced in volume to about 0.5 mL. It was then transferred to a Falcon tube and precipitated 
with cold Et2O. The precipitate was centrifuged at -4 °C for 10 minutes. The solution was 
then carefully decanted off and the precipitate resuspended in cold Et2O before being 
centrifuged again. This resuspending/centrifuging step was repeated five times. Finally, the 
Et2O was decanted off again and the peptide dried under vacuum. The peptides were analysed 
by ES-MS and LC-MS or HPLC or both. 
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Work-up and Purification:  
The precipitate was pelletized and washed four times with cold diethyl ether, before it was 
solubilised in H2O and freeze-dried. After analytical HPLC and LC-MS, a preparative HPLC 
run was performed to obtain the pure heptapeptide (11.73 mg, 14.32 µmol, 4 %).  
  
HPLC system:  Agilent 1100  
Column:      Phenomenex Luna 10 C18(2) 250 x 21.2 mm  
Column temperature:   25°C  
Injection volume:  100 µL  
Solvent A:   H2O (0.0059 % TFA)  
Solvent B:   MeCN  
Gradient:   0 min –   3 % MeCN / H2O (0.0059 % TFA)  
19 min – 33 % MeCN / H2O (0.0059 % TFA)  
20 min – 98 % MeCN / H2O (0.0059 % TFA)  
30 min – 98 % MeCN / H2O (0.0059 % TFA)  
Flow:    22 mL/min  
Elution time:   13.2 min  
  
MS (ESI-MS, H2O/MeOH + 10 mmol/l NH4OAc): m/z (%) = 815.4 (100, MH
+), 817.4 (100, 
MH+), 837.4 (6, M+ 2H++Na+), 839.4 (8, MNa+); - MF: C32H49N8O15P – FW: 816.77 g/mol; 
  
Chapter V Supporting Information Dissertation A. Späth  
 
 - 15 - 
2. 1H – / 13C-NMR and mass spectra of new compounds 
 
For solvents and conditions of measurement, see experimental procedures. NMR spectra were 
recorded on Bruker Avance spectrometers 300, 400 and 600. Measuring temperature was 300 
K. TMS was used as external standard. 
 
 
 
Figure S-1: 1H-NMR spectrum of compound 13a 
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Figure S-2: 13C-NMR spectrum of compound 13a 
 
 
 
Figure S-3: 1H-NMR spectrum of compound 13b 
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Figure S-4: 13C-NMR spectrum of compound 13b 
 
 
 
Figure S-5: 1H-NMR spectrum of compound 14a 
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Figure S-6: 13C-NMR spectrum of compound 14a 
 
 
 
Figure S-7: 1H-NMR spectrum of compound 14b 
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Figure S-8: 13C-NMR spectrum of compound 14b 
 
 
 
Figure S-9: 1H-NMR spectrum of compound 9a 
 
1
7
1
.0
1
1
6
1
5
5
.2
0
7
6
7
8
.8
3
4
7
4
9
.1
7
0
5
4
0
.2
3
3
2
3
9
.9
5
9
7
3
9
.6
7
6
4
3
9
.4
0
2
9
3
9
.1
1
9
7
3
8
.8
4
6
2
3
8
.5
7
2
7
2
7
.8
5
7
6
(ppm)
102030405060708090100110120130140150160170180190
5
.0
5
6
8
1
.9
9
6
6
1
.0
0
9
3
3
6
.0
4
0
5
4
.0
6
6
In
te
g
ra
l
7
.2
9
8
7
5
.0
4
8
4
4
.8
6
5
5
3
.5
9
1
8
3
.3
8
9
7
1
.4
3
5
6
1
.4
1
0
0
1
.3
6
5
2
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5
N N
NN
N N
NN
N
N
N
bocboc
boc
boc
boc boc
N
H
N
H
O
O
O Li
+
N N
NN
N N
NN
N
N
N
bocboc
boc
boc
boc boc
N
H
N
HO
O
Chapter V Supporting Information Dissertation A. Späth  
 
 - 20 - 
 
Figure S-10: 13C-NMR spectrum of compound 9a 
 
 
 
Figure S-11: 1H-NMR spectrum of compound 9b 
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Figure S-12: 13C-NMR spectrum of compound 9b 
 
 
 
Figure S-13: 1H-NMR spectrum of compound 22a 
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Figure S-14: 13C-NMR spectrum of compound 22a 
 
 
 
Figure S-15: 1H-NMR spectrum of compound 22b 
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Figure S-16: 13C-NMR spectrum of compound 22b 
 
 
 
Figure S-17: 1H-NMR spectrum of compound 19a 
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Figure S-18: 13C-NMR spectrum of compound 19a 
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Figure S-19: Mass spectrum of compound 19b 
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Figure S-20: 1H-NMR spectrum of compound 19b 
 
 
 
 
Figure S-21: 1H-NMR spectrum of compound 5 
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Figure S-22: Mass spectrum of compound 5 
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Figure S-23: COSY spectrum of compound 11a 
 
 
 
Figure S-24: HSQC spectrum of compound 11a 
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Figure S-25: Mass spectrum of compound 15a´ 
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Figure S-26: 1H-NMR spectrum of compound 15a 
 
 
 
 
Figure S-27: 13C-NMR spectrum of compound 15a 
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Figure S-28: 1H-NMR spectrum of compound 3a 
 
 
 
 
 
Figure S-29: 1H-NMR spectrum of compound 11b 
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Figure S-30: 13C-NMR spectrum of compound 11b 
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Figure S-31: Mass spectrum of compound 15b´  
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Figure S-32: 1H-NMR spectrum of compound 15b 
 
 
 
 
Figure S-33: 1H-NMR spectrum of compound 3b 
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Figure S-34: 1H-NMR spectrum of compound 11c 
 
 
 
Figure S-35: 13C-NMR spectrum of compound 11c 
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Figure S-36: Mass spectrum of compound 15c´ 
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Figure S-37: 1H-NMR spectrum of compound 15c 
 
 
 
 
Figure S-38: 1H-NMR spectrum of compound 3c 
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Figure S-39: 1H-NMR spectrum of compound 11e 
 
 
 
 
Figure S-40: 13C-NMR spectrum of compound 11e 
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Figure S-41: Mass spectrum of compound 15e´ 
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Figure S-42: 1H-NMR spectrum of compound 15e 
 
 
 
 
Figure S-43: 1H-NMR spectrum of compound 3e 
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Figure S-44: 1H-NMR spectrum of compound 11d 
 
 
 
 
Figure S-45: 13C-NMR spectrum of compound 11d 
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Figure S-46: Mass spectrum of compound 15d´ 
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Figure S-47: Mass spectrum of compound 3d 
 
 
 
 
Figure S-48: 1H-NMR spectrum of compound 11f 
0
.3
4
9
5
1
.9
9
0
5
0
.6
9
3
0
3
.9
5
4
2
2
.0
2
1
6
1
6
.0
5
8
4
4
.0
3
0
6
.0
7
1
5
5
6
.2
1
5
4
.0
9
2
3
In
te
g
ra
l
7
.9
2
8
6
7
.0
4
4
3
5
.8
2
9
1
4
.0
5
7
9
3
.8
9
3
3
3
.7
1
4
1
3
.5
5
2
2
3
.5
2
8
5
3
.5
0
5
6
3
.2
1
9
4
2
.9
9
1
7
2
.9
6
7
0
2
.9
4
2
3
2
.9
1
8
6
1
.3
9
8
8
1
.3
7
4
1
1
.3
4
9
5
1
.3
0
5
6
1
.2
8
4
5
1
.2
6
7
2
1
.0
4
6
8
(ppm)
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
N
H
N
N
N
N
N
N
N
N
NN
N
boc
boc
boc
boc
boc
boc
N
H
O
N
H
O
O
O
O
O
O
O O
O
O
N
O
Zn
2+
Zn
2+
N
N
N
N
N
N
N
N
N
N
N
N
H
O
N
H
O
O
O
O O
O
O
NO
OO
N
H
O
H
H H
H
H
H
ClO4
-
ClO4
-
Chapter V Supporting Information Dissertation A. Späth  
 
 - 44 - 
 
Figure S-49: 13C-NMR spectrum of compound 11f 
 
 
 
 
Figure S-50: COSY spectrum of compound 11f 
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Figure S-51: HSQC spectrum of compound 11f 
 
 
 
Figure S-52: HSQC spectrum (enlarged) of compound 11f 
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Figure S-53: Mass spectrum of compound 15f´ 
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Figure S-54: 1H-NMR spectrum of compound 15f 
 
 
 
 
Figure S-55: Mass spectrum of compound 3f 
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Figure S-56: COSY spectrum of compound 23 
 
 
 
 
 
Figure S-57: HSQC spectrum of compound 23 
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Figure S-58: Mass spectrum of compound 23 
 
N
N
N
O
N
HO
O
O
O
O
O
O
O
O
N
O
Chapter V Supporting Information Dissertation A. Späth  
 
 - 50 - 
 
Figure S-59: 1H-NMR spectrum of compound 6a 
 
 
 
 
Figure S-60: COSY spectrum of compound 25 
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Figure S-61: HSQC spectrum of compound 25 
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Figure S-62: Mass spectrum of compound 25 
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Figure S-63: 1H-NMR spectrum of compound 4a 
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3. UV and emission spectra of selected compounds 
 
Absorption Spectroscopy. Absorption were recorded on a Varian Cary BIO 50 UV/VIS/NIR 
Spectrometer with temperature control by use of a 1 cm quartz cuvettes  (Hellma) and Uvasol 
solvents or of quality for spectrophotometrical investigations (Merck, Baker or Acros). 
Emission Spectroscopy. Fluorescence measurements were performed with UV-grade solvents 
(Merck, Baker or Acros) in 1 cm quartz cuvettes (Hellma) and recorded on a Varian ‘Cary 
Eclipse’ fluorescence spectrophotometer with temperature control. To determine the binding 
constants and Job´s plots fluorescence titration experiments were carried out. 
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Figures S-64: Absorption spectra of compound 11a and 19a (left, c = 2*10-5 mol/L) and 
compound 23 and 25 (right, c = 2*10-5 mol/L) 
The UV spectra of the free ligands (15a-f) and their protected precursors (11a-f) or the free 
bpy ligands (23 and 25) are similar to the spectra of the different zinc-biscyclene (3a-f) and 
zinc or manganese bpy crown ether receptors (4 and 6), respectively, only their maxima are 
slightly shifted from 260 to 270 nm and from 220 to 225 nm. 
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Figures S-65: Absorption- and emission-spectrum of compound 1 (c = 4*10-5 mol/L) 
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4. Screenings and binding studies via fluorescence measurements  
 
The chromophore-containing aza-crown ether amino acids are able to participate in 
photoinduced electron transfer (PET), where, upon excitation an electron of the lone pair on 
the nitrogen is able to travel to the chromophore, quenching the fluorescence.12 Such a photo-
induced electron transfer (PET) can occur over a distance of 10 Å.13 Yoshida et al. showed, 
chromophore containing aza-crown ether compounds maintain their absorption and emission 
wavelengths and absorption intensity, while their fluorescence intensities are significantly 
altered upon cation complexation.14 
Cation complexation disrupts the electrostatic field of the amine and thereby the PET process, 
causing an increase in fluorescence intensity proportional to the amount of complexation and 
therefore the concentration of cation present. However, such crown ethers suffer pH 
dependence problems, where protonation of the amine mimics cation complexation at low pH, 
so the pH has to be maintained by an base like tetraethylammoniumhydroxide or all studies 
have to be conducted in a buffered medium (the system can be used at pH values ≥ 6). The pH 
effects on the luminescence15 and cation selectivity16 of aza-crown-ethers based on this 
signalling principle have been studied.   
 
 
4.1. General methods, material and sample preparation   
 
Sample preparation. HEPES buffer 50 mM with pH 7.4 was used.  The exact solutions 
have been prepared by adding to a weighed amount of receptor or substrate, the calculated 
amount of solvent necessary by means of microliter precision pipettes. This method is more 
accurate than to determine exactly the weighed amount (to 10-5 g) and admit a certain volume, 
since the volume measurement has a higher accuracy than the weight determination.  
Receptor solutions were stored properly stoppered and closed with parafilm at maximum for 
one week in the refrigerator at -4 °C. They were freshly prepared every week from deep 
frozen aliquots of the receptor material. Amino acid and peptide solutions were kept at -4 °C 
properly stoppered and closed with parafilm not longer than for one day or over night. Peptide 
and nucleotide solutions were always freshly prepared from the properly dried and carefully 
stored material (nitrogen, -20 °C). 
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4.2. Fluorescence data  
 
All fluorescence experiments were performed on a Varian Cary Eclipse Fluorimeter. 
To determine the binding constants, fluorescence titration experiments were carried out. The 
screening of the amino acids and the synthesized peptide library was conducted in a microtiter 
plate (384 wells, UV star material). The fluorescence intensity was found to be constant after 
5 min. 
 
Screening conditions:  
Solvent:     HEPES buffer 50 mM pH 7.4 
Well volume:     130 µL  
Concentration [crown ether host complex]:  0.01 mM  
Concentration [amino acid / peptide]: 1.00 mM / 0.20 mM  
 
 
Instrument Parameters:  
Excitation wavelength:   λex = 300 nm   
Detection wavelength:   λ = 330 – 500 nm 
Temperature:     T = 298 K  
PMT voltage:     500 - 600 volts 
Excitation slit:    10 nm 
Emission slit:     10 nm      
  
 
Procedure:  
To each column in the microtiter plate samples of the receptor (65 µL) and the amino acid or 
peptide (65 µL) and the receptor without added peptide but volume corrected as reference 
were given. The mixtures were quickly pipetted row by row, mixed with the aid of the pipette 
and allowed to equilibrate for 10 minutes. Emission spectra (λex = 300 nm) for all wells were 
recorded. All measurements were repeated twice.  
For amino acids and peptides inducing a sufficient emission increase over the parent 
compound (> 10 %) the binding constant and stoichiometry of the respective guest with 
selected receptors were determined by emission titration in a cuvette  
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Emission titrations: 
 
Titration conditions (amino acids and related guests):  
Solvent:      HEPES buffer 50 mM pH 7.4 
Starting volume:     1.0 mL   
Concentration [receptor]:    0.02 mM  
Concentration [amino acid or peptide]:  0.20 – 1.00 mM  
 
 
Instrument Parameters: 
Excitation wavelength:   λex = 300 nm  
Detection wavelength:   λ = 320 – 500 nm  
Temperature:     T = 298 K 
PMT voltage      560 - 600 volts     
 
 
Procedure:  
A cuvette with 1.0 mL of the receptor solution was titrated stepwise with small amounts  
(10 - 50 µL ≙ 0.1 – 1.0 eq.) of the peptide solution. After each addition the solution was 
allowed to equilibrate for 10 min before the fluorescence intensity (λex = 300 nm) was 
recorded. The  stoichiometry  was determined  by  Job´s  plot  analysis  extracted  from  
titration  data.Fehler! Textmarke nicht definiert.  To determine the binding constant the obtained 
fluorescence intensities were volume corrected, plotted against the concentration of peptide 
and evaluated by non linear fitting methods. 
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4.2.1. Titrations of the crown ether part with ammonium guests: 
 
In preparation of the measurements, the binding constants of the crown ether unit alone were 
determined in a cuvette. To 1.0 mL of the receptor in methanol were added small  
(≙ 0.5 to 10 eq.) aliquots of the guest solution. After each addition the solution was allowed 
to equilibrate and the emission intensity was recorded. To determine  the binding  constant  
the  obtained  fluorescence  intensities were  volume  corrected,  plotted against the 
concentration of peptide and evaluated by non linear fitting methods. In all measurements the 
receptor was employed as 2*10-5 molar solutions, the guest were added as 1*10-3 molar 
solutions at 25 °C. The system was excitated at 300 nm. Within the limits of error the values 
show no difference to the literature known ones of the single CEAAs:17 
 
Crown ether zinc 
biscyclene motif 
Log K  
(n-BuNH3
+
) 
Log K  
(KSCN) 
3b 2.15 (4 %) 3.38 (9 %) 
3c 2.21 (5 %) 3.31 (14 %) 
3d 2.07 (3 %) 3.17 (11 %) 
3e 2.12 (5 %) 3.23 (13 %) 
5 2.39 (5 %) 3.71 (10 %) 
3a 2.28 (4 %) 3.66 (11 %) 
 
Table S-1: Binding constants for the zinc-biscyclenes in MeOH against n-butylamine and 
KSCN as guests (error in % in brackets) 
 
Neither n-butylamine nor potassium isothiocyanate cause a difference of the fluorescence 
output in aqueous HEPES buffer. Even if 2000 equivalents of the salts are added, they are not 
bound in this medium by the crown ether moiety. 
 
 
  
Chapter V Supporting Information Dissertation A. Späth  
 
 - 59 - 
4.2.2. Titrations with phosphoserine as guest: 
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Figures S-66: Emission titration of compound 6b (left) and compound 6a (right)  
(c = 2*10-5 mol/L) with phosphoserine (c = 1*10-3 mol/L) 
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Figures S-67: Emission titration of compound 4b (left) and compound 4a (right)  
(c = 2*10-5 mol/L) with phosphoserine (c = 2*10-4 mol/L) 
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4.2.3. Titrations with the PKG substrate (2) as guest: 
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Figures S-68: Emission titration of compound 6b (left) and compound 6a (right)  
(c = 2*10-5 mol/L) with 2 (c = 5*10-4 mol/L) 
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Figures S-69: Job´s Plot of compound 6b (left) and compound 6a (right) (c = 2*10-5 mol/L) 
binding to 2 (c = 5*10-4 mol/L) 
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Figures S-70: Emission titration of compound 4b (left) and compound 4a (right)  
(c = 2*10-5 mol/L) with 2 (c = 2*10-4 mol/L) 
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Figures S-71: Job´s Plot of compound 4b (left) and compound 4a (right) (c = 2*10-5 mol/L) 
binding to 2 (c = 2*10-4 mol/L) 
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4.2.4. Titrations with the CTD heptapeptide (1) as guest: 
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Figures S-72: Emission titration of compound 6b (left) and compound 6a (right)  
(c = 2*10-5 mol/L) with 1 (c = 2*10-4 mol/L) 
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Figures S-73: Job´s Plot of compound 6b (left) and compound 6a (right) (c = 2*10-5 mol/L) 
binding to 1 (c = 2*10-4 mol/L) 
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Figures S-74: Emission titration of compound 3a (left) and compound 3b (right)  
(c = 2*10-5 mol/L) with 1 (c = 2*10-4 mol/L) 
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Figures S-75: Emission titration of compound 3c (c = 2*10-5 mol/L) with 1  
(c = 2*10-4 mol/L) 
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Figures S-76: Job´s Plot of compound 3a (left) and compound 3b (right) (c = 2*10-5 mol/L) 
binding to 1 (c = 2*10-4 mol/L) 
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Figures S-77: Job´s Plot of compound 3c (c = 2*10-5 mol/L) binding to 1 (c = 2*10-4 mol/L) 
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4.3. Fluorescence measurements with Nucleotides.18  
 
Zn(II)cyclene or bis-[Zn(II)cyclene] complexes can bind imide-containing nucleotides like 
uridine (U) and thymidine (T) or their derivatives by specific Zn(II)-imide N-coordination.19  
Such Zn(II)cyclene complexes with appended aromatic ring systems were shown to 
selectively bind to T- or U-rich regions in double stranded DNA or RNA.20 They do not 
interact with the other DNA nucleosides (G, A and C), making the reversible coordination of 
the metal complex highly selective.  
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Figure S-78: Nucleotides AMP (E-1a), ADP (E-1b), ATP (E-1c), GMP (E-2), CTP (E-3) 
and the pyrophosphate anion (PPi, E-4) 
  
Especially these three nucleotides moved in our focus, when observing the ester-cleavage 
upon complexation of compounds 3a to 3f. The combination of the strong and selective 
phosphate coordination of the metal complex together with the two-fold negative charge of 
the phthalic acid favourably oriented by the bowl shape of the crown ether pushed us towards 
studies with these encouraging guests for a quick assay on the basis of the discussed 
recognition motif. We selected these representative targets to measure also the phosphate 
binding abilities of the systems towards mono-, di- and triphosphates. 
All bases exist mainly in the tautomere of the amino- and ketoforms (more then 99.99 %) and 
are under physiological conditions uncharged (5 < pH < 9). A protonation to an only weak 
extent promoted by the intramolecular interaction is absolutely sufficient for binding. In water 
adenine has its absorption maximum at 261 nm with a molar extinction coefficient of 13400 
M-1cm-1, cytosine with 6100 M-1cm-1 at 220 nm, guanine behaves similar21 Due to the 
expected low fluorescence yield (φ < 0.01) a disturbing fluorescence signal of the base is not 
expected.22 
 
In all measurements, the intensity decreases with the increase of the guest concentration 
(Figure S-79). A representative titration with AMP (E-1a) is shown:  
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Figure S-79: Intensity decrease of compound 3e with rising amount of AMP (left) and the 
according titration curve (right); in red: logistic fit 
The data was interpreted with the aid of the origin program package. The falling curves were 
fitted by a logistic plot (equation 1), the result was checked by fitting of the inverted curves 
with the hill plot (equation 2): 
(1) y = A / [1 + (x/x0)
p];  p = 1 
(2) y = (Vmax * x
n) / (kn + xn); n = 1; no cooperativity assumed 
Equation S-1: Calculation of the binding constants 
Both calculations gave comparable results. Representative values are given for receptor 
compound 3e with all guests and for all receptors with the same guest, AMP, in table S-2. 
Guest 
Log K 
(logistic) 
Log K  
(Hill plot) 
 Host 
Log K 
(logistic) 
Log K  
(Hill plot) 
AMP 4.22   (7 %) 4.15    (8 %)  3a 4.05  (10 %) 4.05    (8 %) 
ADP 4.52  (11 %) 4.70  (12 %)  3b 4.05  (10 %) 3.89   ( 8 %) 
ATP 4.70  (13 %) 4.70  (10 %)  3c 4.22  (12 %) 4.00  (10 %) 
CTP 4.70   (6 %) 4.70    (5 %)  3d 4.10  (11 %) 3.95  (13 %) 
GMP 4.30   (8 %) 4.26  (10 %)  3e 4.05  (11 %) 4.20  (12 %) 
PPi 4.36 (10 %) 4.22  (11 %)  3f 4.22    (7 %) 4.15    (7 %) 
    5 4.05  (10 %) 3.89    (7 %) 
Table S-2: Binding constants for compound 3e in with the phosphorylated guests and for all 
biscyclene receptors with AMP (HEPES-buffer, 50 mM, pH 7.4; error in % in 
brackets) 
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An increase in binding strength with increasing number of phosphate residues and therefore 
of the negative charge in the anion is obvious: ATP, CTP and ADP have the highest negative 
charge and thus show the highest binding constants, whereas for AMP with one negative 
charge a slightly weaker association was found. 
 
Figure S-80: Receptor 3e with all used guests, a tendency is observable (blue = binding 
value, red, error). 
As found in earlier investigations with such crown ether receptors,23 an increase in emission is 
expected if a guest molecule is bound in the crown ether ring. The opposite effect is observed, 
which reflects a binding only by the metal complex. Here, the crown ether part acts as a 
signalling beacon without switching off the PET upon binding. This is underlined by binding 
constants corresponding approximately to each other. Consequently the binding is just 
between the cyclene complexed Zn(II)-ions and the phosphate group. The decrease of the 
fluorescence is clearly visible and can be distinguished with the naked eye.  
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Figure S-81: On the left: Luminescence of a solution of 3e in the absence and presence of 
AMP. From left to right: 0, 1, 2, 3, 5 equivalents of AMP were given to a 
solution of 3e. On the right: The corresponding graph. 
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Unfortunately, the ditopic mode of binding could not be confirmed. Binding constants are in 
the normal range as expected for zinc-complex-phosphate interaction, a shift in emission of 
the phthalic acid is not observed.24 The biscyclene-crowns feature a weak selectivity between 
triphosphates over diphospates and monophosphates of nucleotides. The binding is strong in 
buffered aqueous solution or under rather physiological conditions. The corresponding 
luminescence decrease can be observed clearly with the naked eye. Despite the weak 
selectivity, this could be used as a quick test for the presence of any nucleotides in aqueous 
solution. 
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5. Energy minimization calculation pictures with Spartan´06 V.112 
 
 
 
Figure S-82: The stabilizing H-bond network in the CTD heptapeptide 1 (left) and the PKG 
substrate 2 (right) simulated in the gas phase 
 
 
 
Figure S-83: Structure of the stable aggregate of the CTD heptapeptide (1) with 3a simulated 
in the gas phase 
 
  
 
Figure S-84: Structure of the stable aggregate of the PGK substrate (2) with 4a simulated in 
the gas phase 
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1. Syntheses 
 
1.1. General methods 
 
Analytical control of the synthesized compounds was done by common methods.  Melting 
Points were determined on Büchi SMP or a Lambda Photometrics OptiMelt MPA 100 and are 
uncorrected. IR Spectra were recorded with a Bio-Rad FT-IR Excalibur FTS 3000. UV 
spectra were recorded on a Cary 50 BIO spectrometer with temperature control at 25°C. 
Electro spray mass spectra were performed on a Finnigan MAT TSQ 7000 ESI-spectrometer. 
Other Mass Spectra were recorded on Varian CH-5 (EI), Finnigan MAT 95 (CI; FAB and 
FD), Xenon serves as the ionization gas for FAB. 
NMR spectra were recorded on Bruker Avance 600 (
1
H: 600.1 MHz, 
13
C: 150.1 MHz, T = 
300 K), Bruker Avance 400 (
1
H: 400.1 MHz, 
13
C: 100.6 MHz, T = 300 K) or Bruker Avance 
300 (
1
H: 300.1 MHz, 
13
C: 75.5 MHz, T = 300 K) relative to external standards. NMR spectra 
were recorded in CDCl3 at 300 MHz (
1
H) or 75 MHz (
13
C) unless stated otherwise. 
Characterization of the signals: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, 
bs = broad singlet, dd = double doublet, dt = double triplet, ddd = double double doublet. 
Integration  is  determined  as  the  relative  number  of  atoms,  the  coupling  constants  are  
given  in Hertz  [Hz]. The multiplicity of the carbon atoms is given as (+) = CH3 or CH, (-) = 
CH2 and (Cquat) for quaternary carbon atoms. Structural assignments are based on DEPT and 
COSY experiments where applicable. Error of reported values: chemical shift: 0.01 ppm for 
1
H-NMR, 0.1 ppm for 
13
C-NMR and 0.1 Hz for coupling constants. The solvent used is 
reported for each spectrum. 
Analytical TLC plates (silica gel 60 F254) and silica gel 60 (70-230 or 230-400 mesh) were 
used for chromatographic separations. Visualization of the spots was by UV light and/or 
staining with phosphomolybdate or ninhydrin, both in ethanol. DMF, CH3CN, CHCl3, THF, 
and Et2O were dried by standard procedures and stored over molecular sieves. PE means 
petrol ether with a boiling range of 70 - 90 
o
C, EA means ethyl acetate. All other solvents and 
chemicals were of reagent grade and used with out further purification. 
All test substances were of pro analysi grade, checked by NMR or HPLC and used as 
purchased with out further purification. The Solvents for the fluorescence measurements were 
from special spectroscopic purity purchased from Acros or Baker or Uvasol from Merck. 
Millipore water (18 MΩ, Milli QPlus) was used; the HEPES buffer was from according purity, 
suitable for biochemical optical screenings. As far as not stated differently 
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tetraethylammoniumhydroxide or 0.1 molar hydrochloric acid both analytical grade were used 
to adjust the pH in the titrations and screenings. 
 
 
1.2. Syntheses and protection of amino alcohols 
 
The according N-Boc-protected amino acid methyl ester (2.00 g)
1
 was dissolved in dry THF 
(30.0 mL) in a nitrogen atmosphere and NaBH4 and LiCl were subsequently added in small 
portions. The mixture was stirred over night at room temperature under moisture protection. 
After having added 20 mL of water slowly, acetic acid (1.2 mL, 20.0 mmol) was dropped in. 
After short stirring the THF was removed under reduced pressure. A 1:1 mixture of water and 
diethyl ether (50 mL; 50 mL) was added; the solid was completely dissolved. The organic 
phase was separated and the aqueous layer was extracted with diethyl ether (3 x 50 mL). The 
combined ether phases were dried over MgSO4 and the solvent was evaporated under reduced 
pressure. The residue was purified by column chromatography (ethyl acetate / petrol ether 
1:2). 
 
N-(
tert
Butyloxycarbonyl)-2-aminopropane-1,3-diol 
ONH
O
OH
OH
 
N-Boc-L-serine methyl ester (2.00 g, 8.23 mmol) was employed together with 0.69 g NaBH4 
(18.1 mmol) and 0.77 g LiCl (18.1 mmol). The reaction yielded 0.99 g colourless oil  
(4.6 mmol, 59 %).  
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.41 (s, 9 H), 3.54 (m, 1 H), 3.61 (m, 2 H), 3.83 (bs, 
2 H,), 4.11 (m, 2 H), 5.04 (bs, 1 H); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): 
m/z (%) = 192.2 (100, MH
+
); - MW = 191.23; - MF = C8H17NO4. 
 
 
N-(
tert
Butyloxycarbonyl)-2-amino-4-methyl-pentan-1-ol 
ONH
O
OH
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N-Boc-L-leucine methyl ester (2.00 g, 7.72 mmol) was reacted with 0.65 g NaBH4 (17 mmol) 
and 0.72 g LiCl (17 mmol), to obtain 1.66 g colourless oil (7.2 mmol, 87 %).  
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 0.86 (d, 6 H, J = 6.0 Hz), 1.22 (m, 2 H), 1.40 (s, 9 
H), 1.61 (m, 1 H), 3.46 (m, 1 H), 3.68 (bs, 2 H), 4.78 (bs, 2 H); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 218.2 (100, MH
+
); - MW = 217.31; - MF = 
C11H23NO3. 
 
 
N-(
tert
Butyloxycarbonyl)-2-amino-3-phenyl-propan-1-ol 
ONH
O
OH
 
N-Boc-L-phenylalanine methyl ester (2.00 g, 6.6 mmol) was reduced with 0.55 g NaBH4 
(14.5 mmol) and 0.62 g LiCl (14.5 mmol), to give 1.71 g of an off white solid (6.2 mmol,  
94 %).  
M.p. (uncorrected) = 88 – 89 °C; -
 1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.40 (s, 9 H), 
2.76 (m, 1 H), 2.88 (d, 2 H, J = 6.0 Hz), 3.49 – 3.70 (m, 2 H), 3.87 (bs, 1 H), 4.86 (bs, 1 H), 
7.19 – 7.28 (m, 3 H), 7.28 – 7.36 (m, 2 H); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 252.3 (100, MH
+
); - MW = 251.33; - MF = C14H21NO3. 
  
 
N-(
tert
Butyloxycarbonyl) 2-amino-3-(1H-indol-3-yl)propan-1-ol 
ONH
O
OH
N
H
 
N-Boc-L-tryptophan methyl ester (2.00 g, 5.85 mmol) was reacted with 0.49 g NaBH4  
(12.9 mmol) and 0.55 g LiCl (12.9 mmol), to obtain 1.74 g of a white solid (5.5 mmol, 93 %).  
M.p. (uncorrected) = 119 – 120 °C; -
 1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.40 (s, 9 H), 
2.79 (m, 1 H), 2.99 (d, 2 H, J = 6.0 Hz), 3.51 – 3.72 (m, 2 H), 4.00 (bs, 1 H), 4.89 (bs, 1 H), 
7.01 (m, 1 H), 7.06 – 7.24 (m, 2H), 7.34 (app. d, 1 H), 7.68 (app. d, 1 H), 8.29 (bs, 1 H); - MS 
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(ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 291.2 (100, MH
+
); - MW = 
290.37; - MF = C16H22N2O3. 
 
 
3-(N-(
tert
Butyloxycarbonyl)-2-amino-3-hydroxy-propyl)-1-N-(benzyloxycarbonyl)-indole 
ONH
O
OH
N
O
O  
Powdered sodium hydroxide (120 mg, 3.0 mmol) was added to a solution of N-Boc-L-
tryptophanol (290 mg, 1.0 mmol) and tetrabutylammonium hydrogen sulfate (290 mg,  
0.6 mmol) in dried CH2Cl2 (5 mL) and the mixture was stirred for two and a half hours at 
room temperature. Benzylchloroformate (412 mg, 2.4 mmol) was then added and the mixture 
was allowed to stir for 20 h. After dilution with ethyl acetate (10 mL) and stirring for a half 
hour, it was washed three times with water (5 mL). After being dried over MgSO4 the solvent 
was removed under reduced pressure. The residue was purified by flash chromatography 
(silica gel, ethyl acetate / petrolether 1:3) to afford the title compound as a white solid  
(380 mg, 0.921 mmol, 92 %).  
M.p. (uncorrected) = 76 – 78 °C; - 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.47 (s, 9 H), 
3.03 (m, 2 H), 4.16 (m, 2 H), 4.25 (m, 1 H), 4.70 (m, 1 H), 4.94 (bs, 1 H), 5.20 (s, 2 H), 6.95 
(m, 1 H), 7.12 (m, 1 H), 7.21 (m, 1 H), 7.28 – 7.46 (m, 6 H), 7.65 (m, 1 H); - IR (FT-IR, 
film): ν [cm
-1
] = 3346 (bm), 2976 (m), 2886 (m), 1726 (m), 1689 (s), 1528 (m), 1454 (m), 
1397 (m), 1367 (m), 1254 (s), 1162 (s), 1067 (m), 1019 (m), 941 (m), 896 (m), 852 (m), 791 
(m), 739 (s), 697 (s), 660 (m), 593 (m), 556 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 425.1 (48, MH
+
), 442.0 (25, MNH4
+
), 849.3 (100, 2M+H
+
), 866.4 (11, 
2M+NH4
+
); - MW = 424.50; - MF = C24H28N2O5. 
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1.3. Syntheses and deprotections of the building blocks 
 
6-(hydroxymethyl)pyridine-2-carboxylic acid ethyl ester (literature known
2
, improved) 
OH
N
O
O
 
The 2,6-pyridine carboxylic acid diethyl ester (27.9 g, 0.125 mol) and NaBH4 (3.8 g, 0.1 mol) 
were dissolved in 250 mL of dry THF and refluxed for 2 h under moisture protection. The 
solvent was removed and 50 mL water was added. After stirring for 10 mins, the mixture was 
extracted with CHCl3 (3 x 50 mL). The organic phases were combined, dried over MgSO4 
and the solvent was evaporated under reduced pressure. The residue was purified by flash 
chromatography on silica gel with ethyl acetate / ethanol 6:1  3:1 to give the product as 
colourless solid (15.39 g, 85.02 mmol, 85 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.33 (t, 3 H, J = 7.2 Hz), 4.12 (bs, 1 H), 4.39 (q, 2 H, 
J = 7.2 Hz), 4.81 (s, 2 H), 7.49 (d, 1 H, J = 4.6 Hz), 7.78 (app. t, 1 H), 7.92 (d, 1 H, J = 4.6 
Hz); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 14.3 (+, 1 C), 61.9 (-, 1 C), 64.6 (-, 1 C), 123.6 
(+, 1 C), 123.9 (+, 1 C), 137.6 (+, 1 C), 147.2 (Cquat, 1 C), 160.5 (Cquat, 1 C), 165.1 (Cquat, 1 
C); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 182.0 (100, MH
+
); - 
MW = 181.19; - MF = C9H11NO3. 
 
 
6-(aminomethyl)pyridine-2-carboxylic acid ethyl ester (literature known, improved) 
N
O
ONH
2
 
Thoroughly dried 6-hydroxymethyl-pyridine-2-carboxylic acid ethyl ester (5.8 g, 35 mmol) 
was dissolved in small portions in well stirred SOCl2 (11.5 mL) under moisture protection not 
allowing the temperature to rise over 0°C. After 90 min the solution was allowed to reach 
room temperature and the excess of SOCl2 was removed under reduced pressure without 
heating. Toluene (20 mL) was added to the oily residue, the solution was washed with cold 
aqueous 1 M NaHCO3 (2 x 10 mL) and dried over MgSO4. Evaporation of the solvent 
afforded 6.5 g of the product (32.5 mmol, 83 %) as orange oil (analogue to the literature
3
). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.31 (t, 3 H, J = 7.2 Hz), 4.39 (q, 2 H, J = 7.2 Hz), 
4.70 (s, 2 H), 7.62 (d, 1 H, J = 4.6 Hz), 7.81 (app. t, 1 H), 7.97 (d, 1 H, J = 4.6 Hz); - 
13
C-
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NMR (75 MHz, CDCl3): δ [ppm] = 14.2 (+, 1 C), 46.3 (-, 1 C), 62.0 (-, 1 C), 124.3 (+, 1 C), 
126.1 (+, 1 C), 138.1 (+, 1 C), 147.6 (Cquat, 1 C), 157.1 (Cquat, 1 C), 164.7 (Cquat, 1 C); - IR 
(FT-IR, film): ν [cm
-1
] = 2982 (m), 2936 (m), 2884 (m), 1716 (s), 1589 (m), 1454 (m), 1369 
(m), 1313 (s), 1257 (s), 1226 (m), 1175 (s), 1123 (s), 1086 (m), 1021 (m), 945 (m), 863 (m), 
834 (m), 746 (s), 695 (s), 593 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z 
(%) = 202.1 (31, MH
+
), 200.1 (100, MH
+
); - MW = 199.64; - MF = C9H10ClNO2. 
 
2-Chloromethyl-pyridine-6-carboxylic acid ethyl ester (6.0 g, 30 mmol) in anhydrous DMF 
(10 mL) was slowly added to a dry DMF (10 mL) sodium phthalimide solution (6.12 g,  
36 mmol). After stirring for 2 h at room temperature the reaction mixture was centrifuged, the 
solvent was removed under reduced pressure and the residue was dissolved in CHCl3  
(100 mL). The resulting solution was washed with 0.2 M NaOH (2 x 100 mL), then with 
water and dried. Removal of the solvent yielded a solid residue, which was dissolved in warm 
ethanol (500 mL). Hydrazine (1.13 g, 35 mmol) was added and the mixture was refluxed until 
disappearance (monitored by TLC) of the starting material. The mixture was cooled to 5 °C, 
filtered and the solvent was removed to finally receive 4.05 g of yellow syrup (22.5 mmol,  
75 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.27 (t, 3 H, J = 7.2 Hz), 4.28 (q, 2 H, J = 7.2 Hz), 
4.49 (s, 2 H), 7.69 (d, 1 H, J = 4.6 Hz), 7.77 (m, 1 H), 7.87 (d, 1 H, J = 4.6 Hz), 8.61 (bs, 1 
H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 14.2 (+, 1 C), 44.4 (-, 1 C), 62.1 (-, 1 C), 124.5 
(+, 1 C), 126.5 (+, 1 C), 138.2 (+, 1 C), 147.2 (Cquat, 1 C), 154.4 (Cquat, 1 C), 164.8 (Cquat, 1 
C); - IR (FT-IR, film): ν [cm
-1
] = 3402 (bm), 2979 (m), 2901 (m), 2722 (m), 2631 (m), 1720 
(s), 1663 (m), 1591 (s), 1526 (s), 1449 (s), 1388 (m), 1369 (m), 1300 (s), 1253 (s), 1230 (s), 
1180 (s), 1143 (s), 1091 (m), 1020 (m), 997 (s), 894 (m), 862 (m), 831 (m), 760 (s), 655 (m), 
621 (m); - MS (CI-MS, NH3): m/z (%) = 181.0 (100, MH
+
); - MW = 180.21; - MF = 
C9H12N2O2. 
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1.4. Ether syntheses 
 
1.4.1. Phase transfer catalytic etherification of substituted amino alcohols (GP 1) 
The N-Boc-amino alcohol was dissolved with tetrabutylammonium hydrogensulfate  
(0.4 mmol, 98.8 mg) in CH2Cl2 (6 mL). Aqueous NaOH (5.0 M, 6.0 mL) was added, 
bromoacetic acid 
tert
butyl ester (1.2 mmol, 233 mg) in CH2Cl2 (1 mL) was dropped in and the 
reaction mixture was vigorously stirred for 3 h at room temperature. The same amount 
bromoacetic acid 
tert
butyl ester was added again and the heterogeneous solution was stirred 
over night. The mixture was poured on ice (10 g) in a separation funnel, the organic phase 
was separated and the aqueous layer was extracted with dichloromethane (3 x 10 mL). The 
organic phases were combined, dried over MgSO4 and the solvent was removed under 
reduced pressure. The crude product was purified by column chromatography with ethyl 
acetate / petrol ether 1:4 to obtain the pure compound. 
 
 
2-(N-(
tert
Butyloxycarbonyl)-2-amino-4-methyl-pentoxy)-acetic acid 
tert
butylester (7e): 
O
O
N
H
O
O
O
 
The N-Boc-L-leucinol (217 mg, 1.0 mmol) was reacted to obtain 256 mg of a white oily solid 
(0.77 mmol, 77 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 0.86 (d, 6 H, J = 7.2 Hz), 1.36 (m, 2 H), 1.38 (s, 9 
H), 1.41 (s, 9 H), 1.61 (m, 1 H), 3.43 (m, 2 H), 3.70 (m, 1 H), 3.89 (s, 2 H), 4.83 (bs, 1 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 22.4 (+, 1 C), 22.9 (+, 1 C), 24.8 (+, 1 C), 28.1 (+, 3 
C), 28.4 (+, 3 C), 41.0 (-, 1 C), 48.5 (+, 1 C), 68.4 (-, 1 C), 73.8 (-, 1 C), 78.9 (Cquat, 1 C), 82.8 
(Cquat, 1 C), 155.6 (Cquat, 1 C), 166.2 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3354 (bm), 
2959 (m), 2934 (m), 2874 (m), 1748 (m), 1710 (s), 1503 (m), 1457 (m), 1387 (m), 1367 (s), 
1295 (m), 1228 (s), 1164 (s), 1128 (s), 1049 (m), 941 (m), 846 (m), 778 (m), 751 (m); - MS 
(CI-MS, NH3): m/z (%) = 219.1 (13, MH
+ 
- 2 C4H8), 237.0 (20, MNH4
+
 - 2C4H8), 275.2 (48, 
MH
+ 
- C4H8), 293.2 (69, MNH4
+ 
- C4H8), 332.2 (100, MH
+
), 349.2 (83, MNH4
+
); - MW = 
331.46; - MF = C17H33NO5. 
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2-(N-(
tert
Butyloxycarbonyl)-2-amino-3-phenyl-propoxy)-acetic acid 
tert
butylester (7g): 
O
O
N
H
O
O
O
 
The N-Boc-L-phenylalaninol (250 mg, 1.0 mmol) was employed to yield 328 mg of 7g as a 
colourless wax (0.89 mmol, 89 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.33 (s, 9 H), 1.39 (s, 9 H), 2.82 (m, 2 H), 3.37 (m, 2 
H), 3.65 (m, 1 H), 3.87 (s, 2 H), 5.17 (bs, 1 H), 7.18 – 7.30 (m, 5 H); - 
13
C-NMR (75 MHz, 
CDCl3): δ [ppm] = 28.1 (+, 3 C), 28.4 (+, 3 C), 37.1 (-, 1 C), 51.8 (+, 1 C), 68.5 (-, 1 C), 71.6 
(-, 1 C), 79.2 (Cquat, 1 C), 82.9 (Cquat, 1 C), 126.3 (+, 1 C), 128.4 (+, 2 C), 129.5 (+, 2 C), 
138.3 (Cquat, 1 C), 155.5 (Cquat, 1 C), 166.3 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3375 
(bm), 2978 (m), 2932 (m), 2880 (m), 1746 (m), 1710 (s), 1497 (m), 1456 (m), 1389 (m), 1367 
(m), 1294 (m), 1230 (m), 1163 (s), 1130 (s), 1058 (m), 943 (m), 917 (m), 846 (m), 742 (m), 
701 (m); - MS (CI-MS, NH3): m/z (%) = 253.1 (14, MH
+ 
- 2 C4H8), 271.0 (21, MNH4
+
 - 2 
C4H8), 309.1 (82, MH
+ 
- C4H8), 327.1 (63, MNH4
+ 
- C4H8), 366.2 (100, MH
+
), 383.2 (78, 
MNH4
+
); - HRMS (EI-MS 70 eV): calc. for C20H31NO5
*+
: 365.2202, found: 365.2197; - MW 
= 365.47; - MF = C20H31NO5. 
 
 
2-((N-(
tert
Butyloxycarbonyl)-2-amino-3-hydroxy-propyl)-3-(1-N-(benzyloxycarbonyl)-
indole))-acetic acid 
tert
butylester (7i) 
O O
NH
N
O O
Ph
O
O
O
 
The 3-(N-Boc-L-2-amino-3-hydroxy-propyl)-1-N-Cbz-indole (298 mg, 0.7 mmol) was used to 
give 236 mg as colourless oil (0.441 mmol, 63 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.41 (s, 9 H), 1.43 (s, 9 H), 3.06 (m, 2 H), 3.46 (m, 1 
H), 3.98 (s, 2 H), 4.11 (m, 2 H), 4.61 (m, 2 H), 5.19 (bs, 1 H), 6.98 (m, 1 H), 7.10 (m, 1 H), 
7.19 (m, 1 H), 7.29 – 7.41 (m, 7 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 28.1 (+, 3 C), 
28.4 (+, 3 C), 48.5 (-, 1 C), 51.0 (+, 1 C), 67.7 (-, 1 C), 68.5 (-, 1 C), 68.9 (-, 1 C), 79.1 (Cquat, 
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1 C), 81.8 (Cquat, 1 C), 108.9 (+, 1 C), 111.9 (Cquat, 1 C), 119.4 (+, 1 C), 121.9 (+, 1 C), 127.4 
(+, 1 C), 127.9 (-, 1 C), 128.1 (+, 2 C), 128.4 (+, 2 C), 128.6 (+, 1 C), 136.8 (Cquat, 1 C), 137.4 
(Cquat, 1 C), 155.6 (Cquat, 1 C), 167.6 (Cquat, 1 C), 169.0 (Cquat, 1 C), 169.6 (Cquat, 1 C); - IR 
(FT-IR, film): ν [cm
-1
] = 3061 (bm), 2977 (m), 2933 (m), 1745 (s), 1491 (m), 1468 (m), 1389 
(m), 1367 (m), 1299 (m), 1227 (s), 1189 (s), 1128 (s), 1050 (m), 943 (m), 847 (m), 803 (m), 
740 (m), 699 (m), 584 (m); - MS (CI-MS, NH3): m/z (%) = 539.1 (33, MH
+
), 556.1 (36, 
MNH4
+
), 577.1 (100, MK
+
), 599.1 (64, M+HOAc+H
+
); - MW = 538.65; - MF = C30H38N2O7. 
 
 
1.4.2. Sodium hydride catalysed ether synthesis (GP 2) 
In an nitrogen flushed Schlenck-flask the N-Boc-aminoalcohol (5.0 mmol) was added to a 
suspension of NaH (60 % susp., 380 mg, 8.0 mmol) and KI (150 mg, 0.8 mmol) in 30.0 mL of 
dry THF at 0°C. After drop wise addition of ethyl bromoacetate (1.67 g, 1.11 mL, 10.0 mmol) 
in 10 mL of dry THF, the reaction mixture was stirred for 4 h at room temperature. The NaH 
suspension and precipitated solids were settled by a centrifuge. The THF solution was 
decanted off and evaporated to give the crude product. The residue was purified by column 
chromatography (petrol ether / ethyl acetate, 9:1  4:1) to give the according glycol-δ- amino 
acid ester. 
 
 
2-(N-(
tert
Butyloxycarbonyl)-2-amino-4-methyl-pentoxy)-acetic acid ethyl ester (7f): 
O
O
N
H
O
O
O
 
The N-Boc-L-leucinol (1.09 g, 5.0 mmol) was reacted to obtain 790 mg as a white oily solid 
(2.62 mmol, 52 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 0.84 (d, 6 H, J = 7.1 Hz), 1.23 (t, 3 H, J = 7.1 Hz), 
1.38 (s, 9 H), 1.39 (m, 2 H), 1.61 (m, 1 H), 3.48 (m, 2 H), 3.72 (m, 1 H), 4.01 (s, 2 H), 4.16 
(q, 2 H, J = 7.1 Hz), 4.81 (bs, 1 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 14.1 (+, 1 C), 
22.1 (+, 1 C), 22.9 (+, 1 C), 24.7 (+, 1 C), 25.7 (+, 1 C), 28.4 (+, 3 C), 40.6 (-, 1 C), 47.7 (-, 1 
C), 61.1 (-, 1 C), 68.2 (-, 1 C), 71.4 (-, 1 C), 79.5 (Cquat, 1 C), 155.4 (Cquat, 1 C), 167.2 (Cquat, 1 
C); - IR (FT-IR, film): ν [cm
-1
] = 3354 (bm), 2958 (m), 2921 (m), 2874 (m), 1739 (m), 1690 
(s), 1517 (m), 1454 (m), 1388 (m), 1366 (m), 1277 (s), 1251 (m), 1163 (s), 1115 (m), 1049 
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(m), 1003 (m), 870 (m), 780 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z 
(%) = 304.2 (100, MH
+
); - MW = 303.40; - MF = C15H29NO5. 
 
 
2-(N-(
tert
Butyloxycarbonyl)-2-amino-3-phenyl-propoxy)-acetic acid ethyl ester (7h) 
O
O
N
H
O
O
O
 
The N-Boc-L-phenylalaninol (1.25 g, 5.0 mmol) was employed to yield 820 mg of the 
product as a faintly yellow waxy solid (2.44 mmol, 49 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.27 (t, 3 H, J = 7.1 Hz), 1.41 (s, 9 H),  2.86 (m, 2 
H), 3.42 (m, 2 H), 3.81 (s, 2 H), 4.07 (m, 1 H), 4.22 (q, 2 H, J = 7.1 Hz), 5.17 (bs, 1 H), 7.13 
– 7.31 (m, 5 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 14.2 (+, 1 C), 28.3 (+, 3 C), 37.7 (-, 
1 C), 50.8 (+, 1 C), 61.0 (-, 1 C), 66.6 (-, 1 C), 68.5 (-, 1 C), 79.4 (Cquat, 1 C), 126.8 (+, 1 C), 
128.4 (+, 2 C), 129.3 (+, 2 C), 138.2 (Cquat, 1 C), 155.5 (Cquat, 1 C), 167.1 (Cquat, 1 C); - IR 
(FT-IR, film): ν [cm
-1
] = 3366 (bm), 2978 (m), 2933 (m), 1743 (m), 1703 (s), 1498 (s), 1453 
(m), 1388 (m), 1366 (m), 1276 (m), 1247 (m), 1208 (m), 1163 (s), 1132 (s), 1057 (m), 1026 
(m), 851 (m), 742 (m), 701 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z 
(%) = 338.1 (100, MH
+
); - MW = 337.42; - MF = C18H27NO5. 
 
 
2-((N-(
tert
Butyloxycarbonyl)-2-amino-3-hydroxy-propyl)-3-(1-N-(benzyloxycarbonyl)-
indole))-acetic acid-ethylester 
O O
NH
N
O O
Ph
O
O
O
 
The 3-(N-Boc-L-2-amino-3-hydroxy-propyl)-1-N-Cbz-indole (8e) (298 mg, 0.7 mmol) was 
reacted to give 64 mg as colourless waxy solid (0.126 mmol, 18 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.23 (t, 3 H, J = 7.1 Hz), 1.39 (s, 9 H), 3.08 (m, 2 
H), 3.47 (m, 1 H), 3.96 (s, 2 H), 4.11 (m, 2 H), 4,15 (q, 2 H, J = 7.1 Hz), 4.63 (m, 2 H), 5.17 
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(bs, 1 H), 6.97 (m, 1 H), 7.12 (m, 1 H), 7.18 (m, 1 H), 7.26 – 7.43 (m, 7 H); - IR (FT-IR, 
film): ν [cm
-1
] = 3060 (bm), 2981 (m), 2936 (m), 2889 (m), 1743 (s), 1493 (m), 1470 (m), 
1386 (m), 1368 (m), 1301 (m), 1225 (s), 1189 (s), 1123 (s), 1054 (m), 944 (m), 846 (m), 805 
(m), 743 (m), 699 (m); - MW = 510.59; - MF = C28H34N2O7. 
 
 
1.4.3. Alternative prescriptions for the ether synthesis 
Catalyzed by potassium 
tert
butylate   
O
O
N
O
H
OO
 
A 100 mL Schlenck-flask was evacuated and then filled by nitrogen several times. Into the 
solution of N-Boc-protected ethanolamine (0.80 g, 5.0 mmol) in dry THF (10 mL) was given 
ethyl bromoacetate (1.14 mL, 10.0 mmol) and potassium 
tert
butylate (1.39 g, 12.0 mmol) in 
small portions. The mixture changed its colour to orange. The mixture was stirred for 3 hours 
at 0 °C. The base suspension was settled by a centrifuge, the THF solution was decanted off 
and the solvent was evaporated. The crude orange oil was purified by column 
chromatography (ethyl acetate / petrol ether – 1:1). The product (EtOAc / PE 1:1 Rf ~ 0.5) is 
isolated as a slightly yellowish oil (0.58 g, 2.34 mmol, 47 %).  
 
 
2-(2-(2-
tert
Butoxycarbonylaminoethoxy)ethoxy)acetic acid ethyl ester 
N
O
H
O
O
O
O O
 
A solution of N-Boc-ethoxy-ethanolamine (500 mg, 2.5 mmol) in DCM (10 mL) was cooled 
to 5 °C in a nitrogen atmosphere. Copper(II)triflate (90 mg, 0.25 mmol, 10 mol%) and one 
drop of phenyl hydrazine were added, followed by TMEDA (40 mg, 0.25 mmol, 10 mol%). 
After stirring for 30 minutes 2.2 mL of 15 % (weight/weight) azo acetic acid ethyl ester in 
DCM (0.43 g, 3.8 mmol) were dropped in over a period of 3 h at 5 °C. The mixture was 
allowed to warm up slowly to room temperature and was stirred over night. The solution was 
filtered over alumina N, the filter cake was washed with DCM and the solvent was 
evaporated. The raw material was purified by column chromatography (ethyl acetate / petrol 
ether 2:1  1:1) to yield a yellow oil (468 mg, 1.69 mmol, 68 %) (EtOAc / PE 1:2 Rf = 0.2).  
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1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.28 (t, 3 H, J = 7.1 Hz), 1.43 (s, 9 H), 3.31 (m, 2 H), 
3.54 (t, 2 H, J = 5.2 Hz), 3.65 (m, 2 H), 3.71 (m, 2 H), 4.13 (s, 2 H), 4.21 (q, 2 H, J = 7.1 Hz), 
5.03 (bs, 1 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 14.2 (+, 1 C), 28.4 (+, 3 C), 40.4 (-, 
1 C), 61.0 (-, 1 C), 61.2 (-, 1 C), 61.3 (-, 1 C), 68.7 (-, 1 C), 70.8 (-, 1 C), 79.1 (Cquat, 1 C), 
156.0 (Cquat, 1 C), 170.4 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3379 (bm), 2977 (m), 
2953 (m), 1749 (m), 1705 (s), 1515 (m), 1455 (m), 1366 (m), 1248 (m), 1202 (s), 1117 (s), 
907 (m), 863 (m), 779 (m), 718 (m), 579 (m), 530 (m); - MS (CI-MS, NH3): m/z (%) = 192.2 
(8, MH
+ 
- CO2 -C4H8), 235.2 (100, MH
+ 
-C4H8), 253.1 (16, MNH4
+ 
- C4H8), 292.2 (4, MH
+
), 
309.2 (6, MNH4
+
); - MW = 291.35; - MF = C13H25NO6. 
 
 
1.4.4. Deprotection of glycol amino acids 
 
Example procedure for hydrogenolytic deprotection: 2-(2-Aminoethyloxy)acetic acid ethyl 
ester acetate (10c) 
NH
3
+
O
O
O  
Compound 7c (1.55 g, 5.0 mmol) was dissolved in methanol (20 mL), three spatula tips of 
palladium on charcoal (10 % Pd) and acetic acid (0.3 g, 0.3 mL, 5.0 mmol) were added and 
the mixture was stirred for two days in a hydrogen atmosphere (20 bar). The solution was 
filtered over celite, the filter cake was washed with small amounts of methanol and the 
solvent was removed under reduced pressure. The product appears as clear, colourless oil 
(1.14 g, 4.84 mmol, 94 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.45 (s, 9 H), 2.00 (s, 3 H), 3.15 (t, 2 H, J = 5.2 Hz), 
3.77 (t, 2 H, J = 5.2 Hz), 3.99 (s, 2 H), 9.13 (bs, 3 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] 
= 22.0 (+, 1 C), 28.1 (+, 3 C), 39.5 (-, 1 C), 68.0 (-, 1 C), 68.4 (-, 1 C), 82.6 (Cquat, 1 C), 170.3 
(Cquat, 1 C), 176.9 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3373 (bm), 2977 (m), 2929 (m), 
1737 (m), 1666 (m), 1556 (m), 1398 (m), 1369 (m), 1241 (m), 1128 (s), 1014 (m), 839 (m), 
721 (m), 652 (m); - MS (CI-MS, NH3): m/z (%) = 120.1 (13, MH
+ 
- C4H8), 176.1 (100, MH
+
); 
- MW = 235.29; - MF = C10H21NO5. 
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(2-amino-ethoxy)-acetic acid ethyl ester hydrochloride (10b) 
O
NH
3
+
O
O
 
To a solution of 7b (0.52 g, 2.0 mmol) in dried DCM (10 mL) was slowly added 4 mL of HCl 
saturated diethylether. After 3 h of stirring at room temperature the solvent was evaporated. 
The residue was taken up in a little of DCM, and the solvent was removed under reduced 
pressure again. This process was repeated once. The remaining sticky solid was dried in the 
vacuum over night. The yield was 0.38 g of a yellow, deliquescent solid (1.96 mmol, 98 %). 
 
The same result is achieved, if instead of HCl in diethylether TFA is used. The yields and the 
appearance of the product are comparable. Both products show no difference in reactivity. 
 
Hydrochloric Acid Salt: 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.26 (t, 3 H, J = 7.1 Hz), 3.32 (m, 2 H), 3.91 (m, 2 
H), 4.09 – 4.21 (q, 2 H, J = 7.1 Hz), 4.18 (s, 2 H), 6.50 (bs, 3 H); - 
13
C-NMR (75 MHz, 
CDCl3): δ [ppm] = 14.1 (+, 1 C), 39.4 (-, 1 C), 61.3 (-, 1 C), 67.4 (-, 1 C), 68.2 (-, 1 C), 171.0 
(Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3470 (bm), 2937 (m), 2916 (m), 1726 (m), 1669 
(s), 1516 (m), 1430 (m), 1183 (s), 1127 (s), 1020 (m), 965 (m), 836 (m), 799 (s), 721 (m), 673 
(m), 517 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 147.8 (100, 
MH
+
), 294.9 (2M+H
+
, 5%); - MW = 183.63; - MF = C6H14ClNO3. 
 
TFA Salt: 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.28 (t, 3 H, J = 7.1 Hz), 3.32 (m, 2 H), 3.81 (t, 2 H, 
J = 5.2 Hz), 4.14 (s, 2H), 4.21 (q, 2 H, J = 7.1 Hz), 7.78 (bs, 3 H); - IR (FT-IR, film): ν [cm
-1
] 
= 3460 (bm), 2984 (m), 2937 (m), 1720 (m), 1671 (s), 1519 (m), 1428 (m), 1378 (m), 1184 
(s), 1127 (s), 1021 (m), 966 (m), 836 (m), 799 (s), 721 (m), 677 (m), 596 (m), 517 (m), 495 
(m); - MS (CI-MS, NH3, +Q1MS): m/z (%) = 148.1 (100, MH
+
); MS (CI-MS, NH3, -Q1MS): 
m/z (%) = 146.0 (100, M-H
+
); - MW = 261.20; - MF = C8H14F3NO5. 
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(2-Amino-ethoxy)-acetic acid (10a) 
O
O
NH
3
+
O
 
Compound 7a or 7b (270 mg, 1.0 mmol) was dissolved in 0.5 mL of methanol, 1.0 mL of 1 N 
aqueous HCl were added, and the mixture was stirred for 3 h. The solvent was evaporated and 
the residue was lyophilised to yield 10a as colourless sticky oil (118 mg, 1.0 mmol, quant.). 
1
H-NMR (300 MHz, MeOD): δ [ppm] = 3.19 (t, 2 H, J = 5.2 Hz), 3.81 (t, 2 H, J = 5.2 Hz), 
4.26 (s, 2 H), 4.86 (bs, 3 H), 8.08 (bs, 1 H); - 
13
C-NMR (75 MHz, MeOD): δ [ppm] = 40.8 (-, 
1 C), 68.4 (-, 1 C), 68.8 (-, 1 C), 173.2 (Cquat, 1 C); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 119.8 (100, MH
+
); - MW = 119.12; - MF = C4H9NO3. 
 
 
1.4.5. Thiourea synthesis with free acids in dioxane and water (GP 3) 
Benzyloxycarbonyl-isothiocyanate (250 mg, 1.3 mmol) in dioxane (4.0 mL) was added to a 
solution of the amine compound (1.0 mmol) in aqueous NaOH (1 M; 2.2 mL). The mixture 
was stirred at room temperature for 12 h. The organic solvent was removed under reduced 
pressure. The aqueous phase was acidified with 5 % KHSO4 solution to pH 2. After addition 
of ethyl acetate (10 mL) the phases were separated and the water phase was extracted twice 
with ethyl acetate (20 mL). The combined organic phases were dried over Na2SO4 and the 
solvent was removed under reduced pressure. The residue was suspended in diethyl ether  
(10 mL), the ether was decanted off and the remaining precipitate was dried. The crude 
product was purified by column chromatography on silica gel (ethyl acetate). 
 
 
2-(2-[3-N-(benzyloxycarbonyl)thioureido]ethyloxy)acetic acid (12a): 
N
H
N
H
O
O
S
O
OH
O
 
Amino ethoxy acetic acid (118 mg, 1.00 mmol) was used to give 262 mg of yellow oil  
(0.839 mmol, 84 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 3.78 (t, 2 H, J = 5.2 Hz), 3.91 (t, 2 H, J = 5.2 Hz), 
4.14 (s, 2 H), 5.19 (s, 2 H), 7.28 – 7.43 (m, 5 H), 8.10 (bs, 1 H), 9.95 (bs, 1 H); - 
13
C-NMR 
Chapter VI Supporting Information Dissertation A. Späth  
 
 - 17 - 
(75 MHz, CDCl3): δ [ppm] = 44.5 (-, 1 C), 67.2 (-, 1 C), 67.2 (-, 1 C), 68.0 (-, 1 C), 127.3 (+, 
2 C), 127.7 (+, 2 C), 127.8 (+, 1 C), 133.5 (Cquat, 1 C), 151.2 (Cquat, 1 C), 169.8 (Cquat, 1 C), 
178.2 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3285 (bm), 2950 (m), 1719 (s), 1512 (s), 
1452 (m), 1396 (m), 1315 (m), 1218 (s), 1128 (s), 1082 (m), 1023 (m), 974 (m), 838 (m), 738 
(m), 694 (s), 580 (m), 490 (m); - MS (EI-MS, 70 eV): m/z (%) = 312.1 (73, M*
+
), 221.0 (6, 
M*
+
), 91.1 (100, C7H7
*+
); - MW = 312.35; - MF = C13H16N2O5S. 
 
 
6-[3-N-(benzyloxycarbonyl)thioureido]hexanoic acid (13a) 
N
H
N
H
O
O
S
O
OH
 
ε-Aminohexanoic acid (131 mg, 1.0 mmol) was used to obtain 261 mg of an oily, colourless 
solid (0.806 mmol, 81 %). 
1
H-NMR (300 MHz, MeOD): δ [ppm] = 1.37 (m, 2 H), 1.62 (m, 4 H), 2.39 (t, 2 H, J = 7.2 
Hz), 3.61 (t, 2 H, J = 7.2 Hz), 5.17 (s, 2 H), 7.21 – 7.47 (m, 5 H); - 
13
C-NMR (75 MHz, 
MeOD): δ [ppm] = 25.6 (-, 1 C), 27.5 (-, 1 C), 29.1 (-, 1 C), 34.9 (-, 1 C), 46.0 (-, 1 C), 68.8 (-
, 1 C), 128.9 (+, 1 C), 129.5 (+, 2 C), 129.7 (+, 2 C), 136.9 (Cquat, 1 C), 154.9 (Cquat, 1 C), 
177.6 (Cquat, 1 C), 181.2 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3390 (bm), 3040 (m), 
2989 (m), 2937 (m), 2870 (m), 1770 (m), 1706 (s), 1654 (s), 1462 (m), 1397 (m), 1341 (m), 
1215 (m), 1044 (m), 744 (m), 666 (m), 591 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 324.9 (100, MH
+
), 649.1 (46, 2M + H
+
), 666.1 (46, 2M + NH4
+
); - MW 
= 324.40; - MF = C15H20N2O4S. 
 
 
2-(2-[3-N-(benzyloxycarbonyl)thioureido]acetamido)acetic acid (14a) 
N
H
N
H
O
O
S
O
N
H
O
OH
 
Glycyl glycine (132 mg, 1.0 mmol) was employed to give 253 mg of an oily product  
(0.778 mmol, 78 %). 
1
H-NMR (300 MHz, MeOD): δ [ppm] = 3.95 (s, 2 H), 4.38 (s, 2 H), 5.19 (s, 2 H), 7.22 – 7.48 
(m, 5 H); - 
13
C-NMR (75 MHz, MeOD): δ [ppm] = 41.8 (-, 1 C), 67.4 (-, 1 C), 68.8 (-, 1 C), 
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128.9 (+, 1 C), 129.5 (+, 2 C), 129.7 (+, 2 C), 137.0 (Cquat, 1 C), 154.8 (Cquat, 1 C), 170.9 
(Cquat, 1 C), 173.0 (Cquat, 1 C), 182.1 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3299 (bm), 
3236 (m), 3057 (m), 2900 (m), 2456 (m), 2332 (m), 1711 (s), 1656 (m), 1538 (s), 1398 (m), 
1360 (m), 1216 (s), 1136 (m), 1034 (m), 976 (m), 877 (m), 802 (m), 765 (m), 731 (m), 693 
(m), 662 (m), 606 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
326.0 (86, MH
+
), 343.0 (26, MNH4
+
), 651.0 (100, 2M + H
+
), 668.0 (39, 2M + NH4
+
), 976.1 
(17, 3M + H
+
), 993.2 (30, 3M + NH4
+
), 1301.3 (9, 4M + H
+
), 1318.4 (16, 4M + NH4
+
); - MW 
= 325.35; - MF = C13H15N3O5S. 
 
 
1.4.6. Preparation of benzyloxycarbonylthioureas from amino acid esters (GP 4) 
Benzyloxycarbonylisothiocyanat (500 mg, 2.6 mmol) in dichloromethane (10 mL) was added 
slowly to a solution of the according amine compound (2.0 mmol) and triethylamine (300 mg, 
0.4 mL, 3.0 mmol or 500 mg, 0.68 mL, 5.0 mmol if the amine salt is employed) in 
dichloromethane (10 mL) at 2 – 5 °C. The solution was stirred at room temperature until TLC 
indicated no further reaction (2 – 6 h). All volatiles were removed under reduced pressure. 
Ethyl acetate (30 mL) was added, the organic phase was washed with saturated ammonium 
chloride solution (5 mL) and twice with water (10 mL). After drying over MgSO4, the solvent 
was evaporated and the residue was suspended in diethyl ether / petrol ether 1:4 (5 mL). The 
product was allowed to settle completely, the ether mixture was decanted off, and after drying 
the precipitate, it was purified by column chromatography if necessary (ethyl acetate / petrol 
ether 1:1 if not stated otherwise). 
 
  
2-(2-[3-N-(benzyloxycarbonyl)thioureido]ethyloxy)acetic acid 
tert
butylester (12c) 
O
N
H
N
H
S
O
O
O
O
 
The acetate salt of 2-(2-Amino-ethoxy)-acetic acid 
tert
butyl ester (470 mg, 2.0 mmol) was 
reacted according to GP 4 to yield 12c as a colourless oil (640 mg, 1.82 mmol, 91 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.47 (s, 9 H), 3.76 (t, 2 H, J = 5.2 Hz), 3.90 (t, 2 H, J 
= 5.2 Hz), 4.00 (s, 2 H), 5.17 (s, 2 H), 7.30 – 7.41 (m, 5 H), 8.30 (bs, 1 H), 9.93 (bs, 1 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 28.1 (+, 1 C), 45.6 (-, 1 C), 68.1 (-, 1 C), 68.8 (-, 1 
C), 68.9 (-, 1 C), 81.9 (Cquat, 1 C), 128.4 (+, 2 C), 128.7 (+, 1 C), 128.8 (+, 2 C), 134.6 (Cquat, 
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1 C), 152.3 (Cquat, 1 C), 169.4 (Cquat, 1 C), 179.3 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 
3290 (bm), 2977 (m), 2937 (m), 2883 (m), 1720 (s), 1515 (s), 1453 (m), 1368 (m), 1319 (m), 
1220 (s), 1187 (s), 1123 (s), 1023 (s), 961 (m), 913 (m), 840 (m), 758 (m), 735 (m), 696 (m), 
583 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 369.0 (100, MH
+
), 
386.0 (14, MNH4
+
), 737.1 (19, 2M + H
+
), 754.1 (29, 2M + NH4
+
); - C17H24N2O5S: calc. C 
55.4, H 6.6, N 7.6, S 8.7, found. C 55.3, H 6.5, N 7.3, S 8.2; - MW = 368.46; - MF = 
C17H24N2O5S. 
 
 
6-[3-N-(benzyloxycarbonyl)thioureido]hexanoic acid methylester (13b) 
N
H
N
H
O
O
S
O
O
 
ε-Aminohexanoic acid methylester hydrochloride (170 mg, 1.0 mmol) was used to obtain  
281 mg of an oily, colourless solid (0.831 mmol, 83 %). 
1
H-NMR (300 MHz, MeOD): δ [ppm] = 1.39 (m, 2 H), 1.67 (m, 4 H), 2.40 (t, 2 H, J = 7.2 
Hz), 3.62 (t, 2 H, J = 7.2 Hz), 3.65 (s, 3 H), 5.18 (s, 2 H), 7.23 – 7.45 (m, 5 H); - 
13
C-NMR 
(75 MHz, MeOD): δ [ppm] = 25.4 (-, 1 C), 26.9 (-, 1 C), 28.3 (-, 1 C), 34.4 (-, 1 C), 46.1 (-, 1 
C), 52.1 (+, 1 C), 68.9 (-, 1 C), 128.8 (+, 1 C), 129.4 (+, 2 C), 129.5 (+, 2 C), 136.6 (Cquat, 1 
C), 155.2 (Cquat, 1 C), 175.7 (Cquat, 1 C), 181.1 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 
3040 (m), 2986 (m), 2936 (m), 2874 (m), 1772 (m), 1705 (s), 1656 (s), 1464 (m), 1398 (m), 
1342 (m), 1216 (m), 1045 (m), 746 (m), 665 (m), 592 (m); - MS (ESI-MS, CH2Cl2/MeOH + 
10 mmol NH4OAc): m/z (%) = 339.2 (100, MH
+
); - MW = 338.43; - MF = C16H22N2O4S. 
 
 
2-(2-[3-N-(benzyloxycarbonyl)thioureido]acetamido)acetic acid methylester (14b) 
N
H
N
H
N
H
S
O
O
O
O
O
 
Glycyl glycine methyl ester hydrochloride (364 mg, 2.0 mmol) was converted by GP 4 to the 
according thiourea. The product is as a colourless solid (540 mg, 0.839 mmol, 84 %). 
 
M.p. (uncorrected) = 137 – 138 °C; - 
1
H-NMR (300 MHz, acetone-d6): δ [ppm] = 3.68 (s, 3 
H), 4.04 (d, 2 H, J1,1 = 6.0 Hz), 4.40 (d, 2 H, J1,1 = 6.0 Hz), 5.23 (s, 2 H), 7.29 – 7.45 (m, 5 H), 
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7.83 (bs, 1 H), 9.98 (bs, 1 H), 10.32 (bs, 1 H); - 
13
C-NMR (75 MHz, acetone-d6): δ [ppm] = 
41.6 (-, 1 C), 48.9 (-, 1 C), 52.3 (+, 1 C), 68.2 (-, 1 C), 129.1 (+, 2 C), 129.2 (+, 2 C), 129.4 
(+, 1 C), 136.6 (Cquat, 1 C), 154.1 (Cquat, 1 C), 154.2 (Cquat, 1 C), 168.6 (Cquat, 1 C), 170.6 
(Cquat, 1 C), 180.6 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3258 (bm), 3032 (m), 2955 (m), 
1719 (s), 1513 (s), 1437 (m), 1371 (s), 1196 (s), 1131 (m), 1031 (m), 970 (m), 905 (m), 796 
(m), 778 (m), 697 (m), 603 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z 
(%) = 339.3 (31, MH
+
), 357.0 (46, MH
+
 + MeCN), 679.2 (69, 2M + H
+
), 696.2 (100, 2M + 
NH4
+
); - HRMS (EI-MS 70 eV): calc. for C14H17N3O5S
*+
: 339.0889, found: 339.0884; - MW 
= 339.37; - MF = C14H17N3O5S. 
 
 
5-([3-N-(benzyloxycarbonyl)thioureido]methyl)pyrrol-2-carboxylic acid methylester (16) 
O N
H
N
H
SO O
O
N
 
The 2-Aminomethyl-pyridine-6-carboxylic acid ethyl ester (360 mg, 2.0 mmol) was 
submitted to GP 4 to give its according thiourea as orange oil (604 mg, 1.62 mmol, 81 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.49 (t, 3 H, J = 7.2 Hz), 4.09 (q, 2 H, J = 7.2 Hz), 
5.06 (d, 2 H, J = 4.7 Hz), 5.23 (s, 2 H), 7.30 – 7.46 (m, 5H), 7.52 (d, 1 H, J = 7.7 Hz), 7.85 
(dd, 1 H, J = 7.7 Hz), 8.06 (d, 1 H, J = 7.7 Hz), 8.12 (bs, 1 H), 10.81 (bs, 1 H); - 
13
C-NMR 
(75 MHz, CDCl3): δ [ppm] = 13.2 (+, 1 C), 49.4 (-, 1 C), 61.0 (-, 1 C), 67.2 (-, 1 C), 122.2 (+, 
1 C), 123.1 (+, 1 C), 124.1 (+, 1 C), 127.3 (+, 2 C), 127.7 (+, 2 C), 127.9 (+, 1 C), 133.5 
(Cquat, 2 C), 136.8 (Cquat, 1 C), 146.7 (Cquat, 1 C), 151.2 (Cquat, 1 C), 154.2 (Cquat, 1 C), 178.0 
(Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3425 (bm), 3348 (bm), 2960 (m), 2929 (m), 1709 
(s), 1591 (m), 1495 (m), 1453 (m), 1394 (m), 1305 (m), 1220 (s), 1163 (s), 1086 (m), 1053 
(m), 1024 (m), 910 (m), 861 (m), 761 (m), 735 (m), 697 (m), 581 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 373.9 (100, MH
+
), 747.1 (31, 2M+H
+
); - 
HRMS (PI-LSIMS FAB glycerine): calc. for C18H20N3O4S
+
: 374.1175, found: 374.1165; - 
MW = 373.43; - MF = C18H19N3O4S. 
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2-{[2-(4-Bromo-phenyl)-3-(3-benzyloxycarbonyl-thioureido)-tetrahydro-furan-3-carbonyl]-
amino}-propionic acid methyl ester 
 
Diastereomer A (E-2a) 
N
H
O
O
N
H
O
Br
N
H
O O
O
S
NH
3
+
O
Br
N
H
O O
O
E-1a  
The reaction was conducted in half scale after GP 4. Compound E-1a (410 mg, 1.0 mmol) 
was converted to its according thiourea and purified with ethyl acetate / petrol ether 1:2. The 
product is as a pale yellow solid (388 mg, 0.709 mmol, 71 %). 
M.p. (uncorrected) = 131 - 132 °C; - 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 0.91 (d, 3 H, J 
= 7.0 Hz), 2.65 (m, 1 H), 3.48 (m, 1 H), 3.72 (s, 3 H), 4.29 (m, 1 H), 4.38 (m, 1 H), 4.50 (m, 1 
H), 5.24 (d, 1 H, J = 11.8 Hz), 5.28 (d, 1 H, J = 11.8 Hz), 6.24 (bs, 1 H), 6.46 (bs, 1 H), 7.15 
(d, 2 H, J = 8.2 Hz), 7.34 – 7.43 (m, 7 H); - 
13
C-NMR (150 MHz, CDCl3): δ [ppm] = 17.5 (+, 
1 C), 34.2 (-, 1 C), 48.3 (-, 1 C), 52.6 (+, 1 C), 67.0 (+, 1 C), 68.5 (-, 1 C), 70.5 (+, 1 C), 121.6 
(Cquat, 1 C), 126.8 (+, 2 C), 128.7 (+, 2 C), 128.8 (+, 2 C), 129.0 (+, 1 C), 131.3 (+, 2 C), 
134.4 (Cquat, 1 C), 135.6 (Cquat, 1 C), 152.1 (Cquat, 1 C), 170.1 (Cquat, 1 C), 173.0 (Cquat, 1 C), 
176.8 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3371 (bm), 3171 (bm), 2957 (m), 2936 (m), 
2886 (m), 2361 (m), 2348 (m), 1728 (m), 1677 (m), 1500 (s), 1452 (m), 1358 (m), 1312 (m), 
1258 (m), 1217 (s), 1177 (s), 1069 (m), 1010 (s), 975 (m), 909 (m), 798 (m), 730 (s), 697 (m); 
- MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 563.9/565.9 (100, MH
+
), 
582.9/584.0 (90, MNH4
+
), 1146.2/1148.3 (27, (2M+NH4
+
)
+
); - MW = 564.46; - MF = 
C24H26BrN3O6S. 
 
 
Diastereomer B (E-2b) 
N
H
O
O
N
H
O
Br
N
H
O O
O
S
NH
3
+
O
Br
N
H
O O
O
E-1a  
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Compound E-1b (410 mg, 1.0 mmol) was converted by GP 4 to its according thiourea. The 
reaction was conducted in half scale. Ethyl acetate / petrolether 1:2 was used for purification. 
The product is as a pale yellow solid (350 mg, 0.640 mmol, 64 %). 
M.p. (uncorrected) = 143 - 145 °C; - 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 1.22 (d, 3 H, J 
= 7.0 Hz), 2.66 (m, 1 H), 3.45 (m, 1 H), 3.70 (s, 3 H), 3.91 (m, 1 H), 4.09 (m, 1 H), 4.43 (m, 1 
H), 5.25 (s, 2 H), 6.06 (bs, 1 H), 6.70 (bs, 1 H), 7.14 (d, 2 H, J = 8.2 Hz), 7.37 (d, 2 H, J = 8.2 
Hz), 7.38 – 7.42 (m, 5 H), 8.03 (bs, 1 H), 9.36 (bs, 1 H); - 
13
C-NMR (150 MHz, CDCl3): δ 
[ppm] = 18.3 (+, 1 C), 34.1 (-, 1 C), 48.4 (-, 1 C), 52.6 (+, 1 C), 67.0 (+, 1 C), 68.5 (-, 1 C), 
70.0 (+, 1 C), 121.8 (Cquat, 1 C), 127.1 (+, 2 C), 128.7 (+, 2 C), 128.8 (+, 2 C), 129.0 (+, 1 C), 
131.1 (+, 2 C), 135.1 (Cquat, 1 C), 135.6 (Cquat, 1 C), 152.2 (Cquat, 1 C), 170.1 (Cquat, 1 C), 
172.7 (Cquat, 1 C), 177.0 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3363 (bm), 3195 (bm), 
2956 (m), 2932 (m), 2889 (m), 2360 (m), 2348 (m), 1728 (m), 1675 (m), 1500 (s), 1451 (m), 
1358 (m), 1305 (m), 1258 (m), 1214 (s), 1177 (s), 1070 (m), 1010 (s), 975 (m), 910 (m), 800 
(m), 732 (s), 697 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 
563.9/565.9 (100, MH
+
), 583.0/584.0 (50, MNH4
+
), 1127.4/1129.4 (12, (2M+H
+
)
+
), 
1147.4/1149.4 (23, (2M+NH4
+
)
+
); - MW = 564.46; - MF = C24H26BrN3O6S. 
 
 
 
1.5. Syntheses and deprotections of the receptors 
 
1.5.1. Preparation of sym. 1,3-substituted benzyloxycarbonyl-guanidines (GP 5) 
The benzyloxycarbonylthiourea (0.5 mmol) was dissolved together with its according amine 
compound (0.6 mmol) and triethylamine (130 mg, 0.17 mL, 1.3 mmol) in DCM (5 mL). EDC 
hydrochloride (110 mg, 0.6 mmol) was added at 2 – 5 °C in one portion.
4
 The mixture was 
allowed to reach room temperature in 1 hour and was then stirred over night. In the case were 
TLC indicated thiourea still being present at this point, another portion of triethylamine  
(30 mg, 0.04 mL, 0.3 mmol) and EDC hydrochloride (54 mg, 0.3 mmol) was added and 
stirring was continued for 4 h. It was diluted with DCM (25 mL), the organic solution was 
washed with saturated ammonium chloride solution (5 mL) and twice with water (10 mL). 
After drying over MgSO4, the solvent was evaporated and the oily residue was purified by 
column chromatography with ethyl acetate / petrol ether 4:1 to yield the guanidine. 
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 (2-[N-(2-
tert
Butyloxycarbonylmethyloxyethyl)-N- 
(benzyloxycarbonyl)guanidine]ethyloxy)acetic acid 
tert
butylester (17a) 
O
N
H
O
N
H
N
O
O
O
O
O
O
Ph
 
The thiourea compound 12c (176 mg, 0.5 mmol) was reacted with the TFA salt of 2-(2-
Amino-ethoxy)-acetic acid 
tert
butyl ester (10c) (158 mg, 0.6 mmol) following GP 5 to yield a 
clear, faintly yellow oil (198 mg, 0.389 mmol, 78 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.46 (s, 18 H), 3.52 (m, 4 H), 3.67 (m, 4 H), 3.99 (s, 
4 H), 5.11 (s, 2 H), 7.28 – 7.41 (m, 5 H), 9.23 (bs, 2 H); - 
13
C-NMR (75 MHz, CDCl3): δ 
[ppm] = 28.1 (+, 6 C), 41.6 (-, 2 C), 48.8 (-, 2 C), 66.4 (-, 2 C), 70.8 (-, 1 C), 82.0 (Cquat, 2 C), 
127.5 (+, 1 C), 128.0 (+, 2 C), 128.3 (+, 2 C), 137.8 (Cquat, 1 C), 161.1 (Cquat, 2 C), 164.1 
(Cquat, 1 C), further signals were not detectable; - IR (FT-IR, film): ν [cm
-1
] = 3343 (bm), 
2977 (m), 2929 (m), 1743 (s), 1633 (s), 1599 (s), 1455 (m), 1386 (m), 1368 (m), 1303 (m), 
1228 (m), 1129 (s), 1052 (m), 942 (m), 845 (m), 801 (m), 743 (m), 699 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 510.2 (100, MH
+
); - HRMS (PI-LSIMS 
FAB, glycerine): calc. for C25H40N3O8
+
: 510.2815, found: 510.2808; - MW = 509.60; - MF = 
C25H39N3O8. 
 
 
(2-[N-(2-Ethyloxycarbonylmethyloxyethyl)-N-(benzyloxycarbonyl)guanidine]ethyloxy)acetic 
acid ethylester (18) 
O
O
O
O
N
H
N
H
N
O
O
Ph
 
Thiourea 13b (161 mg, 0.5 mmol) was reacted with ε-aminohexanoic acid methylester 
hydrochloride (103 mg, 0.6 mmol) after GP 5 to give a colourless oil (175 mg, 0.391 mmol, 
78 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.38 (m, 4 H), 1.66 (m, 8 H), 2.42 (m, 4 H), 3.63 (m, 
4 H), 3.68 (s, 6 H), 5.17 (s, 2 H), 7.25 – 7.43 (m, 5 H); - 
13
C-NMR (75 MHz, CDCl3): δ 
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[ppm] = 25.5 (-, 2 C), 27.1 (-, 2 C), 28.2 (-, 2 C), 34.5 (-, 2 C), 46.2 (-, 2 C), 52.0 (+, 2 C), 
68.4 (-, 1 C), 128.0 (+, 1 C), 128.2 (+, 2 C), 128.4 (+, 2 C), 136.9 (Cquat, 1 C), 160.1 (Cquat, 2 
C), 161.7 (Cquat, 1 C), 172.1 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3280 (bm), 2986 (m), 
2938 (m), 1743 (s), 1666 (m), 1597 (s), 1519 (m), 1452 (m), 1384 (m), 1276 (m), 1213 (s), 
1134 (s), 1056 (m), 1027 (m), 913 (m), 854 (m), 801 (m), 732 (m), 693 (m); - MW = 449.55; 
- MF = C23H35N3O6. 
 
 
3-Benzyloxycarbonylamino-1,5-dihydro-imidazo[1,5-a]pyridine-5-carboxylic acid ethyl ester 
(21) 
O
O
N
N
NH
O
O
 
The thiourea compound 16 (187 mg, 0.5 mmol) was submitted to the conditions of GP 5 to 
give the product 21 as a red glass (112 mg, 0.328 mmol, 66 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.39 (t, 3 H, J = 7.2 Hz), 4.31 (q, 2 H, J = 7.2 Hz), 
5.18 (s, 2 H), 6.67 (t, 1 H, J = 7.2 Hz), 7.27 – 7.42 (m, 6 H), 7.58 (d, 2 H, J = 4.6 Hz), 8.61 
(bs, 1 H); - 
13
C-NMR (75 MHz, CDCl3): δ [ppm] = 14.1 (+, 1 C), 62.5 (-, 1 C), 67.5 (-, 1 C), 
116.4 (+, 1 C), 120.7 (+, 1 C), 121.6 (+, 1 C), 123.6 (+, 1C), 124.9 (Cquat, 1 C), 128.2 (+, 2 C), 
128.3 (+, 2 C), 128.7 (+, 1 C), 130.7 (Cquat, 1 C), 135.9 (Cquat, 1 C), 153.7 (Cquat, 1 C), 162.8 
(Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 3255 (bm), 2981 (m), 2908 (m), 1722 (s), 1531 
(m), 1454 (m), 1408 (m), 1372 (m), 1266 (s), 1235 (s), 1212 (s), 1171 (m), 1141 (m), 1106 
(m), 1036 (m), 913 (m), 872 (m), 810 (m), 743 (m), 698 (m), 595 (m), 495 (m); - MS (ESI-
MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 340.0 (100, MH
+
), 679.1 (11, 2M+H
+
); 
- UV (MeOH): λ (ε) = 380 (1300), 280 (3200), 230 (13200); - MW = 339.35; - MF = 
C18H17N3O4. 
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(2-[N-(2-Ethyloxycarbonylmethylacetamido)-N-
(benzyloxycarbonyl)guanidine]acetamido)acetic acid ethylester (19) 
N
H
N
H
N
H
N
H
N
O
O
O
O
O
O
O O
Ph
 
Compound 14b (161 mg, 0.5 mmol) was reacted with glycyl glycine hydrochloride (110 mg, 
0.6 mmol) analogue to GP 5 (10 % NMP was added to the reaction mixture) to give a pale 
yellow solid (172 mg, 0.381 mmol, 76 %). 
M.p. (uncorrected) = 92 – 94°C; - 
1
H-NMR (300 MHz, DMSO-d6): δ [ppm] = 3.66 (s, 6 H), 
3.96 (m, 4 H), 4.08 (m, 4 H), 5.05 (s, 2 H), 7.28 – 7.42 (m, 5 H), 7.90 (bs, 1 H), 9.05 (bs, 2 
H); - 
13
C-NMR (75 MHz, DMSO): δ [ppm] = 41.5 (-, 2 C), 44.9 (-, 2 C), 52.2 (+, 2 C), 66.8 
(-, 1 C), 128.3 (+, 1 C), 128.7 (+, 2 C), 129.0 (+, 2 C), 139.2 (Cquat, 1 C), 161.6 (Cquat, 2 C), 
170.9 (Cquat, 1 C), 175.7 (Cquat, 2 C), further signals were not detectable; - IR (FT-IR, film): ν 
[cm
-1
] = 3352 (m), 3290 (bm), 3069 (m), 2951 (m), 1744 (m), 1639 (s), 1572 (m), 1530 (m), 
1434 (m), 1378 (m), 1330 (m), 1283 (m), 1259 (m), 1203 (s), 1171 (s), 1094 (s), 1030 (m), 
1009 (m), 983 (m), 941 (m), 794 (m), 719 (m), 672 (m), 603 (m), 539 (m), 456 (m); - MS 
(ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 452.1 (100, MH
+
), 903.5 (5, (2 
MH
+
); - HRMS (PI-LSIMS FAB, glycerine): calc. for C19H26N5O8
+
: 452.1781, found: 
452.1782; - MW = 451.44; - MF = C19H25N5O8. 
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1.5.2. Bis-TAA-guanidines 
2-[(2-(4-Bromo-phenyl)-3-{N'-[2-(4-bromo-phenyl)-3-(1-methoxycarbonyl-ethylcarbamoyl)-
tetrahydro-furan-3-yl]-N''-benzyloxycarbonyl-guanidino}-tetrahydro-furan-3-carbonyl)-
amino]-propionic acid methyl ester 
 
Diastereomer A (E-3a) 
N
O
O
NH
O
Br
N
H
O
O
O
N
H
O
Br
N
H
O O
O
 
Compound E-2a (273 mg, 0.5 mmol) was reacted with its according diastereomer of the 
TAA-Ala methylester hydrochloride (E-1a) (224 mg, 0.6 mmol) after GP 5 and purified with 
ethyl acetate / petrol ether 1:2 to yield the guanidine as a pale yellow solid (414  mg,  
0.459 mmol, 31 %). 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 0.94 (d, 6 H, J = 7.5 Hz), 2.40 (m, 1 H), 2.63 (m, 1 
H), 3.64 (s, 6 H), 3.67 (m, 2 H), 4.12 (m, 1 H), 4.19 (m, 1 H), 4.48 (m, 2 H), 4.68 (m, 2 H), 
4.78 (s, 1 H), 5.15 (d, 1 H, J = 12.5 Hz), 5.20 (d, 1 H, J = 12.5 Hz), 7.18 (d, 4 H, J = 8.2 Hz), 
7.36 – 7.43 (m, 9 H), 8.91 (bs, 2 H); - 
13
C-NMR (150 MHz, CDCl3): δ [ppm] = 13.3 (+, 2 C), 
35.1 (-, 2 C), 48.5 (+, 2 C), 52.6 (+, 2 C), 67.4 (-, 2 C), 67.9 (+, 2 C), 70.3 (-, 1 C), 122.8 
(Cquat, 1 C), 128.3 (+, 4 C), 127.7 (+, 1 C), 128.3 (+, 2 C), 128.5 (+, 2 C), 131.5 (+, 4 C), 
133.5 (Cquat, 2 C), 136.0 (Cquat, 1 C), 159.9 (Cquat, 1 C), 163.6 (Cquat, 1 C), 169.1 (Cquat, 2 C), 
172.0 (Cquat, 1 C), further signals were not detectable; - MS (ESI-MS, CH2Cl2/MeOH + 10 
mmol NH4OAc): m/z (%) = 900.1/903.9 (100, MH
+
); - MW = 901.61; - MF = 
C32H43Br2N5O10. 
 
 
  
Chapter VI Supporting Information Dissertation A. Späth  
 
 - 27 - 
Diastereomer B (E-3b) 
N
O
O
NH
O
Br
N
H
O
O
O
N
H
O
Br
N
H
O O
O
 
Compound E-2b (273 mg, 0.5 mmol) was reacted with its according diastereomer of the 
TAA-Ala methylester hydrochloride (E-1b) (224 mg, 0.6 mmol) after GP 5 to give a pale 
yellow solid (369 mg, 0.410 mmol, 24 %) after column chromatography with ethyl acetate / 
petrol ether 1:2. 
1
H-NMR (600 MHz, CDCl3): δ [ppm] = 1.21 (d, 6 H, J = 7.5 Hz), 2.40 (m, 2 H), 2.63 (m, 2 
H), 3.49 (s, 6 H), 4.17 (m, 2 H), 4.09 (m, 1 H), 4.48 (m, 2 H), 4.62 (m, 2 H), 4.82 (s, 2 H), 
5.14 (d, 1 H, J = 12.3 Hz), 5.19 (d, 1 H, J = 12.3 Hz), 7.20 (d, 4 H, J = 8.2 Hz), 7.33 – 7.45 
(m, 9 H), 8.83 (bs, 2 H); - 
13
C-NMR (150 MHz, CDCl3): δ [ppm] = 14.1 (+, 2 C), 36.1 (-, 2 
C), 48.1 (+, 2 C), 52.6 (+, 2 C), 67.2 (-, 2 C), 67.9 (+, 2 C), 70.5 (-, 1 C), 122.7 (Cquat, 2 C), 
127.7 (+, 2 C), 128.1 (+, 2 C), 128.2 (+, 4 C), 128.5 (+, 2 C), 131.4 (+, 4 C), 133.6 (Cquat, 2 
C), 136.2 (Cquat, 2 C), 159.6 (Cquat, 1 C), 163.6 (Cquat, 1 C), 169.0 (Cquat, 2 C), 171.7 (Cquat, 2 
C) further signals were not detectable; - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol NH4OAc): 
m/z (%) = 900.1/903.9 (100, MH
+
); - MW = 901.61; - MF = C32H43Br2N5O10. 
 
 
 
1.6. Deprotection of the benzyloxycarbonylguanidine esters 
 
1.6.1. Deprotection of the Cbz-guanidine (GP 6a) 
The symmetric 1,3-substituted benzyloxycarbonylguanidine ester (0.4 mmol) was dissolved, 
depending on the ester in the molecule, in ethanol or methanol (3 mL). Three spatula tips of 
palladium on charcoal (10 % Pd) were added. It was stirred in a hydrogen atmosphere  
(30 bar) for two days at room temperature. The reaction mixture was diluted with the 
according alcohol (10 mL) and filtered over celite. The filter cake was washed with small 
portions of this alcohol. The clear filtrate was evaporated to dryness to give the guanidine free 
base. 
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1.6.2. Synthesis of the guanidinium hexafluorophosphate salts (GP 6b): 
The guanidine free base (0.2 mmol) was dissolved in 6 mL of methanol or ethanol, according 
to its esters. Ammonium hexafluorophosphate (38 mg, 0.24 mmol) was added and the mixture 
was warmed to 40 °C for three hours. The solvent was evaporated and the residue was 
extracted with DCM (1 mL) trice. The solvent was distilled off and the remaining 
guanidinium salt was properly dried in vacuo. The products appear as colourless solids in 
nearly quantitative yield. 
 
 
(2-[N-(2-Ethyloxycarbonylmethyloxyethyl)-N-guanidine]ethyloxy)acetic acid ethyl ester 
hexafluorophosphate (22b) 
O
N
H
O
N
H
NH
O
O
O
O
 
Compound 17b (181 mg, 0.4 mmol) was deprotected after GP 6a to give a colourless, sticky 
oil (97 mg, 0.369 mmol, 92 %). 
 
Free Base:
 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.22 (t, 6 H, J = 7.1 Hz), 3.33 (m, 4 H), 3.62 (m, 4 
H), 4.06 (s, 4 H), 4.12 (q, 2 H, J = 7.1 Hz), 7.76 (bs, 1 H), 9.71 (bs, 1 H), 10.43 (bs, 1 H); - IR 
(FT-IR, film): ν [cm
-1
] = 3308 (bm), 3183 (bm), 2971 (m), 2927 (m), 2882 (m), 1749 (m), 
1630 (s), 1586 (m), 1404 (m), 1317 (m), 1208 (s), 1134 (s), 1049 (m), 881 (m), 704 (m), 587 
(m); - MW = 319.36; - MF = C13H25N3O6. 
 
Hexafluorophosphate Salt:
 
 
MW = 465.33; - MF = C13H26PF6N3O6.
 
 
 
5-[(N'-[(2-Methoxycarbonyl-1H-pyrrole)-5-methyl-guanidino)-methyl]-1H-pyrrole-2-
carboxylic acid methyl ester hexafluorophosphate (23) 
N
H
N
H
NH
N
HO
O
N
H O
O  
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Compound 20 (187 mg, 0.4 mmol) was reacted according to GP 6a to yield a yellow solid 
(117 mg, 0.384 mmol, 96 %). 
 
Free Base:
 
1
H-NMR (300 MHz, MeOD): δ [ppm] = 3.81 (s, 6 H), 4.41 (s, 4 H), 6.12 (m, 2 H), 6.79 (m, 2 
H); - 
13
C-NMR (75 MHz, MeOD): δ [ppm] = 39.5 (-, 2 C), 51.8 (+, 2 C), 110.2 (+, 2 C), 
117.0 (+, 2 C), 124.1 (Cquat, 2 C), 133.5 (Cquat, 2 C), 157.3 (Cquat, 1 C), 163.0 (Cquat, 2 C); - IR 
(FT-IR, film): ν [cm
-1
] = 3179 (bm), 2953 (m), 1660 (s), 1627 (s), 1489 (m), 1439 (m), 1320 
(s), 1279 (m), 1218 (s), 1132 (m), 1003 (s), 930 (m), 800 (m), 762 (s), 656 (m); - MS (ESI-
MS, CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 334.0 (100, MH
+
), 375.0 (38, MH
+
 + 
MeCN), 713.3 (13, 2M + H
+
 + HCOOH); - HRMS (EI-MS, 70 eV): calc. for C15H19N5O4
*+
: 
333.1437, found: 333.1439; - MW = 333.35; - MF = C15H19N5O4. 
 
Hexafluorophosphate Salt:
 
MW = 479.32; - MF = C15H20PF6N5O4. 
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1.7. An alternative route to the receptors 
 
Alternatively, 1,3-substituted symmetric guanidines can be prepared via their according 
thiourea, which is obtained from the amine compound (7b or E-8) and thiophosgene.
5
 The 
thiourea (10b or E-3) can be transformed in the desired guanidine using trifluoroacetamide 
(E-10) as reagent
6
. This route is working well, but is more time consuming, laborious and is 
involving more steps than the reaction sequence via Cbz-NCS. Consequently, the overall 
yield is lower. However, this was investigated for the conversion of 10b and 3-(2-N-
tert
Butyloxycarbonyl-aminoethoxy)propionic acid ethyl ester
7
 and should be presented here: 
 
Cl Cl
SO
O
NHBoc
O
O
O
NH
3
+
O
O
O
O
O
O
N
H
O
N
H
S
N
CF
3
O
O
O
N
H
O
O
O
N
H
O
NH
2
CF
3
O
NH
2
+
O
O
N
H
O
O
O
N
H
O
O
O
N
H
O
O
O
N
H
OS
+
HCl in Et2O
DCM
NaHCO3
H2O, DCM
7b,    n = 1
E-8,   n = 2
10b ,   n = 1
E-3,   n = 2
quant.
E-4,     n = 1, 73%
E-5a ,   n = 2, 69%
1.) CH3I
     acetone
2.) NH4PF6
     DCM, MeOH
PF6
-
DBU
toluene, 
CHCl3
reflux
PF6
-1.) K2CO3
     MeOH, 
     H2O
2.) NH4PF6
     MeOH
quant.
E-5b ,   n = 2, quant.
E-6,   n = 2, 77% E-7,   n = 2, 90%
n n
n n n n
n n n n
E-9
E-10
 
Scheme S-1: Thiourea synthesis with glycol-amino acids and alkylation route to the tweezers 
using trifluoroacetamide for conversion 
 
 
3-(2-amino-ethoxy)propionic acid ethyl ester hydrochloride 
O
NH
3
+
O
O
 
To a solution of 3-(2-N-
tert
Butyloxycarbonyl-aminoethoxy)propionic acid ethyl ester (43) 
(0.52 g, 2.0 mmol) in DCM (10 mL) was slowly added 4 mL of HCl saturated diethylether. 
After 3 h of stirring at room temperature the solvent was evaporated. The residue was taken 
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up in a little of DCM, and the solvent was removed under reduced pressure again. The 
remaining sticky solid was dried under vacuum over night. The yield was 0.38 g of a yellow, 
hygroscopic solid (1.96 mmol, 98 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.94 (t, 3 H, J = 7.1 Hz), 2.56 (t, 2 H, J = 6.8 Hz), 
3.21 (m, 2 H), 3.68 – 3.81 (m, 4 H), 4.08 (q, 2 H, J = 7.1 Hz), 8.11 (bs, 3 H); - 
13
C-NMR (75 
MHz, CDCl3): δ [ppm] = 14.2 (+, 1 C), 34.7 (-, 1 C), 39.5 (-, 1 C), 60.9 (-, 1 C), 65.6 (-, 1 C), 
66.2 (-, 1 C), 172.1 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
]
 =
 3468 (bm), 2976 (m), 2934 (m), 
1716 (m), 1672 (s), 1521 (m), 1425 (m), 1379 (m), 1183 (s), 1123 (s), 1024 (m), 968 (m), 834 
(m), 799 (s), 722 (m), 678 (m), 598 (m); - MS (ESI-MS, CH2Cl2/MeOH + 10 mmol 
NH4OAc): m/z (%) = 162.1 (100, MH
+
); - MW = 197.66; - MF = C7H16ClNO3. 
 
 
1.7.1. Preparation of symmetric thioureas from glycol-amino acid esters (GP 7) 
To an ice-cold solution of the amine compound (3.5 mmol) in 20 mL of chloroform 
containing triethylamine (727 mg, 0.96 mL, 7.2 mmol) thiophosgene (0.13 mL, 1.7 mmol) in 
5 mL of chloroform was added drop wise and the mixture was stirred for 2 d at room 
temperature. The solvent was evaporated and all volatiles were removed under reduced 
pressure. The residue was dissolved in 10 mL of ethanol and cooled to 0 °C for 3 h. It is 
filtered with suction and the crystals are washed with a little ice-cold ethanol. The filtrate is 
reduced to about 2 mL and the thiourea is precipitated by slow addition of diethylether. The 
solvent is decanted off, the residue is suspended in diethylether and after the solid has settled 
completely, the ether is decanted off again. The product is dried in the vacuum. If necessary, 
the material can be purified by column chromatography with ethyl acetate/ petrol ether 1:2.  
 
 
{2-[3-(2-Ethoxycarbonylmethoxy-ethyl)-thioureido]-ethoxy}-acetic acid ethyl ester
8
(E-4) 
O
O
O
N
H
O
O
O
N
H
S
 
The 2-(2-amino-ethoxy)acetic acid ethyl ester hydrochloride (640 mg, 3.5 mmol) was 
submitted to GP 7. The clean product is a clear, yellow sticky oil (417 mg, 1.24 mmol, 73 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.26 (t, 6 H, J = 7.1 Hz), 3.81 (m, 4 H), 3.98 – 4.13 
(m, 8 H), 4.14 – 4.29 (q, 4 H, J = 7.1 Hz), 6.61 (bs, 2 H); - 
13
C-NMR (75 MHz, CDCl3): δ 
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[ppm] = 14.2 (+, 2 C), 40.8 (-, 2 C), 46.9 (-, 2 C), 54.2 (-, 2 C), 60.9 (-, 2 C), 169.0 (Cquat, 2 
C), 181.7 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 2979 (m), 2944 (m), 2870 (m), 1740 (s), 
1496 (m), 1418 (m), 1350 (m), 1261 (m), 1206 (s), 1123 (s), 1026 (m), 861 (m), 805 (m), 661 
(m), 579 (m); - MS (CI-MS, NH3: m/z (%) = 337.2 (100, MH
+
), 354.2 (19, MH4
+
); - MW = 
336.41; - MF = C13H24N2O6S. 
 
 
3-(2-{3-[2-(2-Ethoxycarbonyl-ethoxy)-ethyl]-thioureido}-ethoxy)-propionic acid ethyl ester 
(E-5a) 
O
OO
N
H
O
O O
N
H
S
 
The 3-(2-amino-ethoxy)propionic acid ethyl ester hydrochloride (690 mg, 3.5 mmol) was 
reacted after GP 7 to yield the thiourea as a clear, yellow oil (439 mg, 1.21 mmol, 69 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.20 (t, 6 H, J = 7.1 Hz), 2.51 (t, 4 H, J = 6.0 Hz), 
3.51 – 3.70 (m, 8 H), 3.67 (t, 4 H, J = 6.3 Hz), 4.08 (q, 4 H, J = 7.1 Hz), 6.61 (bs, 2 H); - 
13
C-
NMR (75 MHz, CDCl3): δ [ppm] = 14.2 (+, 2 C), 34.9 (-, 2 C), 44.3 (-, 2 C), 60.7 (-, 2 C), 
66.2 (-, 2 C), 69.5 (-, 2 C), 171.8 (Cquat, 2 C), 182.8 (Cquat, 1 C); - IR (FT-IR, film): ν [cm
-1
] = 
2978 (m), 2942 (m), 2874 (m), 1728 (s), 1546 (m), 146 (m), 1373 (m), 1261 (m), 1189 (s), 
1124 (s), 1064 (m), 860 (m), 802 (m), 659 (m), 603 (m); - MS (CI-MS, NH3: m/z (%) = 364.9 
(100, MH
+
), 381.9 (4, MH4
+
); - MW = 364.46; - MF = C15H28N2O6S. 
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1.7.2.  (2-[N-(2-Ethyloxycarbonylmethyloxyethyl)-N-(2,2,2-
trifluoroacetyl)guanidine]ethyloxy)acetic acid ethyl ester (E-6) 
 
O
O
O
O
O
N
H
O
N
H
S
N
CF
3
O
O
O
N
H
O
O
O
N
H
O
NH
2
CF
3
O
NH
2
+
O
O
N
H
O
O
O
N
H
O
O
O
N
H
O
O
O
N
H
OS
+
E-5a
1.) CH3I
     acetone
2.) NH4PF6
     DCM, MeOH
PF6
-
DBU
toluene, 
CHCl3
reflux
PF6
-1.) K2CO3
     MeOH, 
     H2O
2.) NH4PF6
     MeOH
quant.
E-5b,   n = 2, quant.
E-6,   n = 2, 77% E-7,   n = 2, 90%
n n n n
n n n n
E-10
 
 
To a solution of compound E-5a (364 mg, 1.0 mmol) in acetone (20 mL) methyl iodide  
(0.2 mL, 2.0 mmol) was added and the reaction mixture was stirred at room temperature over 
night under light protection. All volatiles were removed under reduced pressure without 
heating. The residue was dissolved in 30 mL of methanol and dichloromethane (1:1). 
Ammonium hexafluorophosphate (424 mg, 2.6 mmol) was added and the solution was stirred 
over night at room temperature. The solvents were distilled off, the remaining yellow oil was 
taken up in 100 mL of dichloromethane and washed with two 20 mL portions of water. After 
drying over MgSO4, the solvent was evaporated to give the according hexafluorophosphate in 
nearly quantitative yield. 
It was re-dissolved in a mixture of toluene (20 mL) and chloroform (5 mL), DBU (0.45 mL, 
3.0 mmol) and trifluoroacetamide (540 mg, 4.8 mmol) were added. The mixture was refluxed 
over night under vigorous stirring. After cooling to room temperature the solvents were 
distilled off at reduced pressure. The oily raw material was purified by column 
chromatography with ethyl acetate / petrol ether 1:2 to yield the guanidine as clear, yellow oil 
(279 mg, 0.773 mmol, 77 %). 
1
H-NMR (300 MHz, CDCl3): δ [ppm] = 1.25 (t, 6 H, J = 7.1 Hz), 2.61 (m, 4 H), 3.61 (m, 4 
H), 3.72 (m, 4 H), 4.16 (q, 4 H, J = 7.1 Hz), 6.59 (bs, 2 H), 9.67 (bs, 1 H); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 444.0 (100, M+H
+
), 909.3 (6, 2M+Na
+
);  
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Deprotection to the free guanidine: 
The above material (270 mg, 0.75 mmol) was dissolved in methanol (2.0 mL) and a solution 
of potassium carbonate (138 mg, 1.0 mmol) in water (0.5 mL) was added. After warming the 
well stirred mixture to 50 °C for 4 h, the solvents were evaporated. The residue was dissolved 
in a 1:1 mixture of DCM and water (10 mL). The phases were separated and the aqueous 
layer was extracted two times with DCM (5 mL). The combined organic phases were washed 
with brine, dried over MgSO4 and evaporated to dryness. The product E-7 appears as yellow 
oil (232 mg, 0.68 mmol, 90 %). 
 
1
H-NMR (300 MHz, MeOD): δ [ppm] = 1.25 (t, 6 H, J = 7.1 Hz), 2.62 (t, 4 H, J = 6.0 Hz), 
3.11 (t, 4 H, J = 4.9 Hz), 3.67 (t, 4 H, J = 4.9 Hz), 3.76 (t, 4 H, J = 6.0 Hz), 4.16 (q, 4 H, J = 
7.1 Hz); - 
13
C-NMR (75 MHz, MeOD): δ [ppm] = 14.5 (+, 2 C), 35.5 (-, 2 C), 40.5 (-, 2 C), 
61.8 (-, 2 C), 67.5 (-, 2 C), 67.6 (-, 2 C), 160.4 (Cquat, 1 C), 173.7 (Cquat, 2 C); - IR (FT-IR, 
film): ν [cm
-1
] = 3419 (bm), 2986 (m), 2934 (m), 2891 (m), 1670 (s), 1438 (m), 1379 (m), 
1276 (m), 1189 (s), 1123 (s), 1029 (m), 840 (m), 800 (m), 721 (m), 606 (m); - MS (ESI-MS, 
CH2Cl2/MeOH + 10 mmol NH4OAc): m/z (%) = 348.0 (100, MH
+
); 
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2. 1H – and 13C-NMR spectra of selected new compounds 
 
For solvents and conditions of measurement, see experimental procedures. NMR spectra were 
recorded on Bruker Avance spectrometers 300, 400 and 600. Measuring temperature was 300 
K. TMS was used as external standard. 
 
 
Figure S-1: 
1
H-NMR spectrum of compound 7b 
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Figure S-2: 
13
C-NMR spectrum of compound 7b 
 
Figure S-3: 
1
H-NMR spectrum of compound 7a 
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Figure S-4: 
13
C-NMR spectrum of compound 7a 
 
Figure S-5: 
1
H-NMR spectrum of compound 10b 
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Figure S-6: 
13
C-NMR spectrum of compound 10b 
 
Figure S-7: 
1
H-NMR spectrum of compound 10a 
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Figure S-8: 
13
C-NMR spectrum of compound 10a 
 
Figure S-9: 
1
H-NMR spectrum of compound 12b 
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Figure S-10: 
13
C-NMR spectrum of compound 12b 
 
Figure S-11: 
1
H-NMR spectrum of compound 12c 
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Figure S-12: 
13
C-NMR spectrum of compound 12c 
 
Figure S-13: 
1
H-NMR spectrum of compound 12a 
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Figure S-14: 
1
H-NMR spectrum of compound 14b 
 
Figure S-15: 
13
C-NMR spectrum of compound 14b 
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Figure S-16: 
1
H-NMR spectrum of compound 14a  
 
Figure S-17: 
1
H-NMR spectrum of compound 15 
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Figure S-18: 
13
C-NMR spectrum of compound 15 
 
Figure S-19: 
1
H-NMR spectrum of compound 16  
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Figure S-20: 
1
H-NMR spectrum of compound E-2a  
 
Figure S-21: 
13
C-NMR spectrum of compound E-2a  
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Figure S-22: 
1
H-NMR spectrum of compound E-2b  
 
Figure S-23: 
13
C-NMR spectrum of compound E-2b  
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Figure S-24: 
1
H-NMR spectrum of compound 17a 
 
Figure S-25: 
13
C-NMR spectrum of compound 17a 
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Figure S-26: 
1
H-NMR spectrum of compound 19  
 
Figure S-27: 
13
C-NMR spectrum of compound 19 
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Figure S-28: 
1
H-NMR spectrum of compound 21 
 
Figure S-29: 
13
C-NMR spectrum of compound 21 
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Figure S-30: 
1
H-NMR spectrum of compound E-3a 
 
 
 
Figure S-31: 
13
C-NMR spectrum of compound E-3a 
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Figure S-32: 
1
H-NMR spectrum of compound E-3b 
 
 
Figure S-33: 
13
C-NMR spectrum of compound E-3b 
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Figure S-34: 
1
H-NMR spectrum of compound E-4 (left part x2) 
 
 
Figure S-35: 
1
H-NMR spectrum of compound E-5a  
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Figure S-36: 
13
C-NMR spectrum of compound E-5a  
 
 
 
Figure S-37: 
1
H-NMR spectrum of compound E-7  
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Figure S-38: 
13
C-NMR spectrum of compound E-7  
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Figure S-39: 
1
H-NMR NOESY of compound 6, through-the-space contacts marked in red 
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3. Determination of pKa values, simulation of fundamental properties 
The pKa values of the tweezer were determined by pH-titration of 1 mM solutions in water. 
The values for compound 6 were determined with the aid of dilute sodium hydroxide solution, 
for 24 perchloric acid
9
 was used. 
 
Compound pKa (guanidine) pKa (carboxylic acids) 
6 11.5 3.5 
24 ~ 12 4.0 
Table S-1: pKa values of the ligands 
 
Fundamental properties like solubility and polarity, also including the pKa values were 
simulated with ACD Labs program package structure calculator Ver.12.1. The later ones are 
in good accordance to the experimental data. 
 LogD Results
pH LogD
2 -3.3
5.5 -4.72
6.5 -4.77
7.4 -4.77
10 -4.78
1050
-5.5
-5.0
-4.5
-4.0
-3.5
L
o
g
D
 Single-valued Properties
Name Value Error
LogP -1.27 0.73
MW 263.25 -
PSA 140.97 -
FRB 10 -
HDonors 5 -
HAcceptors 9 -
Rule Of 5 1 -
Molar Refractivity, cm^3 58.23 0.5
Molar Volume, cm^3 185.9 7
Parachor, cm^3 509.52 8
Index of Refraction 1.54 4.67e-2
Surface Tension, dyne/cm 56.43 7
Density, g/cm^3 1.42 0.14
Polarizability, 10e-24 cm^3 23.08 0.5
Boiling Point, °C 500.58 60
C ratio 0.5 -
N ratio 0.17 -
NO ratio 0.5 -
Hetero ratio 0.5 -
Halogen ratio 0 -
Num Rings 0 -
Num Aromatic Rings 0 -
Num Rings 3 0 -
Num Rings 4 0 -
Num Rings 5 0 -
Num Rings 6 0 -
1
2 NH
3
NH
4
5
6
7
NH
8
O
9 10
11O
1213
14
O
15
O
16
OH
17
OH
18
 Solubility Results
pH Sol, mg/ml Flags %
2 15.96 BZ 92 / 8
5.5 86.9 A 99
6.5 854.17 A 100
7.4 1000 A 100
10 1000 A 100
1050
250
500
750
1000
S
o
l,
 m
g
/m
l
 pKa Results
Diss. Atom  Acidic/Basic Apparent pKa Value Error
8 MB 11.86 0.7
18 A 3.7 0.1
18 MA 3.1 0.1
4 B -2.39 0.7
 
 
Figure S-40: Simulation of the properties of compound 6 
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 LogD Results
pH LogD
2 -0.83
5.5 -1.92
6.5 -2.26
7.4 -2.31
10 -2.32
1050
-2.5
-2.0
-1.5
-1.0
L
o
g
D
 Single-valued Properties
Name Value Error
LogP 1.18 0.85
MW 305.29 -
PSA 154.09 -
FRB 6 -
HDonors 7 -
HAcceptors 9 -
Rule Of 5 1 -
Molar Refractivity, cm^3 74.9 0.5
Molar Volume, cm^3 189.65 7
Parachor, cm^3 555.57 8
Index of Refraction 1.72 4.67e-2
Surface Tension, dyne/cm 73.65 7
Density, g/cm^3 1.61 0.14
Polarizability, 10e-24 cm^3 29.69 0.5
Boiling Point, °C 679.87 65
C ratio 0.59 -
N ratio 0.23 -
NO ratio 0.41 -
Hetero ratio 0.41 -
Halogen ratio 0 -
Num Rings 2 -
Num Aromatic Rings 2 -
Num Rings 3 0 -
Num Rings 4 0 -
Num Rings 5 2 -
Num Rings 6 0 -
1
2
NH
3
4
NH
5
6
7
NH
8
9
10
11
N
H
12
N
H
13
14
15
16
17
O
18
OH
19
20
OH
21
O
22
 Solubility Results
pH Sol, mg/ml Flags %
2 3.97 B 99
5.5 0.24 AZ 85 / 15
6.5 2.04 A 98
7.4 15.62 A 100
10 603.84 A 100
1050
200
400
600
800
1000
S
o
l,
 m
g
/m
l
 pKa Results
Diss. Atom  Acidic/Basic Apparent pKa Value Error
8 MB 20.25 0.7
12 A 17.33 0.5
13 A 16.7 0.5
19 A 4.74 0.1
21 MA 4.14 0.1
12 B -0.38 0.7
13 B -0.99 0.7
 
 
Figure S-41: Simulation of the properties of compound 24 
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 LogD Results
pH LogD
2 -1.93
5.5 -2.4
6.5 -2.42
7.4 -2.43
10 -2.43
1050
-3.00
-2.75
-2.50
-2.25
-2.00
L
o
g
D
 Single-valued Properties
Name Value Error
LogP 7.23e-2 0.56
MW 182.18 -
PSA 114.99 -
FRB 3 -
HDonors 6 -
HAcceptors 6 -
Rule Of 5 1 -
Molar Refractivity, cm^3 43.89 0.5
Molar Volume, cm^3 114.28 7
Parachor, cm^3 335 8
Index of Refraction 1.69 4.67e-2
Surface Tension, dyne/cm 73.84 7
Density, g/cm^3 1.59 0.14
Polarizability, 10e-24 cm^3 17.4 0.5
Boiling Point, °C 460.9 55
C ratio 0.54 -
N ratio 0.31 -
NO ratio 0.46 -
Hetero ratio 0.46 -
Halogen ratio 0 -
Num Rings 1 -
Num Aromatic Rings 1 -
Num Rings 3 0 -
Num Rings 4 0 -
Num Rings 5 1 -
Num Rings 6 0 -
NH
1
2
3
4
5
6
N
H
7 8
OH
9
O
10
11
NH2
12
NH
13
 Solubility Results
pH Sol, mg/ml Flags %
2 170.06 B 99
5.5 2.36 BZ 3 / 97
6.5 2.29 Z 100
7.4 2.28 Z 100
10 2.31 Z 99
14121086420
80
160
240
320
400
480
S
o
l,
 m
g
/m
l
 pKa Results
Diss. Atom  Acidic/Basic Apparent pKa Value Error
7 A 17.62 0.5
13 MB 13.35 0.7
9 MA 4.41 0.1
7 B -0.7 0.7
12 B -2.94 0.7
 
 
Figure S-42: Simulation of the properties of a fragment of compound 24 
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4. Photophysical properties of glycol-δ-amino acids 
In methanol compounds 7g or 7h have an absorption maximum at 260 nm, the indole 
substituted compounds (7i) at 210 nm and 280. Compounds 7g or 17h (λem = 280 nm; φ = 
0.05
10
) and 7i (λem = 350 nm; φ = 0.15
10
) show emission spectra very similar to the amino 
acids phenylalanine
11
 and tryptophan
11,12
 The absorption and emission properties are only 
marginally affected by the nature of the protection group.  
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Figure S-43: Absorption spectra of compounds 7g, 7i (c = 8.1*10
-5
 and 8.4*10
-5
 mol/L) and 
emission spectra of compounds 7g, 7i (c = 4.1*10
-5
 and 4.0*10
-5
 mol/L) 
 
The imidazo[1,5-a]pyridine derivative 21 shows absorption maxima in methanol at 230 nm, 
280 nm and 380 nm and emits upon excitation at 510 nm with a quantum yield of about φ = 
0.15.
10
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Figure S-44: Absorption spectra of compounds 21 and 16 in comparison (c = 8.3*10
-5
 and 
8.1*10
-5
 mol/L) and the emission spectrum of compound 21 (c = 2.2*10
-5
 mol/L) 
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5. Sample preparation, Fluorescence and UV-vis titrations 
Sample preparation. The exact solutions have been prepared by adding to a weighed amount 
of receptor or substrate, the calculated amount of solvent necessary by means of microliter 
precision pipettes. This method is more accurate than to determine exactly the weighed 
amount (to 10
-5
 g) and admit a certain volume, since the volume measurement has a higher 
accuracy than the weight determination.  
If a solvent mixture 20 % water in methanol was used, the receptor was first dissolved in the 
methanol content of the solvent mixture, then the water content was added lacking 100 µl, to 
have room to adjust the pH. For pH adjusting 0.1 M LiOH or hydrochloric acid of pro analysi 
quality in high-purity water were used. No buffer or salt was added. Thereafter, the water 
difference is filled up to the full volume.   
Receptor solutions were stored properly stoppered and closed with parafilm at maximum for 
one week in the refrigerator at -4 °C. They were freshly prepared every week from deep 
frozen aliquots of the receptor material. Amino acid solutions were kept at -4 °C properly 
stoppered and closed with parafilm for maximal one week. Peptide solutions were always 
freshly prepared from the properly dried and carefully stored material (nitrogen, -20 °C). 
 
 
Absorption spectroscopy.  Absorption  spectra were  recorded  on  a  Varian  Cary  BIO  50 
UV/VIS/NIR  Spectrometer  with temperature  control  by  use  of  a  1  cm  quartz  cuvettes  
(Hellma)  and  Uvasol solvents or of quality for spectrophotometrical investigations (Merck, 
Baker or Acros). 
 
Absorbtion-titrations: 
Solvent:      MeOH or MeOH / H2O 4:1 (vol/vol), pH 6.5 - 7  
Starting volume:     2.0 mL  
Concentration [24]:     0.03 mM  
Concentration [guest]:    20.0 mM  
(Amino acids in 80 % aqueous methanol (pH adjusted, no salt added), n-butylammonium 
chloride and tetrabutylammonium acetate in 80% aqueous methanol (pH adjusted, no salt 
added), DMSO, MeOH) 
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Procedure. The cuvettes have a thickness of 1 cm and were filled with 2 ml solution. As blanc 
sample the pure solvent mixture, 20 % water in methanol, was used.  The cell was temperated 
to 25 °C. The additions were performed using precision microliter pipettes. After each 
addition the solution was given three minutes to reach the new equilibrium before the 
measurement was started. From each titration step UV spectrum in the wavelength range from 
250 to 400 nm was recorded. Prior to the acquisition of spectra a baseline correction was 
performed. At the end of a titration, the pH was checked to exclude protonation reactions. 
For the evaluation of the validity of the Lambert-Beer's a measurement of dilution series was 
conducted. For this a receptor and substrate solution was titrated with aliquots of the solvent 
(pH-adjusted value) under identical experimental conditions.  
 
 
Emission spectroscopy.  Fluorescence measurements were performed with UV-grade solvents 
(Merck, Baker or Acros) in 1 cm quartz cuvettes (Hellma) and recorded on a Varian ‘Cary 
Eclipse’ fluorescence spectrophotometer with temperature control. To determine the binding 
constants and Job´s plots fluorescence titration experiments were carried out. 
  
Emission-titrations: 
Solvent:      MeOH or MeOH / H2O 4:1 (vol/vol), pH 6.5 - 7  
Starting volume:     1.5 mL  
Concentration [24]:     0.03 mM  
Concentration [guest]:    20.0 mM  
(Amino acids in 90 % aqueous methanol (pH adjusted, no salt added), n-butylammonium 
chloride and tetrabutylammonium acetate in 90 % aqueous methanol (pH adjusted, no salt 
added), DMSO, MeOH) 
 
Instrument Parameters. 
Excitation wavelength:   λex = 270 nm  
Detection wavelength:   λ = 290 – 510 nm  
Temperature:     T = 298 K 
PMT voltage      700 volts     
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Procedure: To a cuvette with 1.5 mL of the receptor in 80 % aqueous methanol (pH adjusted, 
no salt added), DMSO or MeOH were added 10 µL (≙ 1 eq.) aliquots of the amino acid or 
peptide solution (pH adjusted) or it was titrated stepwise with small amounts 5  –  100  µL, 
depending  on  the  initial emission  response, of the  substrate solution. After each addition 
the solution was allowed to equilibrate for 5 min before the fluorescence intensity was 
recorded. The stoichiometry was determined by Job´s plot analysis extracted from titration 
data.
13
 
To determine the binding constant the obtained fluorescence intensities were volume 
corrected, plotted against the concentration of peptide and evaluated by non linear fitting 
methods. 
The pH value of aqueous methanol solvent was checked before and after every titration with 
the aid of a suitable pH electrode. Measurements with the pH differing more than one units 
before and after the titrations were not used. 
 
 
5.1. Titrations with tetrabutylammonium acetate 
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Figure S-46: Emission titration of compound 23 with tetrabutylammonium acetate in 
methanol (left) and methanol / water 4:1 (right); Inserts: Job´s Plots 
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Figure S-47: 
1
H-NMR titration of compound 22b (left, guanidinium proton traced) and 23 
(right, pyrrole proton in 4-position traced) with tetrabutylammonium acetate 
in DMSO  
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Figure S-48: Emission titration of compound 24 with tetrabutylammonium acetate in 
methanol (left) and methanol / water 4:1 (right); Inserts: Job´s Plots 
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5.2. Titrations with amino acids 
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Figure S-49: Emission titration of compound 24 with glycine (left) and β-alanine (right) in  
                       Methanol / water 4:1 
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Figure S-50: Emission titration of compound 24 with γ-aminobutyric acid in methanol / 
water 4:1 
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